Classification and evaluation strategies of auto-segmentation approaches for PET: report of AAPM task group No. 211 by Hatt, M et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/96683/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Hatt, M, Lee, J, Schmidtlein, C R, Naqa, I. El, Caldwell, C., De Bernardi, E., Lu, W., Das, S.,
Geets, X., Gregoire, V., Jeraj, R., MacManus, M., Mawlawi, O., Nestle, U., Pugachev, A., Schöder,
H., Shepherd, T., Spezi, Emiliano, Visvikis, D., Zaidi, H. and Kirov, A.S. 2017. Classification and
evaluation strategies of auto-segmentation approaches for PET: report of AAPM task group No.
211. Medical Physics 44 (6) , e1-e42. 10.1002/mp.12124 file 
Publishers page: http://dx.doi.org/10.1002/mp.12124 <http://dx.doi.org/10.1002/mp.12124>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
 1 
 
Classification and evaluation strategies of auto-segmentation 
approaches for PET: Report of AAPM Task Group No. 211 
 
M. Hatt1, J. Lee2, C.R. Schmidtlein3,  I. El Naqa4, C. Caldwell5, E. De Bernardi6,  W. Lu3, S. 
Das7, X. Geets2, V. Gregoire2,  R. Jeraj8, M. MacManus9,  O. Mawlawi10, U. Nestle11, A. 5 
Pugachev12, H. Schöder3, T. Shepherd13, E. Spezi14, D. Visvikis1,H. Zaidi15, A.S. Kirov3* 
 
 
1
 INSERM, UMR 1101, LaTIM, University of Brest, IBSAM, Brest, France 
 
2
 Université catholique de Louvain (IREC/MIRO) & FNRS, 1200 Brussels, Belgium 10 
  
3
 Memorial Sloan-Kettering Cancer Center, New York, NY 10065 
 
4
 University of Michigan, Ann Arbor, MI, 48103 
 15 
5
 Sunnybrook Health Sciences Center, Toronto, ON M4N 3M5, Canada 
 
6
 University of Milano-Bicocca, Monza, Italy  
 
7
 University of North Carolina, Chapel Hill, NC 27599 20 
 
8
 University of Wisconsin, Madison, WI 53705 
 
9
 Peter MacCallum Cancer Centre, Melbourne, Australia 
 25 
10
 MD Anderson Cancer Center, Houston, TX 77030 
 
11
 Universitätsklinikum Freiburg, 79106 Freiburg, Germany 
 
12
 University of Texas Southwestern Medical Center, Dallas, TX 75390 30 
 
13Turku University Hospital, 20521 Turku, Finland  
 
14
 School of Engineering, Cardiff University, Cardiff, Wales, United Kingdom 
 35 
15
 Geneva University Hospital, Geneva, CH-1211, Switzerland 
 
-------------------------------------------------- 
*Corresponding author 
Department of Medical Physics, 40 
Memorial Sloan-Kettering Cancer Center 
1275 York Avenue 
New York, NY  10065 
Tel.: (212) 639-7126 
Fax: (212) 717-3010 45 
E-mail: kirova@mskcc.org  
 2 
 
Abstract 
 
Purpose: The purpose of this educational report is to provide an overview of the 
present state-of-the-art PET auto-segmentation (PET-AS) algorithms and their respective 50 
validation, with an emphasis on providing the user with help in understanding the challenges 
and pitfalls associated with selecting and implementing a PET-AS algorithm for a particular 
application.  
Approach: A brief description of the different types of PET-AS algorithms is provided 
using a classification based on method complexity and type. The advantages and the 55 
limitations of the current PET-AS algorithms are highlighted based on current publications 
and existing comparison studies. A review of the available image datasets and contour 
evaluation metrics in terms of their applicability for establishing a standardized evaluation of 
PET-AS algorithms is provided. The performance requirements for the algorithms and their 
dependence on the application, the radiotracer used and the evaluation criteria are described 60 
and discussed. Finally, a procedure for algorithm acceptance and implementation, as well as 
the complementary role of manual and auto-segmentation are addressed. 
Findings: A large number of PET-AS algorithms have been developed within the last 
20 years. Many of the proposed algorithms are based on either fixed or adaptively selected 
thresholds. More recently, numerous papers have proposed the use of more advanced 65 
image analysis paradigms to perform semi-automated delineation of the PET images. 
However, the level of algorithm validation is variable and for most published algorithms is 
either insufficient or inconsistent which prevents recommending a single algorithm. This is 
compounded by the fact that realistic image configurations with low signal-to-noise ratios 
(SNR) and heterogeneous tracer distributions have rarely been used. Large variations in the 70 
evaluation methods used in the literature point to the need for a standardized evaluation 
protocol.   
Conclusions: Available comparison studies suggest that PET-AS algorithms relying on 
advanced image paradigms provide generally more accurate segmentation than approaches 
based on PET activity thresholds, particularly for realistic configurations. However, this may 75 
not be the case for simple shape lesions in situations with a narrower range of parameters, 
where simpler methods may also perform well. Recent algorithms which employ some type 
of consensus or automatic selection between several PET-AS methods have potential to 
overcome the limitations of the individual methods when appropriately trained. In either case, 
accuracy evaluation is required for each different PET scanner and scanning and image 80 
reconstruction protocol.  For the simpler, less robust approaches adaptation to the scanning 
conditions and the tumor type and location by potential adjustment of parameters is highly 
recommended. The results from the method evaluation stage can be used to estimate the 
contouring uncertainty. All PET-AS contours need to be critically verified by a physician. A 
standard test, i.e., a benchmark dedicated to evaluating both existing and future PET-AS 85 
algorithms needs to be designed, in order to aid clinicians in evaluating and selecting PET-
AS algorithms and to establish performance limits for their acceptance for clinical use. The 
initial steps towards designing and building such a standard are undertaken by the task 
group members.  
  90 
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I. INTRODUCTION  
 
Positron emission tomography (PET) has the potential to improve the outcome of cancer 
therapy because it allows the identification and characterization of tumors to be conducted 140 
based on their metabolic properties1, which are inherently tied to cancer biology. PET is 
helpful in delineating the tumor target for radiation therapy, in quantifying tumor burden for 
therapy assessment, in determining patient prognosis and in detecting and quantifying 
recurrent or metastatic disease. This is especially true when the cancer lesion boundaries 
are not easily distinguished from surrounding normal tissue in anatomical images. Combined 145 
PET/CT (computed tomography) provides both anatomical/morphological and functional 
information in one imaging session. In addition to segmentation, this allows for the division of 
the tumors into subregions based on metabolic activity, which could potentially be used to 
treat/evaluate these subregions differentially (e.g., by increasing the dose to the more 
aggressive and radioresistant sub-volumes, an approach known as “dose painting”2). 150 
Accurate delineation of the metabolic tumor volume in PET is important for predicting and 
monitoring response to therapy. Apart from standardized uptake value (SUV) measurements, 
3,4
 other parameters (e.g., total lesion glycolysis (TLG) or textural and shape features,  as 
well as tracer kinetic parameters) with complementary/additional predictive/prognostic value 
can be extracted from PET images. 155 
For radiation therapy, leaving parts of the tumor untreated, because its extent is 
underestimated by anatomic imaging, or conversely irradiating healthy tissue because 
boundaries between the tumor and the adjacent normal tissue cannot be defined, can result 
in suboptimal response and/or (possibly severe) adverse side-effects. It has been shown in 
several clinical studies that PET, using the [18F]2-fluoro-2-deoxy-D-glucose  160 
(Fluorodeoxyglucose) radiotracer (18F-FDG PET), has led to changes in clinical management 
for about 30% of patients5-7. Other studies, involving non-small-cell lung cancer (NSCLC)8, 9, 
10
  and head and neck (H&N) cancer11 have demonstrated that the incorporation of PET 
imaging in radiotherapy planning can result in significant changes (either increase or 
decrease) in treatment volumes.  165 
In addition, the quantitative assessment of the metabolically active tumor volume, may 
provide independent prognostic or predictive information. This has been shown in several 
malignancies, including locally advanced esophageal cancer12, non-Hodgkin lymphoma13, 
pleural mesothelioma14, cervical and H&N cancers15  and lung cancer16.  
These promising data impose the need to establish and validate algorithms for the 170 
segmentation of PET metabolic volumes before and during treatment. The gross tumor 
volumes (GTV) defined by PET are intended to contain the macroscopic extend of the 
tumors. Currently, inaccuracies in defining PET-based GTV arise from variations in the 
biological processes determining the radiotracer uptake, as well as from physical and image 
acquisition phenomena  which affect the reconstructed PET images4, 17-22. Furthermore, 175 
uncertainty can be introduced by the segmentation process itself. It has been shown that 
volume differences of up to 200% can arise from using different GTV contouring algorithms23.  
Regardless of these uncertainties, many radiation oncology departments have started 
using PET/CT for lesion delineation in radiation treatment planning (RTP)1, 7-9, 11,24. Numerical 
auto-segmentation techniques can be used for guidance in the delineation process, have 180 
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been shown to reduce intra- and inter-observer variations25, 26 and some commercial vendors 
are now offering tools for semiautomatic delineation of tumor volumes in PET images for 
radiotherapy planning or response assessment. While these approaches may work 
reasonably well when applied in conjunction with anatomical imaging and clinical expertise, 
their accuracy and limitations have not been fully assessed.  185 
Due to the complexity of the problem of PET based tumor segmentation and due to the 
abundance of potentially applicable numerical approaches, a large variety of automatic, 
semiautomatic and combined PET-AS approaches have been proposed over the past 20 
years27-30 Multiple semiautomatic approaches derived from phantom data as well as fully 
automated algorithms differing in terms of the algorithmic basis, fundamental assumptions, 190 
clinical goals, workflow, and accuracy have been proposed. In addition, algorithms for 
segmenting combinations of images from PET and other imaging modalities have appeared 
in literature31-34. The majority of these approaches have been tested on either simplistic 
phantom studies or patient datasets where the ground truth is largely unknown. Finally, only 
a few of these algorithms have been tested for their ability to segment lesions with irregular 195 
shapes or non-uniform activity distributions, which are essential for the implementation of 
accurate delineation protocols. In addition, most methods have been evaluated using 
different datasets and protocols, which makes comparing the results difficult, even 
impossible. As a result, in essence, there is currently no commonly adopted technique for 
reliable, routine, clinical PET image auto-segmentation.  200 
In this educational report we provide a description with examples of the main classes of 
PET-AS algorithms (section II), highlight the advantages and the limitations of the current 
techniques (section III) and discuss possible evaluation approaches (section IV). In that 
section the types of available image datasets and the existing approaches for contour 
evaluation are discussed with the intention of laying out a basis for a standard for effective 205 
evaluation of PET auto-segmentation algorithms. The clinician interested in the practical 
aspects of PET segmentation may find most useful section V, which highlights the biological, 
physiological and image acquisition factors affecting the performance of the PET-AS 
methods, as well as preliminary guidelines for their acceptance and implementation. 
  210 
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II. DESCRIPTION AND CLASSIFICATION OF THE ALGORITHMS 
 
The following is a glossary of the abbreviation, definitions and notations used in this 
report: 215 
Abbreviations: 
ARG – Adaptive Region Growing 
ATS – Adaptive Threshold Segmentation 
BTV – Biological Target Volume 
CT – Computed Tomography 220 
CTV – Clinical Target Volume 
DSC - Dice Similarity Coefficient 
FTS – Fixed Threshold Segmentation 
EM – Expectation Maximization 
FCM - Fuzzy C-Means 225 
FDG – [18F]2-fluoro-2-deoxy-D-glucose  (Fluorodeoxyglucose) 
FLT – 18F-3′-fluoro-3′-deoxy- L-thymidine 
F-MISO – 18F-fluoromisonidazole  
FOM – Figure of Merit 
GTV – Gross Tumor Volume 230 
H&N – Head and Neck 
ML - Maximum Likelihood 
MRI – Magnetic Resonance Imaging 
MVLS – Multi Valued Level Sets 
NEMA - National Electrical Manufacturers Association 235 
NSCLC – Non-Small Cell Lung Cancer 
PET – Positron Emission Tomography 
PET-AS – PET Auto - Segmentation  
PPV - Positive Predictive Value 
PSF – Point Spread Function 240 
PTV - Planning Target Volume 
PVE – Partial Volume Effect 
ROC - Receiver Operating Characteristic 
SNR – Signal to Noise Ratio 
 245 
Definitions: 
ROI (Region of Interest): A 2D or 3D region drawn on an image for purposes of restricting 
and focusing analysis to its contents. It is closely related to and often used interchangeably 
with volume of interest (VOI). 
SUV (Standardized Uptake Value): A measure of the intensity of radiotracer uptake in an 250 
object (lesion or body region) or region of interest; measured activity in that region is 
normalized to the injected activity and some measurement of patient size, most commonly 
weight (mass).  
TLG (Total Lesion Glycolysis):  The integral of the FDG-SUV over the volume, also equal to 
the product of the mean FDG-SUV and the volume. The same paradigm can be applied to 255 
other radiotracers and is called for instance Total Proliferative Volume, or Total Hypoxic 
Volume in the case of FLT or FMISO, respectively. 
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VOI (Volume of Interest): A 3D region defined in a set of images for purposes of restricting 
and focusing analysis to its contents. It is closely related to and often used interchangeably 
with region of interest (ROI). 260 
 
Notation: φሺ ሻ: The objective function (see appendix). hሺ ሻ: The constraint equations (see appendix). ܫ: The image set. 265 ܫ�ை�: The VOI in image set ܫ that the segmented region is taken from. I⏞: The segmented region from image set ܫ.
 ܫ௜: The intensity of the �th element (image pixel) from image set ܫ. This element is commonly 
normalized with respect to activity and weight to SUV but can be further normalized. �௜: Normalized uptake for the �th voxel (see appendix). 270 ܶ(Threshold): Commonly used in threshold segmentation. It defines the value at which a 
voxel is segregated between one set and another. ܶ∗ (Threshold): The estimated segmentation threshold. �ሺܶሻ: Volume as a function of threshold. �௞௡௢௪௡: The known volume of a segmented object. 275 �௜:  The position of the �th voxel. ܿ௞௡: The cluster center of the ݇th cluster at the �th iteration. �௜௞௡ : The membership probability of the �th pixel in the ݇th cluster at the �th iteration. � : The number of images sets/modalities. ܿ௜+/−: The internal/external (+/-) mean intensities of the enclosed contour region at level set 280 
= 0 in the �th image set. λi+/-: User defined importance weights for inclusion/exclusion (+/-) from a region defined by 
the enclosed contour at level set in the �th image set. � : A level set function. Ω: The domain of the image. 285 
II.A. Possible classifications  
 The first objective of this document is to provide introductory information about the 
different classes of PET auto-segmentation (PET-AS) algorithms. Classifications of PET-AS 
algorithms can be based on several different aspects: 
1. The segmentation/image processing algorithm employed and its assumptions and 290 
complexity; 
2. The use of pre- and post- processing steps; 
3. The level of automation; 
 The first classification, relying on the type of image segmentation paradigm (e.g., 
simple or adaptive thresholding, active contours, statistical image segmentation, clustering, 295 
etc.), has been used in previous reviews27, 29, 35, 36. In most cases, detailed descriptions of the 
numerical algorithms and their assumptions and limitations are given.  
 The second classification is based on the use of pre- and post- processing steps. Most 
algorithms do not use pre-processing steps, although some use either denoising or 
deconvolution image restoration techniques before the segmentation or as part of the 300 
algorithm itself37, 38. Other algorithms require either an image-based database28, 39, 40 to build 
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a classifier (i.e. learning algorithms), or phantom acquisitions for the optimization of 
parameters (i.e. adaptive threshold algorithms). 
 Regarding the third classification based on automation, Udupa, et al.41 divide image 
segmentation into two processes: recognition and delineation, and point to the “essential” 305 
need of “incorporation of high level expert knowledge into the computer algorithm, especially 
for the recognition step.” For this reason, most existing algorithms rely on the identification of 
the tumor first, by the user drawing a volume of interest (VOI) around the tumor to delineate 
(denoted from here onwards as “standard user interaction”, see Table 1), whereas other 
approaches require the identification of the tumor after the segmentation process in the 310 
resulting map (e.g., Belhassen, et al.28). Other examples of manual interaction are user-
definition of background regions (used by some of the adaptive threshold algorithms), 
manual selection of markers to initialize the algorithm 42, or the manual input of parameters in 
case of failure of the automatic initialization43. Furthermore, the level of automation can be 
quite difficult to assess, as factors such as the requirement of building a classifier for each 315 
image region, the individual optimization for each combination of scanner 
system/reconstruction algorithm, the selection and validation of the parameters of the 
optimization approach, or finally, the detection of lesions to segment, are usually not included 
in these assessments. In practice, all algorithms require some level of user interaction. 
 In the following section we used the first classification scheme with emphasis on the 320 
algorithm complexity.  
II.B. Classes of algorithms for PET auto-segmentation 
II.B.1 Fixed and Adaptive Threshold algorithms  
Segmentation via a threshold is conceptually very simple. It consists of defining a 
specific uptake (often expressed as a fixed fraction or percentage of SUV) between the 325 
background and imaged object’s intensities (tracer uptake) and then using that intensity to 
partition the image and recover the true object’s boundaries. All voxels with intensities at or 
above the threshold are assigned to one set while the remaining voxels are assigned the 
other. The details of how the threshold and the uptake values are normalized, as well as the 
minimization problem, are discussed in Appendix I. 330 
The decision to use threshold segmentation is generally based upon its simplicity and 
the ease of implementation. Threshold segmentation carries a number of implied 
assumptions that should be understood and accounted for. These are:  The true object has a well-defined boundary and uniform uptake near its boundary, 
i.e., the image is bi-modal. 335  The background intensity is uniform around the object.  The noise in the background and in the object is small compared to the intensity 
change at the tumor edge.  The resolution is constant near the edges of the object.  The model, used to define the threshold, is consistent with its application, e.g., a 340 
segmentation scheme designed for measuring tumor volume may not be appropriate 
for radiation therapy and vice versa (see section V.A).  
In practice, these assumptions rarely hold and some effort is required to determine their 
validity/acceptability in the context of the intended application.   
 345 
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Several points above are illustrated in a review of PET segmentation by Lee29. In this 
review, the effect of the thickness of the phantom wall on estimating the segmentation 
threshold and the dependence of this effect on the Point Spread Function (PSF) of the PET 
scanner, were shown via mathematical analysis. This work also showed that to obtain the 
correct threshold on a phantom with cold walls (a certain thickness of material without any 350 
uptake, such as the plastic surrounding spheres in physical phantoms), a lower threshold is 
required than for the case without walls, and that due to the limited PET spatial resolution, 
small volumes require larger thresholds. This was further investigated recently, 
demonstrating the important impact of cold walls on the segmentation approaches, and the 
potential improvement brought by thin-wall inserts 44 45. A similar result was shown by Biehl, 355 
et al. 46, who concluded that for NSCLC the optimal threshold for their specific scanner and 
protocol was related to volume as shown in Appendix I. Finally, it is interesting to note that, 
given knowledge of the local PSF and the assumption of uniform uptake, the threshold for the 
lesion’s boundary can be estimated analytically, with the result being independent from the 
tumor to background ratio, provided the background has been subtracted beforehand47. 360 
Generally, threshold segmentation can be loosely categorized into two separate 
categories: fixed threshold segmentation (FTS) and adaptive threshold segmentation (ATS). 
In FTS a general test/model of the problem is developed and a set of parameters is 
estimated by minimizing the error of the model in order to deduce an “optimal” threshold, ܶ∗. 
The threshold value may be dependent or not (e.g. 42% of peak lesion activity48  or 365 
SUV=2.549) on the tumor to background ratios. Other tumor or image aspects are generally 
ignored. For ATS, an objective function is chosen that generates a threshold based upon the 
properties of each individual tumor/object and PET image. In this case, rather than 
depending on simple measures, such as tumor to background ratio, the threshold calculation 
depends upon an ensemble of lesion properties such as volume 46, 48, 50, 51 or SUV mean-370 
value52, and thus makes the threshold segmentation process iterative. 
Both FTS and ATS have been discussed in several recent literature reviews of general 
segmentation in PET29, 36, 39, 53  Each of these reviews provides a fairly complete literature 
survey of the state of various threshold segmentation algorithms. In addition, the review by 
Zaidi and El Naqa53 provides a brief description and summary of the rationale of many ATS 375 
algorithms. These are summarized in Table A1 of Appendix I.  
 
II.B.2. Advanced algorithms 
A list of some of the advanced PET-AS algorithms published is given in Table 1, with 
a focus on the evaluation protocols that were followed. Below they are divided into three 380 
subcategories (advanced algorithms applied directly to PET images, approaches combined 
with image processing or reconstruction, and those dealing with multiple imaging modalities), 
which are discussed in separate subsections B.2 to B.4. 
II.B.2. a) Gradient-based segmentation 
The underlying assumption in threshold-based delineation (II.B.1) is that the uptake 385 
within the target is significantly different from that in the background. With this idea in mind, 
the gradient naturally finds the transition contour that delineates a high-uptake volume from 
the surrounding low uptake regions. The immediate advantage of this alternative method is 
that uptake inside and outside the target need not be uniform for successful segmentation, 
nor need it be constant along the contour. 390 
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In practice, the method consists of computing the gradient vector for each voxel and 
then using it to form a new image composed of the gradient magnitude values. Segmentation 
based on gradient information is an important part of what the human visual system does 
when looking at natural scenes. The difficulty lies in interpreting the gradient image in order 
to translate the relevant information into target contours. The general idea is to locate and 395 
follow the crests of the gradient magnitude. The points where the gradient is the largest in 
magnitude (where the second derivative, or Laplacian, is null) correspond to the target 
contours. There are several ways to locate the crests. For instance, adaptive contours or 
“snakes“ with various smoothness constraints can be programmed in such a way that the 
contours are attracted towards the crest.54 Another very popular way to track the gradient 400 
crests is the watershed transform. It considers the gradient image as a landscape in which 
the gradient crests are mountain chains. Then it “floods” the landscape and keeps a record of 
the boundaries of all hydrographic basins that progressively merge as the water level rises. 
The hierarchy of all basins can be displayed as a tree in a dendrogram. Clustering tools can 
help in identifying the branch that gathers all basins corresponding to the target. 405 
The quality of gradient-based segmentation depends on the accuracy and precision of 
the gradient information, which can be biased by spatial resolution blur. For objects with a 
concave or convex surface, the uptake spill-in and spill-out caused by blur tends to slightly 
shift, smooth, and distort the real object boundary. This effect can be partially compensated 
for with deblurring methods, such as deconvolution algorithms and some tools for Partial 410 
Volume Effect (PVE) correction. The gradient computation also amplifies the image noise. 
Therefore, denoising tools are needed as well, provided they do not decrease the image 
resolution. 
The algorithm described by Geets, et al.37 relies on deblurring and denoising tools prior 
to segmentation. The deblurring parameters are adjusted according to the resolution of the 415 
PET system and are therefore PET-camera dependent. The watershed transform is applied 
to the gradient magnitude image and a clustering technique creates a hierarchy of basins. 
The user can choose the tree branch associated with the high-uptake region in the images 
expected to correspond to the target volume. In the case of a low signal-to-background ratio 
(surrounding inflammation, other causes of tracer concentration, uptake reduction due to 420 
treatment), the hierarchy can get more complicated and the branch corresponding to the 
target volume might be difficult to isolate. This usually indicates that the images do not 
convey enough information for the target volume to be accurately delineated. This approach 
has been validated using phantom PET acquisitions as well as clinical datasets of both 
H&N37 and lung55 tumors with tri-dimensional (3D) histopathology reconstructions as ground 425 
truths.  
II.B.2. b) Region growing and adaptive region growing   
Region growing algorithms start from a seed region inside the object and progressively 
include the neighboring voxels to the region if they satisfy certain similarity criteria56-58. 
Similarity is often calculated based on image intensity, but can be based on other features 430 
such as textures. Let I(x) represent the image intensity at x. The similarity criteria can be a 
fixed interval: I(x)  [lower, upper], or a confidence interval: I(x)  [m - f, m + f], where m 
and  are the mean intensity and standard deviation of the current region, and f is a factor 
defined by the user58. Region growing with a fixed interval is essentially a connected 
threshold algorithm. Small f restricts the inclusion of voxels to only those having very similar 435 
intensities to the mean in the current region, and thus can result in under growth. Large f 
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relaxes the similarity criteria, and thus may result in over growth into neighboring regions. It is 
often difficult, if not impossible to identify experimentally an optimal f for all objects. For 
example, four different f values were experimentally determined based on the maximum 
intensity and its location using phantoms by Day, et al.59. The authors noted that these f 440 
values are specific to their clinic.  
To overcome this limitation, an adaptive region growing (ARG) algorithm that can 
automatically identify f for each specific object in PET was proposed by Li, et al.54. As 
illustrated in Fig. 1, in ARG f is varied from small to large values so that the grown volume 
changes from the small seed region to the entire image. A sharp volume increase occurs at a 445 
certain f* where the region grows just beyond the object (hot phantom or tumor) into the 
background (warm water or normal tissue). Because the background typically consists of 
large homogeneous regions, a great number of voxels are added to the current region at this 
transition point. The ARG algorithm automatically identifies f* for which the volume would be 
increased by more than 200% at the next iterative value of f. The resulting volume V* was 450 
proven to be quite an accurate representation of the homogeneous object. The quality of the 
segmentation performed by ARG depends mainly on the homogeneity of the background and 
the contrast between the tumor and background. The performance of ARG in segmenting 
tumors with various levels of heterogeneous uptake still needs to be studied. The ARG 
algorithm does not have any parameters that require experimental determination. It uses the 455 
intrinsic contrast between a tumor and its neighboring normal tissue in each image to 
determine the tumor boundary. Therefore, it can be directly applied to various imaging 
conditions such as different scanners or imaging protocols. 
 
 460 
                  (a)       (b)             
   
         (c)           (d) 
Fig.1. An illustration of applying the adaptive region growing (ARG) algorithm to PET: (a) plot 
of segmented volume growing as a function of f, the arrow indicates the location of the 465 
transition point f* for a spherical lesion in a PET/CT of a phantom (b): the thin blue contour 
indicates the delineated volume V*. (c) - (d) selection of f* and results for an esophageal 
tumor. 
f* 
f* 
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Another approach based on adaptive region growing has been recently proposed by 
Hofheinz, et al.60, in which the approach was made able to deal with heterogeneous 470 
distributions. The method is based on an adaptive threshold, in which instead of a lesion-
specific threshold for the whole ROI, a voxel-specific threshold is computed locally in the 
close vicinity of the voxel. The absolute threshold Tabs for the considered voxel is then 
obtained based on a parameter T previously determined with phantom measurements 
(T=0.39): Tabs=T×(R-Bg)+Bg, where R is a tumour reference value (e.g., ROI maximum) and 475 
Bg is the background. Region growing algorithms use statistical properties (mean and 
standard deviation) of the region to stop the iterative process59. The algorithms, which exploit 
the statistical properties of a noisy function and a noisy argument and rely on probabilistic 
calculations, are described in the next subsection.  
 Table 1. Summary of the main characteristics of some representative advanced PET-AS 480 
algorithms (not an exhaustive list) and their respective evaluation. 
Reference(s) 
Image 
segmentation 
paradigm(s) used 
User 
interaction 1 
Pre- and post-
processing steps 
Aimed 
application2 
Validation data 
and ground truth 
3
 
Accuracy 
evaluation 
on realistic 
tumors5 
Robustness 
evaluation6 
Repeatability 
evaluation 
Tylski, et al. 
2006 61  Watershed 
Std + multiple 
markers 
placement 
None Global PA(1): Vol. and CiTu images No No No 
Werner-
Wasik, et al. 
2012 62 
Gradient-based 
Std  + 
initialization 
using drawn 
diameters 
Unknown Global PA(5): Diam. 31 MCST: Vol. Yes Yes Yes 
Geets, et al. 
200737 Gradient-based 
Std  + 
initialization 
Denoising and 
deconvolution 
steps 
Global 
PS(1) and PA(1): 
Vol. + Diam. 
7 CiTuH: 
Complete 
No No No 
El Naqa, et al. 
200863 
 
AT + active 
contours 
Std + several 
parameters to 
set 
None Global PA(1): Vol. 1 CiTu - Ø Yes No Yes 
El Naqa, et al. 
200731 
Multi-modal 
(PET/CT) active 
contours 
Std  + 
initialization of 
the contour 
shape, selection 
of weights 
Normalization and 
registering of PET 
and CT images, 
deconvolution of 
PET images. 
GTV definition 
on  PET/CT 
PA(1): Vol. 
2 CiTu: MC(1), FT Yes No No 
Dewalle-
Vignion, et al. 
201164 
Possibility theory 
applied to MIP 
projections 
Std  None  Global 
PA(1): Vol. 
5 MCST: Vox. 
7 CiTuH: 
Complete 
Yes No No 
Belhassen 
and Zaidi 
201028 
Improved Fuzzy C-
Means (FCM) 
A posteriori 
interpretation of 
resulting classes 
in the 
segmentation of 
entire image 
Denoising, wavelet 
decompositions Global 
3 AST: Vox. 
21 CiTuH: Diam. 
7 CiTuH: 
Complete 
Yes No No 
Aristophanous
, et al. 200765 
Gaussian mixture 
modeling without 
spatial constraints 
Std  + 
initialization of 
the model and 
selection of the 
number of 
classes 
None Pulmonary tumors 7 CiTu: Ø No No Yes 
Montgomery, 
et al. 200766 
Multi scale Markov 
field segmentation 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image 
Wavelet 
decompositions Global 
PA(1) : Vol. 
3 CiTu: Ø No No No 
Hatt, et al. 
200767 
Fuzzy Hidden 
Markov Chains Std  None Global 
PS(1) and PA(2): 
Vox. No No No 
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Hatt, et al. 
200968, 2010 
69
,201143 
Fuzzy locally 
adaptive Bayesian Std None Global 
PS(1) and PA(4): 
Vox. 
20 MCST: Vox. 
18 CiTuH: Diam. 
 Yes Yes Yes 
Day, et al. 
200959 
Region growing 
based on mean 
and SD of the 
region 
Std + 
optimization on 
each scanner 
None  Rectal tumors 18 CiTu: MC(1) No No No 
Yu, et al. 
200940, 
Markel, et al. 
201370 
Decision tree built 
based on learning 
of PET and CT 
textural features 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image 
Learning for 
building  the 
decision tree 
GTV definition 
of H&N and 
lung tumors 
10 CiTu: MC(3) 
31 CiTu: MC(3) No No No 
Sharif, et al. 
201071, 201272 Neural network 
A posteriori 
interpretation of 
resulting 
segmentation on 
the entire image. 
Learning for 
building the neural 
network 
Global 
PA(1): Vol. 
3 AST: Vox. 
1 CiTuH: Diam. 
No No Yes 
Sebastian, et 
al. 200673 
Spherical Mean 
shift Std  
Resampling in a 
different spatial 
domain 
Global 280 AST: Vox. No No No 
Janssen, et 
al. 200974 
Voxels 
classification based 
on time-activity 
curve 
Std  + 
Initialization and 
choice of the 
number of 
classes 
Only on dynamic 
imaging, denoising 
and deconvolution 
steps 
Rectal tumors 
in dynamic 
imaging 
PA(1): Vol. + 
Diam. 
21 CiTu: MC(1) 
No No No 
De Bernardi, 
et al. 201075 
Combined with 
PVE (image 
reconstruction) 
Std + 
initialization 
PSF model of the 
scanner and 
access to raw data  
required 
Global PA(1): Vol. No Yes No 
Bagci, et al. 
201333 
Multimodal random 
walk Std 
Multimodal images 
registration 
Global for 
PET/CT or 
PET/MR 
77 CiTu: MC(3) 
PA(1) Yes No No 
Onoma, et al. 
2014 76 
Improved random 
walk Std None Global PA(1), 4 AST: 
Vox, 14 CiTu: 
MC(2) 
Yes No No 
Song, et al. 
201332 
Markov field + 
graph cut Std None Global 3 CiTu: MC(3) Yes No No 
Hofheinz, et 
al. 201360 
Locally adaptive 
thresholding 
Std + one 
parameter to 
determine on 
phantom 
acquisitions 
None Global 30 AST: Vox. Yes No No 
Abdoli, et al. 
201377 Active contour 
Std + several 
parameters to 
optimize 
Wavelet 
decompositions Global 
1 AST: Vox. 
9 CiTuH: 
Complete. 
3 CiTuH: 
Complete 
2 CiTuH: 
Complete 
No Yes No 
Mu, et al. 
2015 78 
Level set combined 
with PET/CT Fuzzy 
C-Means 
Std None Specific to 
cervix 
7 AST: Vox, 27 
CiTu: MC(2) Yes No No 
Cui, et al. 
2015 79 
Graph cut 
improved with 
topology modeling 
Std + one free 
parameter 
previously 
optimized 
PET/CT 
registration 
Specific to lung 
tumors and 
PET/CT 
20 PA(1), 40 
CiTu(2) Yes No No 
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Lapuyade-
Lahorgue, et 
al. 2015 80 
Generalized fuzzy 
c-means with 
automated norm 
estimation 
Std None Global 
PA(4): Vol. 
34 MCST: Vox. 
9 CiTu: MC(3). Yes Yes Yes 
Devic et al, 
2016 81  
Differential uptake 
volume histograms 
for identifying 
biological target 
sub-volumes 
Selection of 
three ROIs 
encompassing  
PET avid area; 
iterative 
decomposition 
of differential 
uptake 
histograms into 
multiple 
Gaussian 
functions 
None 
Isolation of 
glucose 
phenotype 
driven 
biological sub-
volumes 
specific to 
NSCLC,  
None No No No 
Berthon et al, 
2016 82 
Decision tree 
based learning 
using nine different 
segmentation 
approaches (region 
growing, 
thresholds, FCM, 
etc.) with the goal 
of selecting the 
most appropriate 
method given the 
image 
characteristics 
Std 
Learning on 100 
simulated cases to 
train/build the 
decision tree 
Global 85 NSTuP: Vox. 
 
Yes No No 
Schaefer et 
al, 2016 83 
Consensus 
between contours 
from 3 
segmentation 
methods (contrast-
oriented, possibility 
theory, adaptive 
thresholding) 
based on majority 
vote or  STAPLE 
Std None Global 
22 CiTuH; 
Complete 
10 CiTu: MC(4) 
10 CiTu: MC(1) 
Yes No Yes 
 
Table legend 
1
 std = « standard » interaction (i.e. the metabolic volume of interest is first manually isolated in a 
region of interest that is used as an input to the algorithm.) 485 
2
 global = not application specific 
3
 PA(x) = Phantom (spheres) Acquisitions on x different scanners; PS(x) = Phantom (spheres) 
Simulations on x different scanners; AST = Analytically Simulated Tumors; MCST = Monte Carlo 
Simulated Tumors; NSTuP = Non spherical tumors simulated in phantoms (thin-wall inserts, printed 
phantoms, etc.). CiTu = Clinical Tumors; CiTuH = Clinical Tumors with Histopathology 490 
Vol. = only volume; Vox. = voxel-by-voxel; Diam = histopathology maximum diameter; Complete = 3D 
histopathology reconstruction; MC(x) = manual contouring by x experts; FT = fixed threshold, AT = 
adaptive threshold 
4
 Highly heterogeneous, complex shapes, low contrasts and rigorous ground truth. 
5
 Requires multiple acquisitions on different systems and a large number of parameters. 495 
6 With respect to different scanners and protocols 
 II.B.2. c) Statistical  
Statistical image segmentation 
Statistical image segmentation aims at classifying pixels/voxels and creating regions in 
an image or volume based on the statistical properties of these regions and voxels, by relying 500 
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on probabilistic calculations and estimation for the decision process. Numerous approaches 
have been proposed; most are based on Bayesian inference. In essence, it is assumed that 
the observed image Y (usually taking its values in the set of real numbers) is a noisy and 
degraded version of a ground truth field X (usually taking its values in several classes C). 
Therefore, X has to be estimated from Y, assuming that X and Y can be modeled as 505 
realizations of random variables. These algorithms usually combine an iterative estimation 
procedure of the parameters of interest, since parameters defining the distributions of X and 
Y are not known in real situations. In addition, a decision step to classify voxels (i.e. 
assigning a label among the possible values of X to each voxel, based on its observation Y) 
and the estimated distributions of X and Y, are required. Hence, the voxel classification is 510 
carried out based on the previously estimated statistical properties and the resulting 
probabilities for each voxel to belong to a specific class or region. 
 
Spatial and observation models 
The parameters of interest are usually defined within both a spatial model of X (also 515 
called a priori model) and an observation model of Y (also called a noise model). Most spatial 
models are based on Markovian modeling of the voxels field, such as Markov chains, fields, 
or trees, although simpler spatial neighboring definitions (blind, adaptive or contextual) also 
exist84. Noise models are used to model uncertainty in the decision to classify a given voxel, 
and are most often defined using Gaussian distributions, but more advanced noise models 520 
have also been proposed, allowing for the modeling of correlated, multi-dimensional and non-
Gaussian noise distributions85. Parameters estimation is usually carried out using algorithms 
such as Expectation Maximization (EM), Stochastic EM (SEM) or Iterative Conditional 
Estimation (ICE), depending on the assumptions of the model. These methods have been 
demonstrated to provide robust segmentation results in several imaging applications, such as 525 
astronomical, satellite or radar images, by selecting appropriate noise models. 
 
Adaptation to PET image segmentation 
Some of the algorithms above, have been applied to PET image segmentation. One 
example is the use of a multi-resolution model applied to wavelet decomposition of the PET 530 
images within a Markov field framework66. Another approach is a mixture of Gaussian 
distributions for classification without spatial modeling65. Although these models are robust 
for noisy distributions of voxels (each voxel has an assigned label, but its observation is 
noisy), they do not explicitly take into account imprecision of the acquired data (a given voxel 
can contain a mixture of different classes). Therefore, they do not include the modeling of the 535 
fuzzy nature of PET images. As a result, to be applied efficiently to PET images, which are 
not only intrinsically noisy but also blurry due to Partial Volume Effect (PVE), more recent 
models can be used that allow the modeling of the imprecision within the statistical 
framework, using a combination of “hard” classes and a fuzzy measure. In such a model, the 
actual image, X does not take its values in a set number of classes, but in a continuous [0,1] 540 
interval 86: the fuzzy Lebesgue measure being associated with the open interval (0,1) and the 
Dirac measure being associated with {0} and {1}87. Such a model has been proposed using 
Markov chains88 and fields84 and also using local neighborhoods without Markovian 
modeling. These models retain the flexibility and robustness of statistical and Bayesian 
algorithms versus noise, with the added ability to deal with more complex distributions, due to 545 
the presence of both hard and fuzzy classes in the images. The Fuzzy Locally Adaptive 
Bayesian (FLAB) method takes advantage of this model68, which had previously been 
proposed within the context of Markov chains67. In addition, FLAB modeling has been 
extended to take into account heterogeneous uptake distributions by considering three 
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classes and their associated fuzzy transitions instead of only two classes and one fuzzy 550 
transition. The extended FLAB model has been validated on phantom acquisitions and 
simulated tumors, as well as clinical datasets69. 
II.B.2. d) Learning and texture-based segmentation algorithms  
For PET image segmentation, the learning task consists of discriminating tracer uptake 
in lesion voxels (foreground) from surrounding normal tissue voxels (background) based on a 555 
set of extracted features from these images28. Two common categories of statistical learning 
approaches have been proposed: supervised and unsupervised89, 90. Supervised learning is 
used to estimate an unknown (input, output) mapping from known (labeled) samples called 
the training set (e.g., classification of lesions given a database of example images). In 
unsupervised learning, only input samples are given to the learning system without their 560 
labels (e.g., clustering or dimensionality reduction). 
In machine learning and classification there are two steps: training and testing. In the 
training step, the optimal parameters of the model are determined given the training data and 
its best in-sample performance is assessed. This is usually followed by a validation step, 
aimed at optimal model selection. The testing step then specifically aims to estimate the 565 
expected (out-of-sample) performance of a model with respect to its chosen training 
parameters. A recent example of such a development is the ATLAAS method 82, which is an 
automatic decision tree that selects the most appropriate PET-AS method based on several 
image characteristics, achieving significantly better accuracy than any of the PET-AS 
methods considered alone. There are also numerous other types of machine learning 570 
techniques that could be applied to PET segmentation, such as random forest, support 
vector machines, or even deep learning techniques 91, which have been applied to the task of 
image segmentation in other modalities such as MRI or CT 92, 93. Although these approaches 
are promising for the future of PET image segmentation, the use of these techniques for PET 
is currently rather scarce in the literature 94. Today these techniques are exploited to classify 575 
patients in terms of outcome based on characteristics extracted from previously delineated 
tumors95, 96. 
PET-AS algorithms can be trained on pathological findings or physician contours. The 
advantage of training an algorithm using these contours is that additional information, not 
present in the PET image, is taken into account since the physician draws contours based on 580 
additional a priori information (anatomical imaging, clinical data, etc.). On the other hand, 
training algorithms using physician contours can be biased by the particular physician’s 
background, goals, or misconceptions.  
 
One of the most used approaches to extract image features that can be used for 585 
segmentation is texture analysis. Uptake heterogeneity in PET images can be characterized 
by using regional descriptors such as textures. Unlike intensity or morphological features, 
textures represent more complex visual patterns composed of entities or sub-patterns, that 
have unique characteristics of brightness, color, slope, size, etc.97 “Image texture” can refer 
to the relative distribution of gray levels within a given image neighborhood. It integrates 590 
intensity with spatial information resulting in higher order histograms when compared to 
common first-order intensity histograms. Texture-based algorithms heavily use image 
statistical properties; however, since human visual perception often relies on subtle visual 
properties, such as texture, to differentiate between image regions of similar gray level 
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intensity, they are separated from the iterative, model-based approaches described in the 595 
previous section.  
Furthermore, the human visual system is limited in its ability to distinguish variations in 
gray tone and is subject to observer bias. Variation in image texture can reflect differences in 
underlying physiological processes such as vascularity or ordered/disordered growth 
patterns. The use of automated computer algorithms to differentiate tumor from normal tissue 600 
based on textural characteristics offers an objective and potentially more sensitive algorithm 
of tumor segmentation than those based on simple image thresholds. Among the methods 
that have been suggested to calculate image texture features are those based on (1) Gabor 
filters, (2) discrete wavelet transforms (DWT), (3) the co-occurrence matrix, (4) neighborhood 
gray-tone difference matrices (NGTDM) and (5) run-length matrices.  605 
Gabor filters98 and DWT99 measure the response of images to sets of filters at varying 
frequencies, scales and orientations. The Gabor filter (a Gaussian phasor), using a bank of 
kernels for each direction, scale and frequency, can produce a large number of non-
orthogonal features, which makes processing and feature selection difficult. DWTs take a 
multi-scale approach to texture description. Orthogonal wavelets are commonly used 610 
resulting in independent features. DWT, however, have had more difficulty discriminating 
fractal textures with non-stationary scales100.  
The co-occurrence matrices proposed by Haralick, et al.101 and spatial gray level 
dependence matrix (SGLDM) features, are based on statistical properties derived from 
counting the number of times pairs of gray values occur next to each other. These are 615 
referred to as “second-order” features because they are based on the relationship of two 
voxels at a time. The size of a co-occurrence matrix is dependent on the number of gray 
values within a region. Each row (i) and column (j) entry in the matrix is the number of times 
voxels of grey values i and j occur next to each other at a given distance and angle. Higher 
order features refer to techniques that take into account spatial context from more than two 620 
voxels at a time. Amadasun and King proposed several higher order features based on  
NGTDM102. For every gray level i, the difference between this level, and the average 
neighborhood around it, is summed over every occurrence to produce the ith entry in the 
NGTDM.  
Another category of higher order features makes use of “run-length matrices.” In this 625 
case, analysis of the occurrence of consecutive voxels in a particular direction with the same 
grey level is used to extract textural descriptors such as energy, homogeneity, entropy, 
etc.103 However, run-length matrices are a computationally intensive means of deriving 
texture descriptors103.  
Although textural features have been used to characterize uptake heterogeneity 630 
within tumors after the segmentation step15,96 their use as a means of automatic 
segmentation can also provide additional information beyond simple voxel intensity that may 
improve the robustness of delineation criteria. This has been shown in multiple modalities 
including ultrasound (US)104 and MRI105. PET and CT textures in the lung have been used in 
a series of applications including differentiating between malignant and benign nodes106, 107, 635 
judging treatment response15, 16, diagnosing diffuse parenchymal lung disease108-110, 
determining tumor staging111, detection111 and segmentation111. With dual modality PET/CT 
systems (also PET/MRI in the near future112, 113), it is also possible to make use of image 
textures from PET and CT (MRI) in combination to improve image segmentation results. 
However, this leads to including anatomy for tumor volume characterization, instead of 640 
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characterizing the functional part of the tumor only. In two separate studies, combinations of 
PET and CT texture features in images of patients with H&N cancer114 and those with lung 
cancer70 improved tumor segmentation with respect to the dual modality ground truth, versus 
using PET and CT separately. This is discussed in more detail in section II.B.4 below. 
 645 
Within the learning category would also fall the recent approaches to account for a set 
or contours generated via multiple automatic methods, through averaging/consensus 
methods, 83 statistical methods such as the “inverse–ROC (receiver operating characteristic)“ 
approach,115 STAPLE (simultaneous truth and performance level estimation)-derived 
methods116, majority voting117, or decision tree82 to generate a surrogate of truth.  Most of 650 
these methods would need some type of “training” or preliminary determination of 
parameters for the particular type of lesions and may therefore avoid the limitations of the 
individual methods used. 
 
II. B. 3. Combined with image processing and/or reconstruction 655 
 
The limited and variable resolution of PET scanners, which results in anisotropic and 
spatially variant blur affecting PET images, leads to PVE, spill-in and spill-out of activity in 
nearby tissues17 and is therefore one of the main challenges for segmentation and for uptake 
quantification of oncologic lesions. In principle, all the segmentation strategies not explicitly 660 
intended for blurred images, but widely used for imaging modalities less affected by PVE 
than PET (e.g., thresholding, region growing, gradient-based algorithms, etc.),118 can be 
applied to PET images after a PVE recovery step119. PVE recovery can be performed after120-
124
 or during image reconstruction with algorithms taking into account a model of the scanner 
PSF125-127. These images however, should be handled with caution since PVE recovery 665 
techniques can introduce artifacts (e.g., variance increase related to Gibbs phenomena). The 
accuracy of PVE-recovered images can be improved by introducing regularizations such as a 
priori models, constraints or iteration stopping rules. An approach of this kind has been 
followed by Geets, et al.37 (described in section II.B.2.a) where a gradient-based 
segmentation algorithm was applied on deblurred and denoised images. In order to avoid 670 
Gibbs phenomena artifacts near the edges, deconvolution was refined with constraints on the 
deconvolved uptake. 
An alternative approach to account for blur is to model it explicitly in the segmentation 
procedure. For example, FLAB68, described in section II.B.2.c, or FHMC (Fuzzy Hidden 
Markov Chains)67, parameterize a generic form of uncertainty in order to assign special 675 
intermediate classes for the blurry borders of the main classes. Such algorithms, if combined 
with a post-segmentation PVE recovery technique for objects of known dimension/shape, like 
recovery coefficients, geometric transfer matrix17 or VOI-based deconvolution128, may also be 
able to provide an estimate of PVE-recovered lesion uptake inside the delineated borders129. 
Another means to account for PVE recovery in segmentation is to model it in an 680 
iterative process. The lesion border estimate can be iteratively refined using the result of the 
PVE recovery inside the lesion area and vice versa. Such an approach can potentially 
improve the estimation accuracy while providing a joint estimate of lesion borders and 
uptake. This approach was originally proposed by Chen, et al. for spherical objects130. More 
recently De Bernardi, et al. have further developed the idea by proposing a strategy that 685 
combines segmentation with a PVE recovery step obtained through a targeted maximum 
likelihood (ML) reconstruction algorithm with PSF modeling in the lesion area38. A scheme of 
the approach is shown in figure 2. 
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Fig.2. A schematic representation of the algorithm proposed by De Bernardi, et al.38, which 690 
combines segmentation and PVE recovery within an iterative process. 
To reduce blur in the latter approach, algorithms using transition regions between lesion 
and background are employed. These regions correspond to spill-out due to PVE and are 
modeled by regional basis functions in the PVE recovery reconstruction step. The 
reconstruction adjusts the activity inside each region according to the ML convergence with 695 
respect to the sinogram data. The subsequent segmentation refinement step acts on the 
lesion borders in the improved image, until borders no longer change. A requirement of the 
algorithm is that a model of the scanner PSF and access to raw data are available. 
Conversely, the advantage is that a joint estimate of lesion borders and activity can be 
obtained.  700 
In the work of De Bernardi, et al.38 the segmentation was obtained by using k-means 
clustering and the refinement was achieved by smoothing the result with the local PSF and 
by re-segmenting. The algorithm, suited for the simplest case of homogeneous lesions, was 
validated in a sphere phantom study. More recently, an improved strategy was proposed, in 
which the segmentation is performed with a Gaussian Mixture Model and PVE recovery is 705 
performed on a mixture of regional basis functions and voxel intensities. The algorithm was 
validated on a phantom in which lesions are simulated with zeolites (see section  IV.C.1)131. 
 
II.B.4. Segmentation of multimodality images  
Multimodality imaging is of increasing importance for cancer detection, staging and 710 
monitoring of treatment response132-136.  
In radiotherapy treatment planning, significant variability can occur when multiple 
observers contour the target volume137. This interobserver variability has been shown to be 
reduced by combining information from multimodality imaging and performing single 
delineations on fused images, such as CT and PET, or MRI and PET25, 138-142. However, 715 
traditional visual assessment of multimodality images is subjective and prone to variation. 
Alternatively, algorithms have been proposed for integrating complementary information into 
multimodality images by extending semi-automated segmentation algorithms into an 
interactive multimodality segmentation framework to define the target volume31-34.  
Consequently, the accuracy of the overall segmentation results would be improved, 720 
although, as a word of caution, it should be emphasized that the goal may be different from 
mono-modality delineation and its realization would depend on the application endpoint 
combined with the clinical association objective of the different image modalities. For 
instance, in radiotherapy planning, the main rationale behind the use of combining several 
images of different modalities to define the GTV is that they complement each other by 725 
combining different aspects of the underlying biology, physiology and/or anatomy. However, 
PET volume
Initial lesion 
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Segmentation 
refinement step     
PVE-recovery 
step 
Change?
No
Exit
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in reality, this may not be the case for all patients and all pathologies, for example the lesion 
may not be seen in the additional modality, or may exhibit an artifact. In addition, 
misregistration between the different modalities and respiratory motion may lead to a 
potentially erroneous GTV if the images were simply fused without careful consideration of 730 
geometric correspondence and the logic by which the different image data are combined 
(union, intersection or other forms of fusion). 
Exploitation of multimodal images for segmentation has been applied to define 
myocardial borders in cardiac CT, MRI and ultrasound using a multimodal snake deformable 
model143. Another example is the classification of coronary artery plaque composition from 735 
multiple contrast MRI images using a k-means clustering algorithm144. To define tumor target 
volumes using PET/CT/MRI images for radiotherapy treatment planning, a multi-valued 
deformable level set approach was used as illustrated in Figure 331. This approach was 
extended further later on using the Jensen Renyi divergence as the segmentation metric 34. 
 740 
Fig. 3. (a) PET/CT images of a patient with lung cancer in case of atelectasis (lung collapse), 
with manual segmentation for CT (orange), PET (green) and fused PET/CT (red). (b) The 
multi-valued level sets (MVLS) algorithm initialized (white circle), evolved contours in steps of 
10 iterations (black), and the final contour (red). (c) MVLS results shown along with manual 
contour on the fused PET/CT. (d) MVLS contour superimposed on CT (top) and PET 745 
(bottom). Reproduced with permission from El Naqa, et al.31. 
Mathematically, approaches that aim at simultaneously exploiting several image 
modalities represent a mapping from the imaging space to the ”perception” space as 
identified by experts such as radiation oncologists63. Several segmentation algorithms are 
amenable to such generalization145. Among these algorithms are multiple thresholding, 750 
clustering such as k-means and fuzzy c-means (FCM) and active contours. In the case of 
multiple thresholding, CT volumes can be used to guide selection of PET thresholds46 or 
using thresholds on the CT intensities to constrain the PET segmentation145. These 
conditions are typically developed empirically but could be optimized for a specific 
application. For clustering, the process is carried out by redefining the image intensities and 755 
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clustering centers as vectors (with elements being the intensities of the different modalities) 
in contrast to the typical scalars used in single modality images144. The formalism for FCM is 
given in Appendix I. However, both thresholding and clustering algorithms in their basic form 
suffer from loss of spatial connectivity, which is accounted for in active contour models by 
using a continuous geometrical form such as the level sets. The level set provides a 760 
continuous implicit representation of geometric models, which easily allows for adaptation of 
topological changes and its generalization to different image modalities. Assuming there are 
N imaging modalities, then using the concept of multi-valued level sets (MVLS)146, 147 the 
different imaging modalities are represented by a weighted level set functional objective of 
the different modalities and the target boundary is defined at the zero level set31 (Appendix I). 765 
Finally, other approaches based on the Markov field combined with graph-cut methods32, as 
well as random walk segmentation33 or including topology79, were developed and validated 
on clinical images, for multi-modal (PET, CT, MRI) images tumor segmentation, with 
promising results.  
II.B.5. Vendor implementations 770 
 Here we provide a brief summary of the vendor implementations of PET-AS methods 
at the time when this report was written. Therefore, it may not describe the PET-AS methods 
provided by the vendors at the time of publication due to constant evolution of vendor 
software. Vendors also provide tools for manual segmentation that have been omitted for 
brevity. Since the algorithms implemented by vendors are not exactly known, the summary 775 
and classification provided below do carry a significant degree of uncertainty.   
Gradient based edge detection tool is avaible by MIM Software Inc. (Cleveland, OH, 
see Section II.B.2 a) and Table 1,62,148). VelocityAI (Varian Medical Systems|Velocity Medical 
Solutions, Atlanta, GA) also point that their tool uses “rates of spatial change” in the 
segmentation process. PET-AS methods based on region growing tools (Section II.B.2 b) are 780 
available by Mirada XD (Mirada Medical, Oxford, UK) and RayStation (RaySearch 
Laboratories AB, Stockholm, Sweden).   
Adaptive thresholding approaches (Setion II.B.1) are available by VelocityAI (the 
method by Daisne, et al.149) , GE Healthcare VCARTM system (V 1.10) (GE Healthcare Inc., 
Rahway, NJ, the method by Sebastian, et al.73,see Table 1), and ROVER (ABX GmbH, 785 
Radeberg, Germany, an iterative approach following Hofheinz et al26, 60 ). 
Finally, practically all vendor implementations use some type of fixed or adaptive 
threshold based method (Setion II.B.1). For example, Varian’s Eclipse V.10 (Varian Medical 
Systems, Inc., Palo Alto, CA) as well as other vendor implementations including Philips 
Healthcare PinnacleTM (Philips Healthcare, Andover, MA) and Raystation allow users to 790 
perform PET segmentation using thresholding in different units (Bq/ml or different SUV 
definitions), and percent from peak SUV.   
  
III. COMPARISON OF THE PET-AS ALGORITHMS BASED ON 
CURRENT PUBLICATIONS    795 
A comparison of PET-AS algorithms based on published reports is difficult and subject 
to controversy because each algorithm has been developed and validated (and often 
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optimized) on different datasets, often using a single type of scanner and/or processing 
software. However, some limited conclusions can be drawn. For instance, it is possible to 
compare the algorithms based on their level of validation as well as those algorithms that 800 
have been applied to the same datasets. Table 2 contains a survey of various papers in 
which several algorithms were compared, providing the type of datasets and methods used, 
the conclusions of the study, as well as some comments. 
Most of the algorithms have been optimized/validated on phantom acquisitions of 
spheres, as this is a common tool in PET imaging to evaluate the sensitivities, noise 805 
properties and spatial resolution of PET scanners. On one hand, most algorithms usually 
give satisfactory results in these phantom acquisitions, even for varying levels of noise and 
contrast levels. However, homogeneous spheres on a homogeneous background are not 
realistic tumors. The number of algorithms that have been successfully applied to realistic 
simulated tumors or real clinical tumors with an acceptable surrogate of truth (e.g., 810 
histopathological measurements) is much smaller. Finally, algorithms that have been 
validated for robustness against several scanner models and their associated reconstruction 
algorithms are even less numerous since the datasets are not usually made publicly 
available. 
It should also be emphasized that there are a few algorithms that have been applied to 815 
common (although not publically available) datasets. For instance, the gradient-based 
algorithm by Geets, et al.37, the improved fuzzy c-means (FCM) by Belhassen and Zaidi28, 150, 
the theory of possibility applied to Maximum intensity projections (MIP) by Dewalle-Vignon, et 
al.64 and the Contourlet-based active contour model by Abdoli, et al.77 have all been applied 
to a dataset of seven patients with 3D reconstruction of the surgical specimen in histology 820 
(from a dataset of nine patients originally obtained in a study by Daisne, et al.151), with 
19±22%, 9±28%, 17±13% and 0.29±0.6% volume mean errors, respectively. Similarly, the 
improved fuzzy c-means by Belhassen, et al.36, FLAB by Hatt, et al.69,152 and the level sets 
and Jensen-Rényi divergence algorithm by Markel, et al.34 were applied to the NSCLC 
tumors dataset with maximum diameters from MAASTRO (Maastricht Radiation Oncology)139 825 
(with ±6% error for FLAB, ±15% for the improved FCM and ±14.8% for the level sets 
approach, respectively). In addition, most of the advanced algorithms that have been 
proposed have been compared to some kind of fixed and/or adaptive thresholding using their 
respective test datasets and have, for the most part, demonstrated improvements in 
accuracy and robustness. In particular, it was observed that fixed and adaptive thresholding 830 
might lead to over 100% errors in cases of small and/or low-contrast objects and significant 
underestimation (-20 to -100%) in cases of larger volumes with more heterogeneous uptake 
distributions, whereas advanced methods were able to provide more satisfactory error rates 
(around or below 10 to 20% errors)153, 152. However, it is possible that simpler, e.g., adaptive 
threshold PET-AS-methods optimized for a specific body site, may perform comparably well 835 
or even better than some of the more advanced techniques154. 
 In the largest comparison to date, Shepherd, et al. 115 segmented 7 VOIs in PET using 
variants of threshold-, gradient-, hybrid image-, region growing- and watershed-based 
algorithms, as well as more complex pipeline algorithms. Along with manual delineations, a 
total of 30 distinct segmentations were performed per VOI and grouped according to type 840 
and dependence upon complementary information from the user and from simultaneous CT. 
According to a statistical accuracy measure that accounts for uncertainties in ground truth, 
the most promising algorithms within the wider field of computer vision were a deformable 
contour model using energy minimization techniques, a fuzzy c-means (FCM) algorithm and 
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an algorithm that combines variants of region growing and the watershed transform. Another 845 
important finding was that user interaction proved in general to benefit segmentation 
accuracy, highlighting the need to incorporate expert human knowledge, and this in turn was 
made more effective by visualization of PET gradients or CT from PET-CT hybrid imaging. 
There is little information to date concerning the comparison of the performance of an 
algorithm using datasets from different scanners and/or with the implementation of that 850 
algorithm in different software packages. In one study155, an adaptive threshold segmentation 
algorithm was applied in three centers using two similar types of scanners from the same 
manufacturer. The authors demonstrated that significant differences were observed in the 
optimal threshold values depending on the center and imaging protocols, despite that both 
the scanner and reconstruction method were the same. In addition, significant differences 855 
were also observed, depending on the reconstruction settings (Fig. 4). They concluded that 
synchronization of imaging protocols can facilitate contouring activities between cooperating 
sites. In another investigation, dependence of the segmentation threshold providing the 
correct sphere volume on the reconstruction algorithm was also observed for small 
spheres156.   860 
In a German multicenter study157, Schaefer, et al. evaluated the calibration of their 
adaptive threshold algorithm (contrast-oriented algorithm) for FDG PET-based delineation of 
tumor volumes in eleven centers, using three different scanner types from two vendors. They 
observed only minor differences in calibration parameters for scanners of the same type, 
provided that identical imaging protocols were used, whereas significant differences were 865 
found between scanner types and vendors. After calibrating the algorithm for all three 
scanners, the calculated SUV thresholds for auto-contouring did not differ significantly.  
On the other hand, the FLAB algorithm by Hatt, et al. showed robustness to scanner 
type and performed well without pre-optimization, on four different scanners from three 
vendors (Philips GEMINI GXL and GEMINI TF, Siemens Biograph 16 and GE Discovery LS) 870 
using a large range of acquisition parameters such as voxel size, acquisition duration and 
sphere-to-background contrast.43 
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Fig. 4: Variation of the optimal threshold value (y axis) obtained according to different 
settings of the PET reconstruction with varying number of iterations and subsets (from 2 875 
iterations 1 subset to 8 iterations 8 subsets, colored bars), and for spheres of different 
volumes (x axis) and a sphere-to-background ratio of 3.5, for one single scanner model. 
Reproduced with permission from Ollers, et al.155   
While the natural incentive is to create algorithms which perform universally well across body 
sites and disease types, for at least one body site it was shown154 that simpler (e.g., adaptive 880 
threshold) methods may perform comparably well if specifically optimized for these 
conditions. At present there is not a sufficient amount of published data to give specific 
recommendations for each clinical site. The emerging consensus83 and decision tree82 based 
methods however, provide a potential to provide adequate solution for each site if 
appropriately adapted and trained. 885 
Given the above results, the validation of PET-AS algorithms, as described in current 
publications, does not provide sufficient information regarding which of the known 
approaches would be most accurate, applicable, or convenient for clinical use. In the 
following sections, we attempt to lay the basis for a framework that avoids the methodological 
weaknesses of the past and addresses the challenges inherent in segmentation in PET. 890 
Table 2. A summary of segmentation method comparisons and  reviews.  
No. Reference Compared 
methods 
Images or 
Phantoms 
used 
Results and/or 
recommendations 
reported by the 
authors 
Limitations and 
comments by 
TG211 or others 
as cited 
Comparison studies 
1 Nestle, et 
al. 200523 
Visual 
segmentation, 
40% of 
SUVmax 
threshold, 
SUV>2.5 
threshold, and 
an adaptive 
threshold 
Patient scans Large differences 
between volumes 
obtained with the 4 
approaches 
Only visual 
segmentation 
used as a 
surrogate of truth 
and only clinical 
data. 
2 Schinagl, 
et al. 
2007158 
Visual 
segmentation, 
40% and 50% 
of SUVmax 
threshold, and 
adaptive 
thresholding 
78 Clinical 
PET/CT 
images of 
head and neck 
The 5 methods led 
to very different 
volumes and shapes 
of the GTV. Fixed 
threshold at SUV of 
2.5 led to the most 
disappointing 
results. 
The GTV was 
defined manually 
on CT and used 
as a surrogate of 
truth for PET-
derived delineation 
and only clinical 
data was used. 
3 Geets, et 
al. 200737, 
Wanet, et 
al. 201155 
Fixed and 
adaptive 
thresholding, 
gradient-
based 
segmentation 
Phantom 
(spheres), 
simulated 
images, clinical 
images of lung 
and H&N 
cancers with 
More accurate 
segmentation with 
gradient-based 
approach compared 
to threshold 
Numerous issues 
associated with 
the 3D 
reconstruction of 
the surgical 
specimen used as 
gold standard. 
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histopathology 
3D 
measurements 
4 Greco, et 
al. 2008159 
Manual 
segmentation, 
50% SUVmax, 
SUV>2.5 
threshold and 
iterative 
thresholding 
12 Head and 
neck cancer 
patients.  
Thresholding PET-
AS algorithms are 
strongly threshold-
dependent and may 
reduce target 
volumes significantly 
when compared to 
visual and 
physician- 
determined 
volumes.  
 
Limitations: 
reference GTVs 
defined manually 
on CT and MRI.  
5 Vees, et al. 
2009160 
Manual 
segmentation, 
SUV>2.5 
threshold, 
40% and 50% 
of SUVmax 
threshold, 
adaptive 
thresholding, 
gradient-
based method 
and region 
growing. 
18 Patients 
with high grade 
glioma  
PET often detected 
tumors that are not 
visible on MRI and 
added substantial 
tumor extension 
outside the GTV 
defined by MRI in 
33% of cases. 
The 2.5 SUV 
isocontour and 
“Gradient Find” 
“segmentation 
techniques 
performed poorly 
and should not be 
used for GTV 
delineation”. 
 
Ground-truth 
derived from 
manual 
segmentation on 
MRI only. 
6 Belhassen, 
et al. 
2009161 
Three 
different 
implement-
ations of the 
fuzzy C-
means (FCM) 
clustering 
algorithm 
Patient scans Incorporating 
wavelet transform 
and spatial 
information through 
nonlinear anisotropic 
diffusion filter 
improved accuracy 
for heterogeneous 
cases  
No comparison 
with other 
standard methods 
7 Tylski, et 
al. 201042 
Four different 
threshold 
methods (% 
of max activity 
and three 
adaptive 
thresholding), 
and a model-
Spheres in an 
antropomor-
phic torso 
phantom as 
well as non 
spherical 
simulated 
tumors 
Large differences 
between volumes 
obtained with 
different 
segmentation 
algorithms. Model-
based or 
background-
No clinical data, 
limited to 
threshold-based 
algorithms only, 
only volume error 
considered as a 
metric 
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based 
thresholding 
adjusted algorithms 
performed better 
than fixed 
thresholds. 
8 Hatt, et al. 
201069, 
201143, 152 
Fixed and 
adaptive 
thresholding, 
Fuzzy C-
means, FLAB 
IEC phantom 
(spheres); 
simulated 
images, clinical 
images with 
maximum 
diameter 
measurements 
in 
histopathology 
Advanced 
algorithms are more 
accurate compared 
to threshold- based 
and are also more 
robust and 
repeatable. 
For clinical 
images, only 
maximum 
diameters along 
one axis were 
available from 
histology. 
9 Dewalle-
Vignion, et 
al. 201164, 
2012162 
Manual 
segmentation, 
42% of 
SUVmax, 2 
different 
adaptive 
thresholding, 
fuzzy c-mean 
and an 
advanced 
method based 
on fuzzy set 
theory.  
Phantom 
images, 
simulated 
images, clinical 
images with 
manual 
delineations 
The advanced 
algorithm is more 
accurate and robust 
than threshold-
based and closer to 
manual delineations 
by clinicians 
Only manual 
delineation for 
surrogate of truth 
of clinical data.  
Comments: 
Interesting use of 
various metrics for 
assessment of 
image 
segmentation 
accuracy. 
10 Werner-
Wasik, et 
al. 201262  
Manual 
segmentation, 
fixed 
thresholds at 
25% to 50% 
of SUVmax (by 
5% 
increments) 
and gradient-
based 
segmentation 
IEC phantom 
(spheres) in 
multiple 
scanners, 
simulated 
images of lung 
tumors 
A gradient-based 
algorithm is more 
“accurate and 
consistent” than   
manual and 
threshold 
segmentation.  
Only volume error 
used as a metric 
of performance. 
“…manual 
verification using 
CT scan should be 
performed (…)  
GTV definition 
requires joint 
assessment by the 
radiologist, nuclear 
physician and 
radiation 
oncologist” 163 
11 Zaidi, et al. 
2012150 
Five 
thresholding 
methods, 
Standard and 
improved 
fuzzy c-
means, level 
set technique, 
Patient scans 
with 
histopathology 
3D 
measurements 
(same as #5 
above) N/A 
The automated 
Fuzzy c-means 
algorithm provided 
was shown to be 
more accurate than 
5 thresholding 
algorithms, the level 
set technique, the 
Numerous issues 
associated with 
the 3D 
reconstruction of 
the surgical 
specimen used as 
gold standard. See 
Table 1 
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stochastic 
EM. 
stochastic EM 
approach and 
regular FCM. 
Adaptive threshold 
techniques need to 
be calibrated for 
each PET scanner 
and acquisition/pro-
cessing protocol and 
should not be used 
without optimization.  
12 Shepherd, 
et al. 2012 
115
 
30 methods 
from 13 
different 
groups. 
Tumor and 
lymph-node 
metastases in 
H&N cancer 
and physical 
phantom 
(irregular 
shapes). 
Simulated, 
experimental 
and clinical 
studies 
Highest accuracy is 
obtained from 
optimal balance 
between interactivity 
and automation. 
Improvements are 
seen from visual 
guidance by PET 
gradient as well as 
by using CT.  
Limitation: a small 
number of objects 
(n=7) were used 
for the evaluation. 
13 Schaefer, 
et al. 
2012157 
 
One adaptive 
thresholding 
technique 
Phantoms, 
same 
threshold 
algorithm, 
different 
scanners  
The calibration of an 
adaptive threshold 
PET-AS algorithm is 
scanner and image 
analysis software- 
dependent.  
Confirmation of 
previous findings 
about adaptive 
threshold 
segmentation.  
14 Schinagl et 
al. 2013 164 
Visual, SUV 
of 2.5, fixed 
threshold of 
40% and 
50%, and two 
adaptive 
threshold 
based 
methods 
using either 
the primary or 
the 
metastasis  
Evaluation of 
the segmen-
tation of 
metastatic 
lymph nodes 
against 
pathology in 12 
head and neck 
cancer patients  
SUV of 2.5 was 
unsatisfactory in 
35% of cases; for 
the last four 
methods: i) using 
the node as a 
reference gave 
results comparable 
to visual 
ii) using the primary 
as a reference gave 
poor results;  
Shows the 
limitations of 
threshold based 
methods.  
15 Hofheinz, 
et al. 2013, 
60
 
Voxel-specific 
adaptive 
thresholding  
and standard 
lesion-specific 
adaptive 
threshold  
30 simulated 
images based 
on real clinical 
datasets. 
The  voxel-specific 
adaptive threshold 
method was more 
accurate than the 
lesion-specific one 
in heterogeneous 
cases 
Only simulated 
data were used. 
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16 Lapuyade-
Lahorgue, 
et al. 2015 
80
 
Improved 
generalized 
fuzzy c-
means, fuzzy 
local 
information C-
means and 
FLAB  
34 simulated 
tumors and 9 
clinical images 
with 
consensus of 
manual 
delineations. 3 
acquisitions of 
phantoms for 
robustness of 
evaluation.  
In both simulated 
and clinical images, 
the improved 
generalized FCM led 
to better results than 
another FCM 
implementation and 
FLAB, especially on 
complex and 
heterogeneous 
tumours, without any 
loss of robustness 
on data acquired in 
different scanners. 
Only 9 clinical 
images used. 
 
Reviews 
1 Boudraa, 
et al. 2006 
39
 
N/A Mostly clinical 
images  
Extensive review of 
the fomalism of 
image segmentation 
algorithms used in 
nuclear medicine (not 
specific to PET and 
clinical oncology) 
Only a few 
algorithms have 
been rigorously 
validated for 
accuracy, 
repeatability and 
robustness. 
2 Lee, 
201029 
 
N/A Simulated, 
mostly clinical 
images 
Discussed the main 
caveats of threshold- 
based techniques 
including the effect of 
phantom cold walls 
on threshold. A 
discussion of the 
available and 
desirable validation 
datasets and 
approaches is also 
included.  
Extensive review 
of nuclear 
medicine image 
segmentation 
algorithms (not 
specific to PET 
and clinical 
oncology) 
3 Zaidi and 
El Naqa, 
2010 53 
 
N/AN/A Simulated, 
experimental 
and clinical 
studies  
Despite being 
promising, advanced 
PET-AS algorithms 
are not used in the 
clinic.  
 
4 Hatt, et al. 
201123 
N/A  N/A Only a few algorithms 
have been rigorously 
validated for 
accuracy, 
repeatability and 
robustness. 
See the three last 
columns of Table 
1 
5 Kirov A.S, 
Fanchon, 
N/A  Clinical 
images with 
Articles comparing 
PET-AS methods are 
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L, 2014,165 
 
pathology 
derived 
ground truth.  
summarized 
separately for lesions 
in five groups based 
on location in the 
body with a focus on 
the accuracy, 
usefulness and the 
role of the pathology-
validated PET image 
sets.  
6 Foster, et 
al. 201436  
N/A  N/A  “although there is no 
PET image 
segmentation method 
that is optimal for all 
applications or can 
compensate for all of 
the difficulties 
inherent to PET 
images, development 
of trending image 
segmentation 
techniques which 
combine anatomical 
information and 
metabolic activities in 
the same hybrid 
frameworks (PET-
CT, PET-CT, and 
MRI-PET-CT) is 
encouraging and 
open to further 
investigations.”  
Most exhaustive 
review of the 
state-of-the-art in 
2014. Uses a 
similar 
classification of 
methods as in the 
present report. 
 
IV. COMPONENTS OF AN EVALUATION STANDARD  
A main conclusion of the work of this task group is that a common and standardized 
evaluation protocol or ”benchmark” to assess the performance of PET–AS methods is 895 
needed. The design of such a protocol requires:  
- Selection of evaluation endpoint and definition of performance criteria; 
- Selection of a set of images; 
- Selection of contour evaluation tools; 
 IV.A. Evaluation endpoints   900 
 For the purpose of radiation therapy the PET image is most often used to segment the 
so called gross tumor volume (GTV) which contains the macroscopically observable 
(demonstrable) disease166. Based on the GTV is later generated the clinical target volume 
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(CTV), which is supposed to include additional volume with a high probability of microscopic 
tumor extensions166. The planning target volume (PTV) encompasses the CTV and adds and 905 
additional margin for set-up error and organ motion166. The sub-target volume (sub-GTV) lies 
within the GTV and locates one or more metabolically distinct sub-volumes such as tumor 
growth, burden or hypoxia. Segmentation of the sub-GTV assumes availability of additional 
functional information, which can come from PET or from other imaging modalities2. Within 
this context, the smallest number of cells with uptake that is possible to image using PET has 910 
been assessed as 105 cells167.   
The endpoint for evaluating PET-AS algorithms can be selected at different levels of 
approximation of the tumor border. We consider the following three levels of approximation 
ordered from least to most accurate:  
a) The PET avid tumor volume in the PET image as obtained through standard 915 
reconstruction, which typically leaves some of the physical artifacts (such as 
limited spatial resolution, motion), not routinely and/or fully corrected; 
b) The PET avid tumor volume after optimal correction of more subtle artifacts such 
as resolution, motion and noise;  
c) The spatial distribution of the biological quantity of clinical interest (e.g., the 920 
distribution of cells exhibiting a certain metabolic trait, e.g., proliferation).  
The ideal endpoint for evaluating PET-AS algorithms if they are to facilitate reaching the 
clinical goal is (c). However, variations in the biological environment of the lesion (e.g., 
perfusion and inflammation) and other biological and physical uncertainty in PET images 
decrease the accuracy of numerical algorithms in aiming at the clinical endpoint (e.g., the 925 
GTV). The less ambitious endpoint (b) of contouring the volume based on the real tracer 
distribution is feasible, provided that important factors, such as PVE, motion and noise are 
accurately taken into account or corrected with state-of-the-art approaches (either within 
reconstruction or post-reconstruction).  
Finally, most algorithms have been and can be evaluated against the activity as seen in 930 
the standard PET image (a). This case concerns standard acquisitions with routine clinical 
systems for which some of the physical artefacts (attenuation, scattered and random events, 
etc.) are corrected, but no correction is applied for others (e.g., spatial resolution, motion, 
statistical noise and post-filtering). This method is currently widely used. Nevertheless, for 
future standardized evaluation protocols, our task group recommends considering the three 935 
endpoints listed above168. Such future work should also consider segmenting radiotherapy 
targets using multi-spectral images from hybrid imaging studies31, 114 34 33, dynamic imaging74, 
169
 and/or multi-tracer PET images170.  
IV.B. Definition of performance criteria: accuracy, precision (reproducibility and 
repeatability) efficiency and robustness 940 
In instrumental science any measurement tool can be characterized by its accuracy 
(degree of closeness to the true value) and precision (degree to which repeated 
measurements under unchanged conditions give the same results). Precision can be further 
stratified into repeatability and reproducibility. Reproducibility often implies that tools or 
operators are different, whereas repeatability relies on experimental conditions that are kept 945 
as identical as possible. For complex tools such as segmentation algorithms, stratification 
into reproducibility and repeatability is not necessary and precision suffices, provided all 
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parameters are identified, including those for which the operator has control, e.g., the region 
of an image used to characterize the background tracer uptake. 
For a given segmentation algorithm we define accuracy as the correctness of retrieving 950 
the true 3D object spatial extent, shape and volume based on the reconstructed activity 
distribution in a PET image, irrespective of the correlation between this distribution and the 
underlying physiological process. This means that an image segmentation algorithm is not 
expected to differentiate specific from non-specific tracer uptake (e.g., inflammation and 
tumor in the case of FDG) if they are of the same intensity. 955 
Within the context of this report, repeatability1 is defined as the ability of a given 
algorithm to reach the same result when applied multiple times on a single image replicate 
(single acquisition), given potentially differing algorithmic initializations. In such a task, 
deterministic, fixed threshold approaches will always give the same result when applied to a 
given image. On the other hand, more advanced algorithms are susceptible to providing 960 
different results when applied with multiple runs on the same image because they could rely 
on more complex initializations or estimation processes, including random ones. 
We define robustness as the ability of a given algorithm to generate consistent, 
segmented volumes under varying acquisition and image reconstruction conditions, including 
issues related to statistical counts and multiple replicates (multiple acquisition of the same 965 
object) due to noise. This robustness is determined as the variability of the segmentation 
results when a PET-AS algorithm is applied on images of the same object acquired using 
various scanners, and for each scanner, under various contrast and noise conditions, using 
different reconstruction and associated correction algorithms. 
Finally, an important parameter of the algorithms is their efficiency, which may 970 
determine their practical viability41. Efficiency includes workflow and computational 
complexity required for completion of the segmentation task. Considering the computing 
power evolution and possibilities (parallel computing, graphical processing units, etc.) the 
main limiting factor is workflow and human interaction. 
 Below is laid out the vision of the task group for a future standard for PET-AS method 975 
evaluation. It has two main components: 1) Benchmark image set; 2) Performance evaluation 
criteria. 
IV.C. Benchmark image sets 
This section is dedicated to the selection of the benchmark images, which should cover 
a realistic range of parameters so that it ensures that the tested PET-AS algorithms can meet 980 
the challenges that may be encountered in various clinical cases. However, in order to allow 
for a practical and realistic evaluation and interpretation of the results, the number of images 
and datasets should be kept to a minimum. Therefore, the images that are likely to offer the 
most realistic, rigorous way to assess the performance of the various algorithms should be 
selected. A classification of the possible types of benchmark images is given in Table 3. 985 
                                               
1
 The term reproducibility or repeatability is also used to denote the variability assessed using double 
baseline PET scan acquisitions (repeated acquisitions at a few days interval without treatment). This 
“physiological” reproducibility is a different topic than the repeatability/reproducibility of the PET-AS 
algorithm discussed here. 
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Table 3.  Advantages and disadvantages of the different methods used for generation of test 
images. 
 
Experimental images Simulated images 
Simple 
Phantoms 
Realistic 
phantoms 
Clinical 
images 
Forward 
Projected 
Images 
Monte Carlo 
(MC) 
Simulations 
Advantages:  Exact 
representation 
of the scanner 
resolution, 
image noise 
and other 
image artifacts  Ground truth 
accurately 
known  Easy to 
generate and 
use 
 Exact 
representation of 
the scanner 
resolution, 
image noise and 
other image 
artifacts  Capable to 
produce  lesion 
shapes 
corresponding to 
actual tumors  Known ground 
truth 
 Exact 
representation of 
the scanner 
resolution, image 
noise and other 
image artifacts  Real tumors 
 
 Precise experimental 
control  Flexibility in phantom 
design  Precise knowledge of 
the reference object  Computationally 
cheap 
 Precise experimental 
control   Realistic count 
distributions  Flexibility in phantom 
design  Precise knowledge of 
the reference object  Camera-specific 
information 
Dis-
advantages: 
 The objects 
have simplistic 
and unrealistic 
shape and 
activity 
distribution  Most with few 
exceptions171, 
172
 have cold 
walls 
 
 Some 
uncertainties in 
the experiment 
can be hard to 
quantify  Difficult to 
generate 
inhomogeneous 
activity  Labor intensive 
 Uncertainties in 
the knowledge of 
the reference 
object, even with 
histopathology 
reference  
 
 Scatter count 
distributions and 
noise are usually less 
accurately modeled  Detailed physics and 
system information 
ignored 
 Computationally 
expensive  Model requires 
extensive up front 
experience 
 
The advantages and disadvantages of the different classes of datasets and of particular 
published image sets are discussed in more detail below. The various phantoms considered 990 
for a common PET-AS evaluation protocol are summarized in Appendix III. 
IV.C.1 Physical phantoms 
The main advantage of physical phantoms is that they contain the same exact 
degradations, namely resolution, noise, scatter, etc., as clinical PET scans, while also 
ensuring that the ground truth is both reproducible and known for repeated testing using 995 
prescribed conditions. 
Most PET-AS algorithms are initially developed and optimized against simple phantoms 
containing uniform activity spheres or cylinders. Therefore, these phantoms are essential in 
evaluating segmentation accuracy for well-defined, simple-shaped objects. However, 
spherical targets oversimplify the segmentation problem and can erroneously favor an 1000 
algorithm that would break down in the presence of a complex topology or heterogeneous 
tracer uptake distribution seen in real tumors. Testing the PET-AS algorithms against these 
images can nevertheless provide: 1) assurance that the algorithms compared are trustworthy 
for simple cases; 2) agreement limits for initial, basic evaluation; 3) opportunity for verifying 
algorithm operation over time (e.g., routine quality assurance) and 4) a convenient tool for 1005 
testing the robustness of the algorithms under different experimental conditions (Fig. T.A1.1 
in Appendix III) using for instance the National Electrical Manufacturers Association  (NEMA) 
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image quality phantom86, available in most PET centers. However, with few exceptions172,173 
these phantoms contain objects with cold walls in a homogeneous background86. 
Furthermore, most of the algorithms have already been optimized and assessed on these 1010 
simplistic, physical phantom acquisitions at the development stage. 
More realistic phantoms are of interest for more demanding evaluations with respect to 
the activity distribution endpoint. The contribution by Zito, et al.174 regarding the use of 
phantoms containing zeolites (microporous, aluminosilicate minerals commonly used as 
commercial adsorbents which can absorb aqueous solutions of (18)F-FDG) is promising. 1015 
This phantom allows tumor-like objects to be generated with any desired shape, size and 
contrast levels without cold walls. They also provides ground truth with sub-voxel resolution 
that is available from the associated co-registered CT images.       
A limitation of these images (e.g. obtained from zeolite phantoms) is the lack of control 
and knowledge of the potential heterogeneity of the tracer uptake in the background and the 1020 
"tumor." Several alternatives allow experimental modeling of non-uniform activity inside the 
lesions and in the background. These phantoms include structures generated by stacking 
paper sheets containing PET images printed with radioactive ink175, 176 (see Fig.T.A1.6. in 
Appendix III), or 3D printers using radioactive ink177. Another option for generating non-
uniform uptake distributions is the use of thin sheets to displace activity (see Fig.T.A1.7 in 1025 
Appendix III)178.  
IV.C.2 Simulated images 
Virtual or numerical phantoms associated with a PET-image generation process 
represent an inexpensive, precise way to test PET software and clinical methodologies179. 
One definition of a virtual or numerical PET simulation framework corresponds to any 1030 
computer-generated object that is processed to produce a PET-like image. It should be clear 
that virtual phantoms are distinct from the resulting PET images and represent a reference 
source distribution from which the PET-like image is produced. In order to be useful the 
resulting image needs to be representative of what is observed in the images produced by a 
real PET camera. 1035 
Generating PET-like images for virtual phantoms can be done in several ways. Below 
we describe methods that range from simple to complex, as more realism is included in the 
simulation, and therefore, in the produced images.  
Inserted Tumor PET-Like Images:   
The simplest method is to insert an object with added noise, representing a tumor, 1040 
directly into an existing PET image180. However, this method requires considerable effort to 
blend the noise and edge characteristics of the lesion into the image in order to avoid 
obvious edges from threshold or texture mismatches. This method is the least realistic of the 
various approaches for generating PET-like images. Because of these weaknesses and the 
difficulties in accurately matching the noise/spatial resolution properties of real PET images, 1045 
it is not further discussed.  
Forward Projected Tumors:  
Alternatively, a more robust method is to consider a synthetic lesion that can be forward 
projected, have noise added and then inserted into the noiseless forward-projection of the 
existing PET image that is scaled appropriately to match the desired noise level of the tumor. 1050 
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The projection data can then be reconstructed to preserve the basic characteristics of the 
original image. Care must be taken to ensure that the forward and backward projectors are 
matched, i.e., adjoint, that the original PET image is sufficiently oversampled and that the 
reconstruction process does not greatly alter the underlying PET image. Although this 
process is conceptually simple, its realism is limited by inaccuracies introduced in modeling 1055 
the spatial variation of the PSF, the noise model and the effects of the reconstruction 
process. 
Forward Projected Phantom Images:  
Forward projected phantoms and tumors represent a middle ground between full Monte 
Carlo PET simulations of phantoms and directly inserting tumors into PET images. This has 1060 
been implemented in an open source simulation tool181 and used in several PET studies, as it 
is a standard means for evaluating image reconstruction methods182, 183. 
In this method, noiseless tumor and phantom images are forward projected and scaled 
to produce a similar number of total counts as would be seen in the equivalent projection 
data and then fused, which represents the reference images. Noise is then added to the 1065 
resulting projection data via a Poisson distribution to create PET-like projection data. These 
data are then reconstructed to produce the PET-like images of the original virtual phantom. 
Additional realism can be included by blurring the images with a PSF (derived from physical 
parameters: positron range, annihilation photon non-collinearity, detector solid angle, block 
effects, etc.), adding attenuation, random and scatter counts and altering the fidelity of the 1070 
projection matrix or the type of reconstruction. This process is described in Figure T5.8 in 
Appendix III. Motion can also be simulated by applying the appropriate motion-blurring kernel 
to the image prior to forward projecting the image into sinogram space. This method can be 
extended to insert realistic tumors into existing PET images181. 
Monte Carlo simulations:  1075 
 The most realistic data can be obtained by simulating the entire positron emission, 
annihilation, interaction and detection processes with Monte Carlo (MC) simulations. The 
subsequent projection data can be reconstructed to produce very realistic images.  
Using recent, state-of-the-art anthropomorphic phantoms such as the XCAT (4D 
NURBS-based Cardiac-Torso)184 or Zubal phantoms184, 185 and MC simulators such as 1080 
SORTEO (Simulation Of Realistic Tridimensional Emitting Objects)186, GATE (Geant4 
Application for Tomography Emission)187, 188 or SimSET (Simulation System for Emission 
Tomography)189, combined with scanner system modeling (geometry, detectors, etc.)190, can 
provide highly realistic simulations, including respiratory motion153 with regular or irregular 
respiratory signals. Simulated tumors can be placed in various anatomical locations and 1085 
generated with non-spherical shapes and complex uptake distributions, including realistic 
“activity gradients” (see Figure T.A1.9 in Appendix III). PET data are then simulated by 
assigning an uptake to each organ/tumor of the anatomical phantom. Parameters such as 
tumor-to-background or intra-tumor heterogeneities can be varied within any desired range. 
Similarly, it is possible to generate various noise realizations, as well as various SNR ratios, 1090 
by selecting different parts of the overall simulated list mode data (lines of response) before 
reconstruction. It is therefore also possible to select lines of response corresponding to true 
coincidences only, or including the random and scattered data. Different scanner designs 
and reconstruction algorithms and/or parameters (number of iterations, post-filtering 
smoothing, voxel dimensions, etc.) can also be modeled if detailed information about the 1095 
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scanner is available; hence this method allows the assessment of robustness and 
“universality” of the PET-AS algorithms. 
Simulated data can provide a high level of realism without the disadvantages and 
inconveniences of real phantom acquisitions. It is possible to Increasing the number of 
activity levels to realistic numbers approximating ground truth to the voxel level achievable by 1100 
some experimental approaches.177, 178 This however can increase the complexity and time 
required for the design of the simulation. 
IV. C.3.  Clinical images  
In patients, the “ground truth” is defined by the actual underlying extent of disease; 
however, the true biological margins are usually unknown. This is in contrast to phantoms, 1105 
where the ground truth is clearly defined by the phantom design and therefore well-known. 
For clinical images the following surrogates of truth can be used: i) a consensus of several 
physicians or expert-drawn contours and/or ii) histopathological measurements of lesions 
resected within a reasonably short timeframe after the image acquisition and for which 
special precautions are taken as described below.  1110 
Consensus of several physician-drawn contours  
If the clinical endpoint is selected as the decision basis in the absence of histopathology 
information, consensus of several physician-drawn contours is sometimes used as a 
surrogate of truth. When the segmentation contours can potentially be used in different 
clinical applications, images contoured by several experts or physicians from different 1115 
specializations (e.g., the study by Bayne et al.191 in which 2 radiologists, 2 radiation 
oncologists and 2 nuclear medicine physicians contoured 5 NSCLC patients), might reduce 
bias due to personal and specialty-based preferences at the price of a likely slightly higher 
inter-observer variability due to differences in training and habits. On the other hand, when 
considering a specific clinical application, such an approach may be less accurate than using 1120 
consensus of contours drawn by several specialists in this specific application. Indeed, 
contouring by physicians from only one specialty, e.g., radiation oncologists25, may provide 
more reliable estimates for an endpoint corresponding to the goals of this specific sub-
specialty (target volume definition in this case). 
The use of the consensus based methods discussed at the end of Section 2.B.2.d, 1125 
which can account for a set of manual contours, may be expected to reduce errors under 
certain assumptions about the operators, as differences in performance or training can be 
taken into account (e.g., within the STAPLE framework). 
 
Histopathological validation of PET image segmentation  1130 
This type of PET-AS validation can be carried out by using PET images of tumor 
specimens for which histopathological characterization is also available. In this case, PET-AS 
contours can be tested directly against the histopathology-derived contours. At present, 
these data serve as the most clinically relevant ground truth of tumor extent. However, there 
are several sources of errors that limit the accuracy of this surrogate of truth for PET-AS 1135 
validation: (i) variable amount of deformation of the surgical specimen after excision, (ii) time 
difference between the PET scan and the specimen excision, (iii) uncertainty associated with 
manual delineation (usually by a single observer) of the tumor boundaries in digitized 
histopathology and (iv) imperfect co-registration of histopathology slices and PET volumes. 
While these errors can potentially limit the validity of the comparison, histopathological 1140 
validation is an important part of thorough PET-AS evaluation. At present, there are several 
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datasets in which effort was made to minimize these errors165. Examples are: the lung tumor 
dataset from the MAASTRO (Maastricht Radiation Oncology) team with pathology-validated 
maximum diameters139, the tumor datasets used in the study from the Jefferson Medical 
College (max. diameter)192, the HNSCC (Head and Neck Squamous Cell Carcinoma),151 the 1145 
NSCLC55 full 3D volumes reconstruction datasets from the Université Catholique de Louvain 
studies and the lobectomy-based dataset from The Netherlands Cancer Institute (NKI)193. 
Despite the challenges with respect to the accuracy of the reference contours, these 
pathology-validated images provide an important test for PET-AS methods. This justifies the 
need for further improvement of the current experimental approaches, as well as 1150 
development of new techniques to improve the accuracy of histopathological validation165, 194, 
195
. 
 It is important to note that because histopathological validation of PET image 
segmentation is carried out for a particular tissue and tracer pair, it cannot be implied that the 
results apply to alternative PET tracer/tissue combinations; hence, one should exercise care 1155 
when using PET-AS algorithms to segment tracer/tissue pair images different from those for 
which they were validated. It should be noted that evaluating PET segmentation against 
anatomic or surgical delineation could be potentially misleading since biodistribution of a 
particular PET radiotracer may not conform to these structures. This is especially true for 
non-FDG tracers such as hypoxia probes where the entire tumor volume is not expected to 1160 
display uptake. 
IV.C.4. Blind study and updates  
 
In order to facilitate the training and validation of PET-AS algorithms, it would be 
optimal to separate the images of the future standard into two groups: a) With ground truth 1165 
given to the PET-AS developers for learning/training and b) Blind study (without ground truth) 
for testing. The rationale behind a) is that some algorithms, e.g., the learning algorithms may 
need to be trained, whereas b) will ensure more objective evaluation and validation. Simple 
geometrically shaped phantoms naturally fall in the first category, whereas clinical images 
are a natural candidate for the second group. Simulated images, or complex shape 1170 
experimental phantoms, can be distributed among the two. 
Since both experimental and numerical phantoms are currently in rapid development, it 
is important to make provisions for updating and expanding the set of images. The 
benchmark’s goal can be better reached if it can facilitate and encourage the sharing of new 
acquired datasets by contributing users. As new data and PET-AS algorithms become 1175 
available, the evaluation process can be organized so that the new, shared datasets become 
gradually included in the standard. For example, a rule may be considered according to 
which, a certain fraction of the images (e.g., ~ 60%) must have been used for evaluating at 
least ten algorithms. 
IV.D. Figures of merit and evaluation criteria  1180 
Choosing the best set of Figures of Merit (FOM) depends on the complexity of the 
segmentation problem as well as on the evaluated endpoint. For example, when using 
spheres in a standard compartmental phantom, shape modifications and volume translations 
are unlikely to be observed. In this case, simple volumetric differences may be enough. In 
more realistic images, inaccuracies in shape or location are more likely and need to be 1185 
detected with a more complex FOM. A statistical approach can further distinguish between 
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two types of errors with respect to assigning a voxel to a lesion or normal tissue: Type I -  
false positives and Type II - false negatives. The various FOMs are discussed in detail in 
Appendix IV. The FOMs listed in Table 4 were considered for use in the future standard196. 
Most of these FOMs have advantages and drawbacks, some of which are listed in 1190 
Table 4. For example, optimizing sensitivity alone would favor methods that encompass and 
therefore overestimate the true volume. Similarly, optimizing positive predictive value alone 
would instead favor methods that underestimate the true volume. Other criteria are not strict 
enough (e.g., volume difference), computationally expensive (e.g., Hausdorff distance), or 
unable to distinguish between the two error types (false positive and false negative, 1195 
e.g., Jaccard and DSC). Therefore, we caution against using a single performance metric for 
segmentation evaluation and rather suggest reporting several FOMs such as the combination 
of sensitivity and positive predictive value, in order to convey complementary information.   
Table 4. A comparison of various volume/contour agreement measures and their sensitivities 
to the properties of the segmented lesions. The important properties are whether they 1200 
account for volume differences, shape discrepancies, false positive vs. false negative. The 
computational complexity is graded between easy (+) and complicated (+++), although none 
of the metrics are particularly slow to compute using modern toolkits and computers 
(Barycenter distance is the distance between the centers of mass of two sets).  
 Evaluation criteria Location Size Shape Type I/II  Complexity 
Volume difference no yes no no + 
Barycenter distance yes no no no ++ 
Jaccard similarity 
coefficient 
yes yes yes no ++ 
Dice similarity coefficient 
(DSC) 
yes yes yes no ++ 
Hausdorff distance yes no yes no +++ 
Sensitivity + Positive 
Predictive Value (PPV) 
yes yes yes yes ++ 
 1205 
Notice that the Type I/II error distinction in sensitivity and PPV requires the knowledge 
of which of the two volumes is the actual ground truth, whereas other measures treat both 
volumes in the same way. In the absence of a ground truth volume (neither A nor B is 
preferred), then the Dice similarity coefficient can be used instead of Sensitivity + PPV. 
As discussed in section IV.B, some image datasets, e.g., simulated and experimental 1210 
images, may have more accurately defined ground truth than others, (e.g., clinical images 
accompanied with pathological results or manual contours). In the case of a less accurately 
defined ground truth, the inverse-ROC approach, used by Shepherd, et al.115, can give a 
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reliable evaluation of the algorithms, provided a set of contours (e.g., manual delineations) 
that encompass the ground truth contour exist. 1215 
Due to the complexity of the PET segmentation problem, more appropriate evaluation 
metrics will need to be derived from investigations of correlations between the assessment of 
these metrics and a clinical endpoint. In the case of radiotherapy treatment planning, an 
example would be the geometrical concordance of the delivered dose distributions to the 
PET segmentation contour and the treatment outcome. Tools which can account for such 1220 
information have recently been proposed197. 
V. DISCUSSION OF SEGMENTATION LIMITATIONS, DEPENDENCIES 
AND IMPLEMENTATION 
V.A Biological limitations of the segmentation concept 
It has long been realized that cancer is an abnormal growth caused by unregulated cell 1225 
proliferation. Cancerous tissue morphology is highly irregular and characterized by chaotic 
vascularization, resulting in a unique pattern of blood flow for every tumor, which modifies 
PET tracer availability and uptake in a way unique for each patient. Also, different parts of the 
same tumor can have very different micro-environmental status, including different levels of 
glucose metabolism. Other factors affecting intratumoral PET tracer distribution are the 1230 
presence of necrosis and stromal tissue intertwined with cancer cells. As a result, the 
intratumoral pattern of FDG uptake is highly heterogeneous.  
While it is possible to carry out in vitro studies to relate PET tracer binding/uptake to 
environmental parameters of the cells in culture, direct in vivo application of such data is 
highly speculative and lacks strong foundation due to the reasons listed above. The 1235 
uniqueness and stochastic nature of the factors governing PET tracer uptake and its 
intratumoral distribution in each patient represents one of the biggest challenges for PET 
image segmentation. The complexity of the problem hampers the widespread adoption of 
auto-segmentation tools for routine clinical use. 
Other factors can also potentially affect PET-based lesion segmentation. Tumors may 1240 
lack a well-defined boundary separating them from the surrounding normal tissues. 
Microscopic cancer extensions can produce additional blurring of this idealized, macroscopic 
boundary. Furthermore, in addition to heterogeneities of tracer uptake in the lesion, 
surrounding normal structures are likely to be characterized by different levels of tracer 
uptake. Inflammation, if present, can result in further complications by significantly increasing 1245 
FDG uptake. Correspondingly, the biological meaning of the segmented volume should be 
interpreted in the context of all these biological factors governing image formation in PET. 
Therefore, both PET image segmentation as well as interpretation of the segmentation result 
are very non-trivial tasks and should be approached with caution. However, for situations 
where tumor delineation is needed, e.g., radiation therapy treatment planning, the right 1250 
choice of properly validated PET-AS methods used as a guidance tool by the physician can 
result in increased target definition accuracy and better treatment.   
 
V.B.  Dependence on segmentation task 
 1255 
There may be significant differences in terms of tumor segmentation algorithm 
parameterization and use, depending on the task. At the same time, it should be emphasized 
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that most published methods have been proposed either as a general PET segmentation 
approach, which can be used in any application (although rarely tested or validated for all), or 
as a method developed and validated for a specific clinical application (e.g., radiotherapy 1260 
planning, without being tested in another setting). 
In treatment planning the PET information can be used in two ways198:  
1. Target volume delineation: The PET-based GTV should safely encompass the entire 
tumor volume without missing regions with low radiotracer accumulation. In order to 
avoid cancer under treatment, even equivocal voxels would usually be included. 1265 
However, to avoid over irradiation of too large a volume of normal tissue, the GTV 
should not be larger than needed. To account for microscopic disease the radiation 
oncologist then draws the CTV by adding a margin to the GTV (section IV.A). 
Uncertainties to the tumor contour for external radiotherapy may be generated based on the 
accuracy of the method as determined during the evaluation stage. The delineation 1270 
uncertainty can be approximated as a shell or annular volume around the segmented 
volume. The thickness of the annular shell could, for example, be derived from the average 
thickness of the annular volume between the overlap and union volumes of the segmentation 
and reference surfaces determined during the evaluation stage. Other options are to use 
distance metrics between these surfaces, which can be based on the Hausdorff distance or 1275 
similar methods199. 
2. Target substructure determination: In contrast, PET-based definition of tumor sub-
volumes for so-called biologically conformal radiotherapy or dose painting2 requires a 
different approach. In dose painting, radiation is shaped according to the PET uptake, 
theoretically delivering higher dose to the radiation resistant and/or tumor-rich parts of 1280 
the tumor. In order to achieve this goal, one needs to rely on a detailed understanding 
of the underlying tumor biology and PET signal (e.g., PET tracer uptake and retention 
mechanisms), as well as how to determine the dose prescription function based on 
the PET signal. In that specific context, radiotracers different than FDG have been 
investigated, e.g., use of FMISO-PET might indicate hypoxic regions  and the use of 1285 
FLT-PET might indicate tumor proliferative regions where increased dose  is needed. 
In such cases PET-AS methods would need to be able to define both the entire tumor 
volume as well as sub-volumes with different levels of activity. In some rare cases, 
multi-tracer datasets can be available and the images combined to define a biological 
target volume (BTV). Methods based on information fusion have been proposed to 1290 
address this specific challenge170, 200-202. 
For treatment response assessment: 
1. Segmentation can be used for the estimation of various uptake measurements (mean 
SUV, total SUV, heterogeneity of uptake using, e.g., histogram-derived first order 
features or more complex second and third order textural features), which may 1295 
correlate better with the clinical outcome than less comprehensive metrics, such as 
maximum or peak SUV.   
2. Automatic segmentation can be used for more consistent longitudinal tracking of 
treatment response to various cancer therapies. Repeatability and reproducibility of 
segmentation in this case could be more important than absolute accuracy, especially 1300 
within the context of the known relatively high test-retest variability of PET scan 
imaging203, 204.  
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The PET avid volume and/or on tumor-to-background ratio may change as a result of 
therapy.  Therefore for PET-AS methods which are dependent on these parameters (e.g. 
some adaptive threshold methods23, 51) use of the same method for segmentation of PET 1305 
images before and after therapy without proper adjustment of parameters may result in 
incorrect and inconsistent segmentation. This may then affect the accuracy of the metrics 
derived from the segmented volume.  In general using FDG for adaptive radiation therapy 
may be problematic due to change of the SNR as a result from reduction of the tumor uptake 
and/or inflammation. This means that, for example,  a threshold set to 42% of peak activity 1310 
may provide erroneous results if the tumor/background ratio changes substantially or if the 
PET avid volume decreases under a certain value 48.  This volume was found to be about 1.5 
mL for older PET scanners but will be partial volume and therefore scanner dependent. 
Similarly, if the PET avid volume has an irregular shape with both wide and thin parts, the 
threshold may have to be adapted to the effective size of these parts of the volume. 1315 
 The time saved by using automatic segmentation is also important; lack of time in 
daily practice is one of the major limitations preventing investigators from using ROI-based 
methods for treatment response assessment in cases where volume (or volume-derived) 
information is important. As a result, in current practice, SUVmax and SUVpeak, which are less 
dependent on accurate edge
 
and volume definition, are more widely used for response 1320 
assessment. Automatic segmentation provides consistency and time efficiency in longitudinal 
studies. However, consistency is harder to achieve for PET measures dependent on the 
segmented volume (e.g., SUVmean, SUVtotal), compared to measures that do not depend on it, 
but simply follow the voxel(s) with highest activity concentration anywhere within the GTV 
(e.g., SUVmax, SUVpeak).  1325 
In addition, even for a single clinical goal (e.g., radiation treatment planning), the PET-
AS methods may meet different requirements for different disease types and body sites. This 
may profoundly affect the method evaluation process. For example, this may result in 
favoring relatively simple, e.g., adaptive threshold methods, optimized for each lesion type 
versus more complex advanced methods, which may do equally well in different parts of the 1330 
body. During the development of a future evaluation standard, this possibility may be 
investigated by sorting the performance results of the PET-AS methods between body sites 
and tumor types. 
 
V.C. Dependence on scanner, image acquisition and reconstruction protocol 1335 
One major consideration in PET image analysis is the lack of standardization of clinical 
imaging protocols resulting from hardware and software variability, as well as the variation of 
procedures between clinical centers (injected dose, delay between injection and acquisition, 
acquisition duration, etc.). Thus, every post-acquisition, post-reconstruction analysis and 
extraction of relevant parameters from PET images depend on the actual qualitative and 1340 
quantitative characteristics of the analyzed PET image (e.g., resolution and noise), which are 
strongly influenced by the acquisition protocol. For this reason users are cautioned to always 
evaluate and validate published PET-AS methods for their specific clinical application and 
scanning protocol before clinical use. 
Recently, there have been several efforts to propose ways for the standardization of 1345 
imaging procedures. These efforts have sought to minimize the impact of acquisition 
protocols on the resulting visual quality and quantitative accuracy and consistency of PET 
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images4, 205, 206 207. One of the main reasons is to help improve consistency in multi-center 
trials that combine images acquired from different clinical centers, scanners and imaging 
protocols.  1350 
These efforts are to be encouraged. By reducing the existing variability in PET images 
encountered in clinical practice, they will contribute toward improved data consistency, which 
will facilitate the use of PET-AS algorithms across different centers and thus allow the use of 
advanced quantitative tools for treatment assessment. This will also contribute to reducing 
the dependence of PET defined tumor volumes on the specific instrumentation and protocols 1355 
in a given clinical center.  
The quality of an image is defined by several parameters, which may have different 
importance for different tasks208-211.  Segmentation differs from typical diagnostic tasks in that 
it seeks to identify the boundary locations and therefore uses a much larger parameter 
space. Based on this, there is an expectation that this problem is more ill-posed and requires 1360 
less noisy data to reduce errors.   
This can be achieved by modifying the injected activity, uptake period, acquisition and 
image reconstruction. Increasing the injected activity may improve the noise equivalent count 
rate. Typically, the injected activity is unaltered from that used for diagnostic imaging and it is 
possible that the risk from therapy is large enough that it outweighs the risks associated with 1365 
injecting a larger amount of activity. For the case of FDG-PET, a 1-hour post-injection delay 
is used; however, the contrast ratio of uptake to background continues to increase with 
time. This 1 h selection is due to tradeoffs between workflow, consistency, diagnostic 
efficacy, etc. Increased dwell times over the tumor regions and/or additional spot scans can 
also be used to improve the images. 1370 
Increasing the number of counts in the data using these approaches would allow 
achieving higher resolution image by increasing the number of iterations while preserving the 
noise level212, 213. Beyond this, some penalized image reconstruction methods with edge 
preserving prior models have been developed214-218. These may produce images with edges 
that are more easily segmented. These tradeoffs may be considered for future protocol 1375 
optimizations together with the risks associated with higher doses related to therapy. 
 
V.D. Dependence on tracer type and physical isotope  
Current investigations are dominated by FDG and 18F-based tracers. This is 
understandable because FDG remains the most widely used radiotracer in oncologic 1380 
imaging. However, there is a growing interest in non-FDG tracers, including radiolabeled 
amino acids such as L-methyl-11C-methionine (MET) or O-(2-18F-fluoroethyl)-L-tyrosine (FET) 
for brain tumor delineation, proliferation markers such as 18F-3′-fluoro-3′-deoxy-L-thymidine 
(FLT) or hypoxia tracers such as 18F-fluoromisonidazole (F-MISO). At least some of these 
agents show a lower intensity of uptake in tumor lesions than FDG (e.g., FLT and FMISO), 1385 
and thus physicians may apply different criteria for what constitutes significant radiotracer 
uptake (for instance in comparison to background reference regions or blood activity). In fact, 
little attention has been given to the question of how the use of these alternate radiotracers 
can affect the accuracy of the various segmentation algorithms. Most of the segmentation 
approaches have been designed for FDG-PET. Also most fixed and adaptive threshold-1390 
based methods are optimized for a specific range of tumor-to-background ratios. However, 
some methods have been used successfully on different radiotracers219, 220. For some tracers 
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a lower target-to-background ratio may lead to significant problems in the use of threshold-
based algorithms.  Tracers other than FDG may be of great interest for dose painting and 
contouring of tumor sub-volumes. However, for isotopes other than 18F, differing physical 1395 
parameters, such as positron range and emission of cascade gamma rays, may degrade 
image quality and must be taken into account. This emphasizes the need for more robust 
algorithms that can deal with varying contrast and noise levels in reconstructed images. 
Histological validation of such tracer accumulation is necessary to determine sensitivity, 
specificity and detection limits before these agents can be considered for dose modulation.  1400 
It should be noted that multi-tracer datasets have been acquired in research protocols 
and clinical trials in order to investigate the complementary value of different tracers. Since 
the acquisition and investigation of multi-tracer data is currently in its dawn and their 
segmentation is a very specific and challenging task outside common clinical practice we are 
limiting their discussion only to this paragraph. Several novel methods have been developed 1405 
to segment such data, usually with the goal of deriving a single biological target volume 
(BTV) from multi-tracer images. The use of information fusion has been suggested to achieve 
this as early as 2011200-202  and some recent fusion-based methods have been evaluated with 
promising results170. 
New, more sophisticated pattern recognition/machine learning algorithms are also on 1410 
the horizon; these may make use of more subtle image characteristics, including noise 
distribution, underlying PSF, and nominal biological distribution. Such algorithms will require 
training sets of expert identified and segmented data and will only be valid for the type of 
data they were trained to process (see section II.B.2). Therefore, while at present most 
segmentation schemes are radiotracer/isotope agnostic, this may rapidly change, as more 1415 
sophisticated image-processing techniques become available. 
V.E. Effect of motion 
Motion can have an important impact on the apparent size, shape and contrast of 
lesions in PET images, especially in the thoracic area, due to respiratory motion. There has 
been a significant advancement of respiratory motion correction algorithms based on breath 1420 
hold, external or internal gating, deformation corrections and post-frame summing, blur 
deconvolution and others221-238. Of these the data driven gating approaches of PET images 
promise to yield comparable results with less discomfort for the patients and to be more 
efficient than hardware driven approaches239-241. The development of synergistic algorithms, 
which account for motion simultaneously with segmentation, is also expected242-244.  1425 
 
In the context of stereotactic body radiotherapy (SBRT) it has been shown that it may 
be useful to derive respiratory correlated target volumes from gated (4D) PET/CT scans in 
addition to 4D-CTs 243, 245, 246. However, the current common practice still is to segment the 
PET volume integrated over the scan time. If PET-AS algorithms are evaluated on clinical 1430 
images against the activity as seen in the uncorrected PET image, endpoint a) as described 
in section IV.A, the potential effect of breathing motion in these images is disregarded. If the 
CT images are also used in the segmentation process, the uncorrected PET images should 
not be used for cases potentially affected by motion due to possible misalignment between 
the CT and PET. 1435 
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V.F.  Guidelines for acceptance and implementation for PET auto-segmentation 
algorithms  
Vendors have adapted and further developed some of the PET-AS methods when 
implementing them in commercial software. However, the number of published algorithms is 
much larger than the number of those implemented (see section II.B.5). The algorithms 1440 
implemented by vendors, while being adaptations of published algorithms, may have 
modifications and enhancements that have a “black box” quality if vendors are reluctant to 
disclose proprietary techniques. Therefore, the vendors may have specific recommendations 
on how to test their PET-AS algorithms, which the user should address first.  
An additional factor to consider is the variability in implementations in the various 1445 
commercial software visualization and analysis platforms. As it has been recently 
demonstrated, even for very simple metrics such as SUVmax, considerable variability has 
been shown to exist across various vendors and software, likely due to implementation 
errors, as well as different interpretation of, or assumptions about the data247. The developed 
digital reference object is a very useful tool that will allow verification and validation of the 1450 
vendor’s implementation. Indeed, similar observations were made regarding contours and 
volumes that were substantially modified when transferred from one station to another248. It 
is, indeed, not uncommon to transfer segmentation results such as contours from one station 
to another (e.g., a nuclear medicine-dedicated analysis station to a radiotherapy planning 
station) and the user should verify their consistency. In that respect, considerable 1455 
standardization efforts are needed to ensure that adopted PET-AS methods will be correctly 
implemented and the results are compatible across the various platforms of different 
vendors.  
Following vendor suggested acceptance testing, this task group envisions a three   
phase procedure (Table 5) for the implementation of segmentation algorithms that reflect the 1460 
different level of closeness to reality of the PET images (see section IV). The images to be 
used in the three stages would contain lesions represented by; (1) spherical/cylindrical 
objects, (2) irregularly shaped objects and (3) human datasets. Since each of these image 
types may present a different evaluation endpoint (IV.A) and specific challenges that depend 
on how it was generated, this will allow a more thorough evaluation of PET-AS methods.  1465 
Most current implementation tests typically stop with the first phase, incorrectly 
assuming that the PET-AS algorithm would be sufficiently accurate for realistic clinical 
images. For the first phase, phantoms with spherical inserts (diameter: 1 cm – 4 cm) imaged 
at varying object-to-background ratios (e.g., 2:1 to 10:1) can be used. In addition, iodinated 
contrast can be used to aid in segmenting the ground truth volumes and in excluding the wall 1470 
of the objects in the CT images. Simple shape (e.g., spherical) objects in uniform 
background, preferably without cold wall,171, 172, 174 are also most convenient for robustness 
evaluation across scanners and reconstruction schemes.  
For the second phase, a combination of physical phantoms capable of constructing 
irregularly shaped objects115, 174 and non-uniform activity distributions178, as well as 1475 
numerically simulated phantoms that contain irregular shaped objects and/or non-uniform 
uptake, can be selected among the family of phantoms discussed in IV.C.1 and IV.C.2. 
Finally, for the third phase for which we suggest using clinical images, the main limitation is 
insufficient knowledge of the ground truth. As discussed in IV.C.3, ground truth surrogates 
such as pathology findings of excised specimens and/or statistical consensus from several 1480 
manually drawn contours (preferably by different experts) can be used. Since both ground 
 44 
 
truth surrogates have a fair degree of uncertainty, the benchmark dataset should ideally 
comprise both of these image types.  
The evaluation metrics for assessment of the segmentation accuracy are described in 
IV.D. While several of these tools can be used, a combined metric, e.g., including sensitivity, 1485 
positive predictive value and Hausdorff distance is expected to provide a more reliable 
method assessment (see. IV.D.3). However, further investigations are needed to generate a 
combined evaluation metric that is not affected by biases of the metrics or correlations 
between them. We suggest that the results of the evaluation stage be used to estimate the 
contouring uncertainty as discussed in section V.B. 1490 
A standard, which will provide access to the selected benchmark datasets and various 
performance metrics, is currently under construction by members of the task group 168, 249, 250. 
As pointed out in the last column of Table 5, the ultimate evaluation of segmentation will be 
analyzing the outcome of treatments using the respective segmentation approach. 
Table. 5 Stages of evaluation of PET auto-segmentation (PET-AS) methods. DSC (Dice 1495 
Similarity Coefficient), PPV (Positive Predictive Values), HD (Hausdorff Distance). 
Step 1. Vendor 
acceptance 
2. Basic 
evaluation 
3.  Phase two 
evaluation:  
4. Phase three 
evaluation 
5. Impact 
evaluation 
Objective Proper 
functioning 
of software 
Accuracy of 
clinic-specific 
images; 
robustness of 
image 
properties 
Accuracy, 
repeatability and 
robustness of 
realistic shapes and 
variable uptake;  
Accuracy, 
repeatability and 
robustness of 
clinical images 
from the intended 
application 
Evaluation of 
clinical impact 
Datasets Vendor 
recommen
dation 
Simple 
objects in 
uniform 
background; 
repeated 
acquisitions 
Irregular shape 
and/or non-uniform 
uptake lesions in 
experimental or 
digital  phantoms 
without cold wall; 
multiple realizations 
Clinical images Clinical images, 
treatment plans 
and follow-up 
records 
Ground 
truth 
Vendor 
recommen
dation 
CT defined 
voxel level 
accuracy. 
High resolution CT 
or digital ground-
truth defined voxel 
level accuracy. 
Digitized 
histopathology 
and/or consensus 
of several manual 
delineations 
 Treatment 
outcome data 
Metrics Vendor 
recommen
dation 
Volume 
errors, DSC 
DSC, Sensitivity, 
PPV, HD 
DSC, Sensitivity, 
PPV, HD, 
Statistical 
evaluation of 
clinical endpoint 
(prognostic/predicti
ve value)  
Statistical multi-
parameter 
treatment 
outcome analysis 
 
Ideally, a segmentation algorithm would be portable across different scanners with their 
individual and sometimes proprietary reconstruction schemes and parameters. Since this 
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may not always be realistic for many PET-AS algorithms, the implementation should be 1500 
appropriately tagged as being optimized for specific scanner types and protocols. 
The minimum requirements for an algorithm depend on the intended application goal: 
diagnostic, therapy planning, or treatment/prognostic assessment. For diagnosis, the most 
important aspect of the PET-AS method is its ability to identify the tumor (not necessarily 
exact extents/boundaries) for a large range of tumor sizes on either original or PVE corrected 1505 
images, in order to provide the most accurate volume and the associated activity.  
For radiotherapy planning, the minimum requirements include the PET-AS’s accuracy 
in the delineation of the gross tumor volume and the ability to identify sub-volumes (for dose 
boosting/painting/redistribution applications), as is its ability to achieve a high sensitivity (to 
be sure to include the entire target) with minimal loss of specificity (to reduce irradiation of 1510 
healthy tissues and organs at risk).  
In the case of response assessment, the main requirement is that the portion of the 
tumor image that maximizes the predictive power of the particular parameter (biomarker) 
used, is correctly segmented. As a result, for this type of segmentation task, the link to the 
physical aspects of the tumor and imaging system are difficult to convincingly establish, and 1515 
the need for the clinical impact evaluation step (Step 4, Table 5) is especially important251. 
Also in most cases, for follow-up and therapy assessment applications, the PET-AS 
algorithm will have to be applied to serial scans independently, although developments 
dedicated to consider simultaneously sequential scans are also being developed200, 201, 252-255. 
Therefore, its robustness versus different contrast, heterogeneity and tumor size is extremely 1520 
important in order to provide non-biased results regarding the evolution of tumors during 
therapy. TG 174 (Utilization of 18F-Fluorodeoxyglucose Positron Emission Tomography 
(FDG-PET) in Radiation Therapy) is working towards standardizing the methodology used for 
sequential scanning (or even inter-patient scanning for clinical trial patients), so as to allow 
segmentation techniques to be used for fair comparison between the pre- and intra/post-1525 
treatment PET scans. 
Type of disease and body site dependence of the performance of PET-AS methods 
should also be expected. This means that the user should evaluate the chosen PET-AS 
algorithm for the intended body site. Furthermore, within the context of multi-centric studies, it 
is important that the chosen algorithm be validated for robustness against the varying noise 1530 
and texture properties associated with different scanner models and reconstruction 
algorithms and their associated parameters (voxel sizes, etc.). Alternatively, the algorithm 
should be easy to adapt/optimize to the characteristics of each individual center/scanner. 
Scanning the same phantom at the involved institutions and comparing PET-AS method 
performance is suggested. The limitations of the selected phantom need to be well-1535 
understood as discussed in IV.C. 
V.G.  The complementary role of manual and auto-segmentation for PET  
In order to satisfy the requirements laid out in the previous sections, PET-AS algorithms 
need to accurately account for the physical and technical sources of bias and uncertainty in 
the PET images. In addition, the ideal PET-AS algorithm should be able to account for 1540 
anatomical, physiological and other clinical information not present in a PET image, which 
can alter the location of a contour. Although some of the algorithms listed in Table 1 promise 
to answer most of the physical requirements, accounting for clinical information not present in 
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the PET image is beyond the capabilities of most available PET-AS algorithms. As a result, 
there is a need for active physician involvement in the segmentation process. Therefore, at 1545 
present and in the near future, automatically generated contours can be used only as a 
starting point for GTV delineation by the physician, who may decide to change them based 
on his/her knowledge. It is likely that human supervision will remain necessary, both before 
and after the process of automatic contouring, although this rule may change in the future256. 
A recent work has presented a method for head-and-neck, in which user interaction is kept 1550 
minimal but exploited nonetheless so that the user can provide simple cues to guide the 
segmentation algorithm in an efficient and intuitive manner 257. 
Before auto-contouring:  
Because automatic contouring algorithms cannot distinguish between malignant and 
benign tissue tracer uptake, the selection of the lesion, i.e., the diagnostic decision to regard 1555 
a certain region of elevated tracer uptake as malignant, must be done by a knowledgeable 
physician. This step includes all forms of diagnostic decision making, considering clinical 
information not present in the image, topography, pattern and anatomical location of the 
suspected uptake, as well as the probability for malignant spread.  
After auto-contouring:  1560 
The review and editing of the final contour is required for consistency with known 
diagnostic information, including findings by other imaging modalities, endoscopy results and 
clinical knowledge. The contours drawn on the same lesion may differ if the goal is 
therapeutic (need to include all malignant tissue) compared to the case when the goal is 
diagnostic (need to mark structures containing tumor with a high probability).  1565 
To ensure a smooth workflow in daily practice, the contouring software should facilitate 
both automatic contouring and user interactions for lesion selection and contour editing or 
algorithm guidance (by providing better initialization, for example258). It is also necessary to 
enable co-viewing or fusing of the PET scan with other imaging modalities to include all 
diagnostic information in the contouring process. In this context, beyond the application of 1570 
well-designed and thoroughly evaluated algorithms for automatic contouring, the use of multi-
modality imaging and collaboration between radiation oncologists and/or oncologists, and 
imaging specialists (e.g., diagnostic radiologist and/or nuclear medicine expert) are 
necessary to ensure better understanding of planning images.  
VI. CONCLUSIONS 1575 
Given the large number of published PET-AS algorithms, their different level of 
validation and because most of these published algorithms are not yet implemented in 
commercially available software, recommending a single PET-AS method is challenging and 
premature. Furthermore, even if such a recommendation could be made it may become 
obsolete considering the rapid development of the field. Instead, we have provided basis for 1580 
understanding the logic and the limitations of the main classes of approaches and a 
framework for their rigorous evaluation and comparison, which we believe will be of greater 
value for future developments. 
As reviewed in this report, there is accumulating evidence in the literature pointing to 
the higher accuracy and robustness of the approaches based on more advanced image 1585 
segmentation and analysis paradigms, when supplemented with manual and visual 
verification, compared to simple threshold-based approaches. These advantages, however, 
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come at the expense of the ease of implementation and understanding of the simpler 
algorithms. At the same time it is possible that simpler (e.g., adaptive threshold) methods 
may perform comparably well, if not better, for a certain body site/disease type if specifically 1590 
optimized for these conditions. Recent algorithms which employ some type of consensus or 
automatic selection between several PET-AS methods have potential to overcome the 
limitations of the individual methods when appropriately trained. In either case, accuracy 
evaluation is required for each different PET scanner and scanning and image reconstruction 
protocol. For the simpler, less robust approaches, adaptation to scanning conditions, tumor 1595 
type and tumor location by optimization of parameters is highly recommended. The results 
from the method evaluation stage can be used to estimate the contouring uncertainty. All 
PET-AS contours should be critically verified by a physician.  
Clearly, further research for solving the dilemma of PET image segmentation is 
needed, and one potential solution for going forward is the creation of a standardized 1600 
protocol (i.e., a benchmark) for consistent evaluation and comparison of the PET-AS 
methods. This task group suggests the following considerations for generating such a 
standard: 
1) The evaluation endpoints need to be clearly separated based on algorithmic 
accuracy and clinical relevance. In order of increasing clinical relevance the 1605 
reference choices are:  a) the unmodified PET images; b) the tracer distribution 
corrected for artifacts; c) the underlying histopathology. 
2)  At present, the benchmark needs to consist of several image datasets of different 
types: experimental (phantoms), numerically simulated and clinical, in order to 
compensate for the deficiencies of each of them. Also, a complete set of images 1610 
should include images from all body sites, since algorithm performance may depend 
on local tracer uptake specifics.  
3)  The performance of the methods needs to be evaluated using different metrics, 
which include volume overlap measures, classification evaluation tools as well as 
voxel-to-voxel distance metrics. 1615 
 
These considerations are the core of the guidelines for PET-AS algorithm evaluation 
presented in more details in section V.F. 
 
A standard that conforms to these requirements will provide a more objective 1620 
comparison of the algorithms by mitigating the large variability of image sets and metrics 
used for evaluation. At present, a benchmark following these recommendations is under 
development within the task group. Different PET-AS methods are currently being tested 
within this framework to evaluate the benchmark design and components168, 249,250. A publicly 
available tool such as this should aid users in evaluating current algorithms to increase 1625 
confidence in selecting the most adequate PET-AS method to use for a particular application 
under physician supervision and to provide reference criteria to evaluate future methods.  
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Appendix I 
PET-AS Formalism examples 
 
A) Fixed and Adaptive Threshold algorithms  1640 
 
Thresholding could be expressed as follows: ܫ⏞ ∈ Υ�ሺܫ௜ሻ = {ͳ,Ͳ, ܫ௜ ൒ ܶ,ܫ௜ < ܶ, ܫ௜ ∈ ܫ�ை�    (A1) 
where  Υ�ሺ∙ሻ is the indicator function for threshold T, I⏞ is the segmented subset of the voxels 
within a Volume of Interest (VOI) in image I, and Ii is the uptake value (generally normalized 1645 
to SUV) at voxel �. 
 
The particular thresholds for performing segmentation are often found by minimizing the 
difference between known volumes, Vk୬୭୵୬, (typically a phantom study) and the volumes 
defined by applying different thresholds,  VሺTሻ. This often is described as, 1650 ܶ∗ = argmin� (�௞௡௢௪௡ − �ሺܶሻ)ଶ     (A2) 
which could be solved by a least-squares estimation technique. Additionally, it is possible to 
add some topological constraints to I⏞ to ensure its connectedness and/or that it is simply 
connected, to avoid islands or holes within the segmentation ROI. In case of NSCLC the 
optimal threshold for their specific scanner and protocol was related to volume via, 1655 ܶሺ�ሻ = ܫ௠௔௫ ቀ5ͻ − ͳͺ logଵ଴ � ቀܫ⏞ቁቁ ,    ܫ௜ ∈ ܫ⏞   (A3) 
where  I୫ୟ୶ is the maximum uptake in the segmented subset and  V ቀ I⏞ቁ is the segmented 
volume. The functional forms of various threshold segmentation schemes are given in Table 
A 1. 
 1660 
Table A1: Functional forms of various threshold segmentation schemes. 
Comments Threshold Estimator 
Drever, et al.’s single-parameter FTS fit259: It is most 
notable for its use of the histogram’s mode for more stable 
estimation of the background. 
 ܶ = ܽ(ܫ௠௔௫ − ܫ௕௞௚) + ܫ௕௞௚ 
Nestle, et al.’s single-parameter FTS fit23: This fit uses the 
mean of voxels greater than 70% of the lesion’s maximum. 
The use of the mean instead of the maximum uptake 
reduces the variability. 
 
 ܶ = ܽ ܫ௠௘௔௡,7଴%௠௔௫ + ܫ௕௞௚ 
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Zaidi, et al.’s two-parameter FTS fit28: The scaling 
parameter, I୫ୟ୶, can be recast as a mean-value or 
volume-based measure for an ATS algorithm260. 
ܶ = ܽ + ܾ ܫ௕௞௚ܫ௠௔௫ 
Schaefer, et al.’s two-parameter FTS fit30: This fit is 
extended from Nestle’s scheme above23.   ܶ = ܽ ܫ௠௘௔௡,7଴%௠௔௫ + ܾ ܫ௕௞௚ܫ௠௔௫  
Erdi, et al.’s two-parameter FTS fit48: uses a fixed 
threshold of 42%. It was noted that it worked well for large 
lung tumors, however the authors go on to say that its use 
should be limited to homogeneous uptake distributions. 
 ܶ = ܽ ݁−௕ �ሺ�ሻ 
 
Black, et al.’s two-parameter ATS fit52: The use of the 
mean SUV to make the algorithm more stable to noise 
requires a threshold for its calculation. 
ܶ = ܽ + ܾ ܫ௠௘௔௡(�ሺܶሻ) 
 
Biehl, et al.’s two-parameter ATS fit46: The log of the 
volume requires a threshold. This algorithm is shown to 
work for a wide range of tumor volumes in NSCLC.  
ܶ = ܫ௠௔௫ ቀܽ + ܾ ݈�(�ሺܶሻ)ቁ 
 
Jentzen, et al.’s three-parameter ATS fit50: The parameters 
were fitted from phantom data. The inverse volume 
requires a threshold. 
ܶ = ܽ�ሺܶሻ + ܾ ܫ௕௞௚ܫ௠௔௫ + ܿ 
 
Nehmeh, et al.’s four-parameter ATS fit51: The fit used 
Monte Carlo simulation results to avoid cold wall effects 
(see the end of p.9 and the beginning of p.10). 
ܶ = ܫ௠௔௫ (ܽ + ܾ �௖ሺܶሻ݁ௗ �ሺ�ሻ⁄ ) 
 
Burger, et al.’s Background Subtracted Lesion (BSL) 261:  
Not meant as segmentation but rather a volume estimation 
scheme, an equivalent volume threshold can be found (Li 
et al.262) Note that this method tends to overestimate the 
volume by including spill-out. 
Procedure: ܶ, such that the volume from a 
threshold matches the volume 
used in the BSL measurement. 
 
B) Segmentation of multimodality imaging: 
In the case of FCM multimodality segmentation, a fuzzy membership function and the cluster 
center ܿ௞௡ are updated according to 1665 �௜௞௡ = ‖௫�−௖��‖∑ ‖௫�−௖��‖−మ��=భ , ܿ௞௡+ଵ = ∑ (���� )�௫���=భ∑ (���� )���=భ    (A4) 
where �௜௞௡  is the fuzzy membership probability that image pixel �௜ belongs to cluster ݇ at 
iteration �, and ܿ௞௡ is the updated cluster center intensity. 
 
In the case of MVLS, the objective functional could be modified to: 1670 
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infୡ ܬሺܥ, ܿ+, ܿ−ሻ ∝ ͳ� ∑ �௜+ ∫ |ܫ௜ − ܿ௜+|ଶܪሺ�ሻ ݀�Ω + �௜− ∫ |ܫ௜ − ܿ௜−|ଶ(ͳ − ܪሺ�ሻ) ݀�Ω௜  
           (A5) 
where � is the level set function. ܿ௜+ሺܿ௜−ሻ corresponds to the pixel intensity mean values 
inside (outside) of the contour C.  ܪሺ∙ሻ is the Heaviside function and ሺ�௜+, �௜−ሻ are user-defined 
parameter pairs providing relative importance weights for each of the imaging modalities. The 1675 
target boundary is defined at the zero level ሺ�ሺܥሻ = Ͳሻ.  
 
Appendix II. Uptake Normalization and Threshold Parameter Estimation 
Uptake normalization: 
Preprocessing the uptake data is important for inter-patient comparisons and for 1680 
defining a segmentation scheme. The most common uptake preprocessing is the conversion 
to SUV. The use of it or something similar is essential to making the selection of a threshold 
activity independent and applicable across patients and institutions47. SUV itself comes in 
many flavors, with normalization being carried out with respect to total body mass, lean body 
mass, body surface area, etc. Beyond SUV, several studies have advocated normalizing 1685 
patient data to the aortic arch (RTOG 1106) or to mean liver uptake. For inter-patient 
comparisons these normalizations are likely sufficient, but for segmentation, the tumors 
themselves may need additional and individual normalization. 
For segmentation, further normalizing the intensity within the images or VOI allows for 
greater consistency between different image sets. Although several segmentation algorithms 1690 
based on contour detection or region determination through contrast measurements do not 
require nor benefit from any SUV conversion, such SUV normalization is often used for 
segmentation. Some algorithms23, 30, 31, 52, 259, 260, 263 find it useful to further normalize the 
image with respect to the background subtracted image (i.e., contrast), which is given by, �௜ = �(�௜ , �௕௞௚, ��௘௙) = ( ௫�−௫��೒)( ௫�೐೑−௫��೒)     (A6) 1695 
where xrୣ୤ is a reference voxel value and xୠk୥ is the background value, often xrୣ୤ = x୫ୟ୶.  As 
a further simplification, the image can be normalized solely to x୫ୟ୶ under the assumption that xୠk୥ is small and does not vary much between images. In either of these cases, the 
maximum contrast results in ξ୫ୟ୶ = ͳ, so all voxels for which ξi ൒ T within the VOI are 
included in the segmented volume. While alternatives to the equation above exist, the 1700 
various values that compose it are often similar. As a result, some discussion regarding their 
choice is useful. 
In choosing the voxel values used to define the equation above, some care is 
necessary to ensure that they are relatively insensitive to the segmentation region and image 
noise264. In the case of the background value, xୠk୥ is often taken to be the mean intensity 1705 
over a large region, where the mean is taken from voxels that are far enough from the edge 
of the object to avoid PVE. Alternatively, when using a histogram approach the mode (the 
most frequent value) of the voxels’ intensity distribution can be chosen instead of the 
mean263, 265. The mode has the advantage of being less susceptible to PVE near the edge of 
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the lesion. In either case, both the mean and the mode are typically well-defined and 1710 
relatively insensitive to image noise. 
On the other hand, for the reference uptake value, xrୣ୤, the choice of the maximum 
intensity voxel in the object tends to be sensitive to the image noise thus using x୫ୟ୶ is 
problematic23, 30, 52, 260. Virtually all phantom-based threshold models assume that the activity 
is uniform in the lesion. Yet the maximum intensity voxel of a region is very sensitive to the 1715 
size of the object; large objects will exhibit a larger variation of their maximum SUV than 
small ones. In patient data, this is less clear due to tumor heterogeneity, but it has prompted 
the use of alternative definitions to maximum SUV for characterizing tumor uptake, such as 
peak SUV, a grouping of the 10 highest uptake voxels, or similar266. One approach described 
in Nestle, et al.23 and later expanded on by Schaefer, et al.30 is to define the reference value 1720 
as the mean of a region defined by a percent threshold of the maximum voxel (in both papers 
70% max SUV). This approach helps reduce the noise associated with a single voxel and 
provides some stability to the measurement. In addition, it has the nice property of making 
the segmentation scheme independent of the lesion’s volume. Using the mean of the 
segmented volume as well as in approaches using decomposition of image histograms65, 267 1725 
is even more insensitive to noise, but makes the threshold a function of the segmentation 
boundary and requires an iterative solution. 
Threshold Segmentation: 
The choice of a threshold for segmentation is an optimization problem in which an 
objective function, based on a model of the lesion and the image (and possibly other 1730 
parameters) as functions of threshold, is minimized with respect to the threshold. This can be 
written as ܶ∗ = argmin� (�ሺܫ, ܶ, �௜ , �௠௔௫ , �, … ሻ) 
 
Subject to:  hሺf, T, xi, x୫ୟ୶, V, … ሻ ൑ Ͳ    (A7) 1735 
where  φሺI, T, xi, x୫ୟ୶, V, … ሻ is the objective function of the image,  I, the threshold,  T, 
normalized uptake,  x, and possibly other independent variables (noise, etc.). The constraint 
equation,  hሺf, T, xi, x୫ୟ୶, V, … ሻ, provides constraints on the optimization in order to meet 
predefined conditions on the segmentation boundary (topological constraints: VOI boundary, 
connectivity, simply connected region, etc.). Here the threshold T*, which minimizes the 1740 
constrained optimization problem, still directly defines the segmentation boundary. However, 
the inclusion criteria in the constraint equation can force some voxels above and below this 
assignment threshold to be assigned into the alternative volume. 
 
APPENDIX III.  PET Phantoms 1745 
Table A1. A summary of the existing phantoms that are considered as potential candidates to 
provide data for a future PET-AS evaluation protocol. 
Name or type 
and Reference 
Example figure and brief description Advantages Disadvantages 
Experimental phantoms 
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IEC,  NEMA 
NU 2-200186 
 
Known 
ground truth, 
Variable 
sphere size, 
Widely 
available 
Overly simple 
unrealistic 
lesion shapes; 
Uniform 
background; 
cold walls 
“Porous 
phantom,” 
Di Filippo, et 
al. 2004172 
 
Fig. T.A1.2. Perforated discs used for the 
construction of the hot spheres: multi 
resolution (left), multi contrast (right). 
Reprinted with permission from Med. 
Phys. J.. 
Adds variable 
contrast, 
eliminates 
cold walls 
Simple shapes, 
Uniform uptake 
Tedious 
manufacturing 
“Swiss 
cheese,”  
Hunt, et al. 
2007173  
 
Similar to the 
“Porous 
phantom,” 
above 
Easier 
manufacturing 
Simple shapes, 
Uniform uptake 
 
Tumor 
phantom, 
Shepherd, et 
al. 2012115 
 
Fig. T.A1.4. PET images and CT image 
based iso-surface of the tumor model 
phantom. 
Irregular 
shapes 
including 
branching 
Based on 
clinical 
images 
Ground truth 
in PET image 
space from 
hybrid CT 
thresholding 
Cold walls of 
glass 
compartments 
 
Does not 
recreate 
heterogeneity 
(requires 
internal medium 
of spatially 
varying 
absorbance)  
Fig. T.A1.1. Image 
of a transaxial slice 
through the center 
of the spheres 
Fig. T.A1.3. A cut 
view of the 
phantom, 
produced by 
rapid prototyping. 
Reprinted with 
permission from 
Med. Phys. J.. 
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Molecular 
sieves, 
Zito, et al. 
2012174 
 
Known 
ground truth; 
irregular 
shapes 
Uniform lesion 
uptake; uniform 
background 
Using 
Radioactive 
Ink in 2D and 
3D printers, 
Larsson, et al. 
2000175, El-Ali, 
et al. 2003176, 
Miller & 
Hutchins, 
2008268,177 
 
 
Fig. T.A1.6. PET image of the human 
brain phantom produced by incorporating 
a radioactive dye in rapid prototyping.268 
(Reprinted with permission.) 
Can match 
the irregular 
shape and 
non-uniform 
uptake of real 
lesions 
A specially 
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Fig. T.A1.7. 
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Fig. T.A1.8. A schematic showing the 
generation of PET-like images from 
reference activity, tumor and attenuation 
distribution images. These reference 
images are forward projected, scaled, 
blurred and noise is added to simulate 
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tumor and 
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tissues and 
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APPENDIX IV: Evaluation Criteria for Segmentation Tools 1750 
 
Agreement between sets of voxels 
Let A and B be two volumes lying in space S composed of voxels. This space can be 
the 3D image matrix or the field of view of a scanner. Volumes A and B are subsets of this 
space. A and B are therefore sets of voxels. 1755 
The measured volume of A is equal to v|A|, where v is the voxel size expressed in 
volume units and |A| denotes the cardinality of A. The voxel size does not need to be 
specified and the volume of A can be expressed by its cardinality without loss of generality. 
The agreement between A and B basically depends on the cardinality of their 
intersection |ܣځܤ| . The disagreement is reflected by the two set differences |ܣ\ܤ| and |ܤ\1760 ܣ|, i.e., elements of A that are not elements of B and vice versa, respectively. There are 
therefore two types of errors. These are also absolute errors. The simplest normalization 
factor is |A∪B|−1. In this case, we have  |஺ځ஻||஺ڂ஻| + |஺\஻||஺ڂ஻| + |஻\஺||஺ڂ஻| = ͳ   (A8) 
The first term is known as the Jaccard similarity coefficient, which varies between 0 and 1. 1765 
For example, let us assume that A and B are different volumes but |ܣ| = |ܤ| and |ܣځܤ| =|ܣ| ʹ⁄ . Given this then we have |ܣڂܤ| = ͵/ʹ|ܣ| and the Jaccard coefficient is equal to 1/3, 
whereas the overlap actually represents 50% of A. This distortion of the intuitive perception 
of the overlap is addressed by the Dice Similarity Coefficient (DSC), which is defined as  Diceሺܣ, ܤሻ = ଶ|஺ځ஻||஺|+|஻|.   (A9) 1770 
The normalization factor is the inverse of the average volume. In the same example as 
above, the DSC is equal to 1/2 and concurs with the intuition. It can easily be verified that the 
DSC varies between 0 and 1.  
At this point, both A and B have been considered on the same footing. Let us now 
define A as representing some ground truth and that B is defined as an observation of A with 1775 
some inaccuracies. In this case, |ܣ\ܤ| and |ܤ\ܣ|are the numbers of false negatives (FN) and 
false positives (FP), respectively. This, and the above information, can be written in a 
confusion matrix as [|ܣځܤ| |ܣ\ܤ||ܤ\ܣ| |ܵ\ሺܣڂܤሻ|] ,   (A10) 
where |ܵ\ሺܣڂܤሻ| is the number of true negatives (TN), which is obviously of little interest, as 1780 
it depends primarily on the unimportant volume of space S, contrary to true positives (TP) in |ܣځܤ|. The most natural normalization factor here is |A|. The ratio |ܣځܤ|/|ܣ| is closely 
related to the DSC, provided we have |ܤ| = |ܣ|. We have here a single equality given by |஺ځ஻||஺| + |஺\஻||஺| = |஺||஺| = ͳ   (A11) 
 57 
 
because  1785 |஺ځ஻||஺| + |஻\஺||஺| = |஻||஺|   (A12) 
can obviously be larger than 1 as soon as |ܤ| > |ܣ|. This issue can be addressed by using 
the specificity and sensitivity, defined by  spec. = |�ே||�ே|+|�௉|   and  sens. = |�௉||�௉|+|�ே| .  (A13) 
Because the number of true negatives depends on the space volume, the specificity makes 1790 
little sense and only the sensitivity conveys useful information. The specificity can be 
replaced with the positive predictive value (PPV) (see Fig.A1 for visual illustration of 
sensitivity and PPV), defined as  
   PPV = |஺∩஻||஻| = |�௉||�௉|+|�௉| .    (A14) 
 
 
 1795 
Fig. A1. Graphical illustration of the sensitivity and positive predictive value 
All quantities described above assume that set operations can be computed. If only the 
cardinalities |ܣ|and |ܤ| are known, then only the volume difference |ܣ| − |ܤ|can be found. 
The normalization factor can be either |ܣ| or ሺ|ܣ| + |ܤ|ሻ ʹ⁄ . The volume difference has two 
critical shortcomings. First, there is no possibility of distinguishing Type I and Type II errors, 1800 
apart from the difference sign. Second, the volume difference is overly optimistic: it can be 
optimal ሺ|ܣ| − |ܤ| = Ͳሻ with actually no overlap (|ܣ| = |ܤ| but |ܣ ∩ ܤ| = Ͳ). The overlap can 
be approximated with the distance between the centroids (or barycenters) of A and B, for 
instance. 
Hausdorff distance 1805 
If set A is rewritten as {ܽ௜} and set B as { ௝ܾ}, then �(ܽ௜ , ௝ܾ) can denote the distance 
between voxels ܽ௜ and ௝ܾ. This distance can be the Euclidean distance from the center of ܽ௜ 
to the center of ௝ܾ. Starting from this voxel-to-voxel distance, the Hausdorff distance is 
defined as 271: 
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HDሺܣ, ܤሻ = max {max௜ min௝ �(ܽ௜, ௝ܾ) , max௝ min௜ �(ܽ௜, ௝ܾ)} . (A15) 1810 
The first term calculates the maximum of the distances from each element of A to the closest 
element of B. The second term performs the symmetric computation, with respect to B 
instead of A. The maximum of these two quantities is the Hausdorff distance and they can be 
considered separately to extract information about errors of Types I and II. 
The main shortcoming of the Hausdorff distance is its (relative) computational 1815 
complexity. Notice also that the maximum and minimum operators involved in the definition 
are very sensitive to image noise. A straightforward variant of the Hausdorff distances 
addresses this issue by replacing the max operators with averages. This leads to 272: MHDሺܣ, ܤሻ = ଵ|஺| ∑ min௝ �(ܽ௜, ௝ܾ)௜ + ଵ|஻| ∑ min௜ �(ܽ௜, ௝ܾ)௝  . (A16) 
The Hausdorff distance is good at reflecting translations between A and B, as well as shape 1820 
discrepancies. Its interpretation, in terms of volumetric changes, is less obvious. In that 
sense, it is complementary to the volume difference and to overlap indexes. 
The Hausdorff distance can be computed on contours and surfaces as well, instead of 
sets of voxels. However, in this case the implementation is more specific and requires the 
user to make some specific choices and/or to adjust additional parameters. 1825 
It can be noted that all quantities described above depend on the image matrix or voxel 
grid. The finer the grid is, the closer the estimated quantities will be to their actual value. 
 
 
  1830 
 59 
 
REFERENCES 
 
 
1
 M. MacManus, U. Nestle, K.E. Rosenzweig, I. Carrio, C. Messa, O. Belohlavek, M. 
Danna, T. Inoue, E. Deniaud-Alexandre, S. Schipani, N. Watanabe, M. Dondi, B. 1835 
Jeremic, "Use of PET and PET/CT for radiation therapy planning: IAEA expert report 
2006-2007," Radiother Oncol 91, 85-94 (2009). 
2
 C.C. Ling, J. Humm, S. Larson, H. Amols, Z. Fuks, S. Leibel, J.A. Koutcher, "Towards 
multidimensional radiotherapy (MD-CRT): biological imaging and biological 
conformality," Int. J. Radiat. Oncol. Biol. Phys. 47, 551-560 (2000). 1840 
3
 S.C. Huang, "Anatomy of SUV. Standardized uptake value," Nuclear medicine and 
biology 27, 643-646 (2000). 
4
 R. Boellaard, "Standards for PET image acquisition and quantitative data analysis," J 
Nucl Med 50 Suppl 1, 11S-20S (2009). 
5
 S.S. Gambhir, J. Czernin, J. Schwimmer, D.H. Silverman, R.E. Coleman, M.E. 1845 
Phelps, "A tabulated summary of the FDG PET literature," J Nucl Med 42, 1S-93S 
(2001). 
6
 D.E. Heron, R.S. Andrade, S. Beriwal, R.P. Smith, "PET-CT in radiation oncology: the 
impact on diagnosis, treatment planning, and assessment of treatment response," Am 
J Clin Oncol 31, 352-362 (2008). 1850 
7
 H. Zaidi, H. Vees, M. Wissmeyer, "Molecular PET/CT imaging-guided radiation 
therapy treatment planning," Acad Radiol 16, 1108-1133 (2009). 
8
 U. Nestle, W. Weber, M. Hentschel, A.L. Grosu, "Biological imaging in radiation 
therapy: role of positron emission tomography," Phys Med Biol 54, R1-R25 (2009). 
9
 M.P. Mac Manus, R.J. Hicks, "The role of positron emission tomography/computed 1855 
tomography in radiation therapy planning for patients with lung cancer," Seminars in 
nuclear medicine 42, 308-319 (2012). 
10
 M.P. Mac Manus, S. Everitt, M. Bayne, D. Ball, N. Plumridge, D. Binns, A. Herschtal, 
D. Cruickshank, M. Bressel, R.J. Hicks, "The use of fused PET/CT images for patient 
selection and radical radiotherapy target volume definition in patients with non-small 1860 
cell lung cancer: Results of a prospective study with mature survival data," 
Radiotherapy and Oncology 106, 292-298 (2013). 
11
 V. Gregoire, K. Haustermans, X. Geets, S. Roels, M. Lonneux, "PET-based treatment 
planning in radiotherapy: a new standard?," J Nucl Med 48 Suppl 1, 68S-77S (2007). 
12
 S. Chua, J. Dickson, A.M. Groves, "PET imaging for prediction of response to therapy 1865 
and outcome in oesophageal carcinoma," Eur J Nucl Med Mol Imaging (2011). 
13
 T. Cazaentre, F. Morschhauser, M. Vermandel, N. Betrouni, T. Prangere, M. 
Steinling, D. Huglo, "Pre-therapy 18F-FDG PET quantitative parameters help in 
predicting the response to radioimmunotherapy in non-Hodgkin lymphoma," Eur J 
Nucl Med Mol Imaging 37, 494-504 (2010). 1870 
14
 H.Y. Lee, S.H. Hyun, K.S. Lee, B.T. Kim, J. Kim, Y.M. Shim, M.J. Ahn, T.S. Kim, C.A. 
Yi, M.J. Chung, "Volume-based parameter of 18)F-FDG PET/CT in malignant pleural 
mesothelioma: prediction of therapeutic response and prognostic implications," Ann 
Surg Oncol 17, 2787-2794 (2010). 
15
 I. El Naqa, P. Grigsby, A. Apte, E. Kidd, E. Donnelly, D. Khullar, S. Chaudhari, D. 1875 
Yang, M. Schmitt, R. Laforest, W. Thorstad, J.O. Deasy, "Exploring feature-based 
approaches in PET images for predicting cancer treatment outcomes," Pattern 
Recognit 42, 1162-1171 (2009). 
16
 M. Vaidya, K.M. Creach, J. Frye, F. Dehdashti, J.D. Bradley, I. El Naqa, "Combined 
PET/CT image characteristics for radiotherapy tumor response in lung cancer," 1880 
Radiother Oncol 102, 239-245 (2012). 
17
 M. Soret, S.L. Bacharach, I. Buvat, "Partial-volume effect in PET tumor imaging," J 
Nucl Med 48, 932-945 (2007). 
 60 
 
18
 A.M. Alessio, P.E. Kinahan, P.M. Cheng, H. Vesselle, J.S. Karp, "PET/CT scanner 
instrumentation, challenges, and solutions," Radiologic clinics of North America 42, 1885 
1017-1032, vii (2004). 
19
 C. Lartizien, P.E. Kinahan, R. Swensson, C. Comtat, M. Lin, V. Villemagne, R. 
Trebossen, "Evaluating image reconstruction methods for tumor detection in 3-
dimensional whole-body PET oncology imaging," J Nucl Med 44, 276-290 (2003). 
20
 D. Visvikis, D. Griffiths, D.C. Costa, J. Bomanji, P.J. Ell, "Clinical evaluation of 2D 1890 
versus 3D whole-body PET image quality using a dedicated BGO PET scanner," Eur 
J Nucl Med Mol Imaging 32, 1050-1056 (2005). 
21
 O. Mawlawi, T. Pan, H.A. Macapinlac, "PET/CT imaging techniques, considerations, 
and artifacts," J Thorac Imaging 21, 99-110 (2006). 
22
 A.S. Kirov, C.R. Schmidtlein, H. Kang, N. Lee, "Rationale, Instrumental Accuracy, and 1895 
Challenges of PET Quantification for Tumor Segmentation in Radiation Treatment 
Planning," in Positron Emission Tomography-Current Clinical and Research Aspects, 
edited by C.-H. Hsieh ((Ed.), ISBN:978-953-307-824-3, InTech, Available from: 
http://www.intechopen.com/books/positron-emission-tomography-current-clinical-and-
research-aspects/rationale-instrumental-accuracy-and-challenges-of-pet-1900 
quantification-for-tumor-segmentation-in-radia, 2012). 
23
 U. Nestle, S. Kremp, A. Schaefer-Schuler, C. Sebastian-Welsch, D. Hellwig, C. Rube, 
C.M. Kirsch, "Comparison of different methods for delineation of 18F-FDG PET-
positive tissue for target volume definition in radiotherapy of patients with non-Small 
cell lung cancer," J Nucl Med 46, 1342-1348 (2005). 1905 
24
 S.A. Terezakis, M.A. Hunt, A. Kowalski, P. McCann, C.R. Schmidtlein, A. Reiner, M. 
Gonen, A.S. Kirov, A.M. Gonzales, H. Schoder, J. Yahalom, "[(1)F]FDG-positron 
emission tomography coregistration with computed tomography scans for radiation 
treatment planning of lymphoma and hematologic malignancies," Int J Radiat Oncol 
Biol Phys 81, 615-622 (2011). 1910 
25
 R.J. Steenbakkers, J.C. Duppen, I. Fitton, K.E. Deurloo, L.J. Zijp, E.F. Comans, A.L. 
Uitterhoeve, P.T. Rodrigus, G.W. Kramer, J. Bussink, K. De Jaeger, J.S. Belderbos, 
P.J. Nowak, M. van Herk, C.R. Rasch, "Reduction of observer variation using 
matched CT-PET for lung cancer delineation: a three-dimensional analysis," Int J 
Radiat Oncol Biol Phys 64, 435-448 (2006). 1915 
26
 F. Hofheinz, C. Potzsch, L. Oehme, B. Beuthien-Baumann, J. Steinbach, J. Kotzerke, 
J. van den Hoff, "Automatic volume delineation in oncological PET. Evaluation of a 
dedicated software tool and comparison with manual delineation in clinical data sets," 
Nuklearmedizin 51, 9-16 (2012). 
27
 H. Zaidi, "Quantitative analysis in Nuclear Medicine Imaging,"  (Springer, Singapore, 1920 
2006). 
28
 S. Belhassen, H. Zaidi, "A novel fuzzy C-means algorithm for unsupervised 
heterogeneous tumor quantification in PET," Med Phys 37, 1309-1324 (2010). 
29
 J.A. Lee, "Segmentation of positron emission tomography images: some 
recommendations for target delineation in radiation oncology," Radiother Oncol 96, 1925 
302-307 (2010). 
30
 A. Schaefer, S. Kremp, D. Hellwig, C. Rube, C.M. Kirsch, U. Nestle, "A contrast-
oriented algorithm for FDG-PET-based delineation of tumour volumes for the 
radiotherapy of lung cancer: derivation from phantom measurements and validation in 
patient data," Eur J Nucl Med Mol Imaging 35, 1989-1999 (2008). 1930 
31
 I. El Naqa, D. Yang, A. Apte, D. Khullar, S. Mutic, J. Zheng, J.D. Bradley, P. Grigsby, 
J.O. Deasy, "Concurrent multimodality image segmentation by active contours for 
radiotherapy treatment planning," Med Phys 34, 4738-4749 (2007). 
32
 Q. Song, J. Bai, D. Han, S. Bhatia, W. Sun, W. Rockey, J.E. Bayouth, J.M. Buatti, X. 
Wu, "Optimal co-segmentation of tumor in PET-CT images with context information," 1935 
IEEE Trans Med Imaging 32, 1685-1697 (2013). 
33
 U. Bagci, J.K. Udupa, N. Mendhiratta, B. Foster, Z. Xu, J. Yao, X. Chen, D.J. Mollura, 
"Joint segmentation of anatomical and functional images: Applications in 
 61 
 
quantification of lesions from PET, PET-CT, MRI-PET, and MRI-PET-CT images," 
Medical image analysis 17, 929-945 (2013). 1940 
34
 D. Markel, H. Zaidi, I. El Naqa, "Novel multimodality segmentation using level sets 
and Jensen-Rényi divergence. ," Med Phys 40, 121908 (2013). 
35
 M. Hatt, N. Boussion, C. Cheze-Le Rest, D. Visvikis, O. Pradier, "[Metabolically active 
volumes automatic delineation methodologies in PET imaging: Review and 
perspectives.]," Cancer Radiother (2011). 1945 
36
 B. Foster, U. Bagci, A. Mansoor, Z.Y. Xu, D.J. Mollura, "A review on segmentation of 
positron emission tomography images," Comput Biol Med 50, 76-96 (2014). 
37
 X. Geets, J.A. Lee, A. Bol, M. Lonneux, V. Gregoire, "A gradient-based method for 
segmenting FDG-PET images: methodology and validation," Eur J Nucl Med Mol Im 
34, 1427-1438 (2007). 1950 
38
 E. De Bernardi, E. Faggiano, F. Zito, P. Gerundini, G. Baselli, "Lesion quantification in 
oncological positron emission tomography: a maximum likelihood partial volume 
correction strategy," Med Phys 36, 3040-3049 (2009). 
39
 A.O. Boudraa, H. Zaidi, "Image Segmentation Techniques In Nuclear Medicine 
Imaging,," in Quantitative analysis in Nuclear Medicine Imaging, edited by H. Zaidi 1955 
(Springer, Singapore, 2006), pp. 308-357. 
40
 H. Yu, C. Caldwell, K. Mah, D. Mozeg, "Coregistered FDG PET/CT-based textural 
characterization of head and neck cancer for radiation treatment planning," IEEE 
Trans Med Imaging 28, 374-383 (2009). 
41
 J.K. Udupa, V.R. Leblanc, Y. Zhuge, C. Imielinska, H. Schmidt, L.M. Currie, B.E. 1960 
Hirsch, J. Woodburn, "A framework for evaluating image segmentation algorithms," 
Comput Med Imaging Graph 30, 75-87 (2006). 
42
 P. Tylski, S. Stute, N. Grotus, K. Doyeux, S. Hapdey, I. Gardin, B. Vanderlinden, I. 
Buvat, "Comparative assessment of methods for estimating tumor volume and 
standardized uptake value in (18)F-FDG PET," J Nucl Med 51, 268-276 (2010). 1965 
43
 M. Hatt, C. Cheze Le Rest, N. Albarghach, O. Pradier, D. Visvikis, "PET functional 
volume delineation: a robustness and repeatability study," Eur J Nucl Med Mol 
Imaging 38, 663-672 (2011). 
44
 B. Berthon, C. Marshall, A. Edwards, M. Evans, E. Spezi, "Influence of cold walls on 
PET image quantification and volume segmentation: a phantom study," Med Phys 40, 1970 
082505 (2013). 
45
 B. Berthon, C. Marshall, M. Evans, E. Spezi, "Evaluation of advanced automatic PET 
segmentation methods using nonspherical thin-wall inserts," Med Phys 41, 022502 
(2014). 
46
 K.J. Biehl, F. Kong, F. Dehdashti, J. Jin, S. Mutic, I. El Naqa, B. Siegel, J. Bradley, 1975 
"FDG-PET definition of gross tumor volume for radiotherapy of non-small-cell lung 
cancer: Is a single SUV threshold approach appropriate?," Int J Radiat Oncol Biol 
Phys 66, S153-S154 (2006). 
47
 J.A. van Dalen, A.L. Hoffmann, V. Dicken, W.V. Vogel, B. Wiering, T.J. Ruers, N. 
Karssemeijer, W.J. Oyen, "A novel iterative method for lesion delineation and 1980 
volumetric quantification with FDG PET," Nucl Med Commun 28, 485-493 (2007). 
48
 Y.E. Erdi, O. Mawlawi, S.M. Larson, M. Imbriaco, H. Yeung, R. Finn, J.L. Humm, 
"Segmentation of lung lesion volume by adaptive positron emission tomography 
image thresholding," Cancer 80, 2505-2509 (1997). 
49
 A.C. Paulino, P.A. Johnstone, "FDG-PET in radiotherapy treatment planning: 1985 
Pandora's box?," Int J Radiat Oncol Biol Phys 59, 4-5 (2004). 
50
 W. Jentzen, L. Freudenberg, E.G. Eising, M. Heinze, W. Brandau, A. Bockisch, 
"Segmentation of PET volumes by iterative image thresholding," J Nucl Med 48, 108-
114 (2007). 
51
 S.A. Nehmeh, H. El-Zeftawy, C. Greco, J. Schwartz, Y.E. Erdi, A. Kirov, C.R. 1990 
Schmidtlein, A.B. Gyau, S.M. Larson, J.L. Humm, "An iterative technique to segment 
PET lesions using a Monte Carlo based mathematical model," Med Phys 36, 4803-
4809 (2009). 
 62 
 
52
 Q.C. Black, I.S. Grills, L.L. Kestin, C.Y. Wong, J.W. Wong, A.A. Martinez, D. Yan, 
"Defining a radiotherapy target with positron emission tomography," Int J Radiat 1995 
Oncol Biol Phys 60, 1272-1282 (2004). 
53
 H. Zaidi, I. El Naqa, "PET-guided delineation of radiation therapy treatment volumes: 
a survey of image segmentation techniques," Eur J Nucl Med Mol Imaging 37, 2165-
2187 (2010). 
54
 H. Li, W.L. Thorstad, K.J. Biehl, R. Laforest, Y. Su, K.I. Shoghi, E.D. Donnelly, D.A. 2000 
Low, W. Lu, "A novel PET tumor delineation method based on adaptive region-
growing and dual-front active contours," Medical Physics 35, 3711-3721 (2008). 
55
 M. Wanet, J.A. Lee, B. Weynand, M. De Bast, A. Poncelet, V. Lacroix, E. Coche, V. 
Gregoire, X. Geets, "Gradient-based delineation of the primary GTV on FDG-PET in 
non-small cell lung cancer: A comparison with threshold-based approaches, CT and 2005 
surgical specimens," Radiother Oncol 98, 117-125 (2011). 
56
 R. Adams, L. Bischof, "Seeded region growing," IEEE Trans Pattern Anal Mach Intell 
16, 641-647 (1994). 
57
 T. Pavlidis, Y.T. Liow, "Integrating region growing and edge-detection," IEEE Trans. 
Pattern Anal. Mach. Intell. 12, 225-233 (1990). 2010 
58
 L. Ibanez, W. Schroeder, L. Ng, J. Cates, The ITK Software Guide. (Kitware, 2005). 
59
 E. Day, J. Betler, D. Parda, B. Reitz, A. Kirichenko, S. Mohammadi, M. Miften, "A 
region growing method for tumor volume segmentation on PET images for rectal and 
anal cancer patients," Medical Physics 36, 4349-4358 (2009). 
60
 F. Hofheinz, J. Langner, J. Petr, B. Beuthien-Baumann, J. Steinbach, J. Kotzerke, J. 2015 
van den Hoff, "An automatic method for accurate volume delineation of 
heterogeneous tumors in PET," Med Phys 40, 082503 (2013). 
61
 P. Tylski, G. Bonniaud, E. Decenciere, J. Stawiaski, J. Coulot, D. Lefkopoulos, M. 
Ricard, presented at the IEEE Nuclear Science Symposium Conference2006 
(unpublished). 2020 
62
 M. Werner-Wasik, A.D. Nelson, W. Choi, Y. Arai, P.F. Faulhaber, P. Kang, F.D. 
Almeida, Y. Xiao, N. Ohri, K.D. Brockway, J.W. Piper, A.S. Nelson, "What is the best 
way to contour lung tumors on PET scans? Multiobserver validation of a gradient-
based method using a NSCLC digital PET phantom," Int J Radiat Oncol Biol Phys 82, 
1164-1171 (2012). 2025 
63
 I. El Naqa, "Radiotherapy Informatics: Targeted Control," Enterprise Imaging & 
Therapeutic Radiology Management 18, 39-42 (2008). 
64
 A.S. Dewalle-Vignion, N. Betrouni, R. Lopes, D. Huglo, S. Stute, M. Vermandel, "A 
New Method for Volume Segmentation of PET Images, Based on Possibility Theory," 
IEEE Trans Med Imaging 30, 409-423 (2011). 2030 
65
 M. Aristophanous, B.C. Penney, M.K. Martel, C.A. Pelizzari, "A Gaussian mixture 
model for definition of lung tumor volumes in positron emission tomography," Med 
Phys 34, 4223-4235 (2007). 
66
 D.W. Montgomery, A. Amira, H. Zaidi, "Fully automated segmentation of oncological 
PET volumes using a combined multiscale and statistical model," Med Phys 34, 722-2035 
736 (2007). 
67
 M. Hatt, F. Lamare, N. Boussion, A. Turzo, C. Collet, F. Salzenstein, C. Roux, P. 
Jarritt, K. Carson, C. Cheze-Le Rest, D. Visvikis, "Fuzzy hidden Markov chains 
segmentation for volume determination and quantitation in PET," Phys Med Biol 52, 
3467-3491 (2007). 2040 
68
 M. Hatt, C. Cheze le Rest, A. Turzo, C. Roux, D. Visvikis, "A fuzzy locally adaptive 
Bayesian segmentation approach for volume determination in PET," IEEE Trans Med 
Imaging 28, 881-893 (2009). 
69
 M. Hatt, C. Cheze le Rest, P. Descourt, A. Dekker, D. De Ruysscher, M. Oellers, P. 
Lambin, O. Pradier, D. Visvikis, "Accurate automatic delineation of heterogeneous 2045 
functional volumes in positron emission tomography for oncology applications," Int J 
Radiat Oncol Biol Phys 77, 301-308 (2010). 
 63 
 
70
 D. Markel, C. Caldwell, H. Alasti, H. Soliman, Y. Ung, J. Lee, A. Sun, "Automatic 
Segmentation of Lung Carcinoma Using 3D Texture Features in 18-FDG PET/CT," 
International journal of molecular imaging 2013, 980769 (2013). 2050 
71
 M.S. Sharif, M. Abbod, A. Amira, H. Zaidi, "Artificial Neural Network-Based System for 
PET Volume Segmentation," International journal of biomedical imaging, 105611 p 
(2010). 
72
 M.S. Sharif, M. Abbod, A. Amira, H. Zaidi, "Artificial neural network-statistical 
approach for PET volume analysis and classification," Advances in Fuzzy Systems, 2055 
Article ID 327861, , 327810 p (2012). 
73
 T.B. Sebastian, R.M. Manjeshwar, T.J. Akhurst, J.V. Miller, "Objective PET lesion 
segmentation using a spherical mean shift algorithm," Lect Notes Comput Sc 4191, 
782-789 (2006). 
74
 M.H. Janssen, H.J. Aerts, M.C. Ollers, G. Bosmans, J.A. Lee, J. Buijsen, D. De 2060 
Ruysscher, P. Lambin, G. Lammering, A.L. Dekker, "Tumor delineation based on 
time-activity curve differences assessed with dynamic fluorodeoxyglucose positron 
emission tomography-computed tomography in rectal cancer patients," Int J Radiat 
Oncol Biol Phys 73, 456-465 (2009). 
75
 E. De Bernardi, F. Fiorani Gallotta, C. Gianoli, F. Zito, P. Gerundini, G. Baselli, "ML 2065 
segmentation strategies for object interference compensation in FDG-PET lesion 
quantification," Methods of information in medicine 49, 537-541 (2010). 
76
 D.P. Onoma, S. Ruan, S. Thureau, L. Nkhali, R. Modzelewski, G.A. Monnehan, P. 
Vera, I. Gardin, "Segmentation of heterogeneous or small FDG PET positive tissue 
based on a 3D-locally adaptive random walk algorithm," Comput Med Imaging Graph 2070 
38, 753-763 (2014). 
77
 M. Abdoli, R.A. Dierckx, H. Zaidi, "Contourlet-based active contour model for PET 
image segmentation," Med Phys 40, 082507 (2013). 
78
 W. Mu, Z. Chen, W. Shen, F. Yang, Y. Liang, R. Dai, N. Wu, J. Tian, "A Segmentation 
Algorithm for Quantitative Analysis of Heterogeneous Tumors of the Cervix with 18F-2075 
FDG PET/CT," IEEE transactions on bio-medical engineering (2015). 
79
 H. Cui, X. Wang, J. Zhou, S. Eberl, Y. Yin, D. Feng, M. Fulham, "Topology 
polymorphism graph for lung tumor segmentation in PET-CT images," Phys Med Biol 
60, 4893-4914 (2015). 
80
 J. Lapuyade-Lahorgue, D. Visvikis, O. Pradier, C. Cheze Le Rest, M. Hatt, 2080 
"SPEQTACLE: An automated generalized fuzzy C-means algorithm for tumor 
delineation in PET," Med Phys 42, 5720-5734 (2015). 
81
 S. Devic, H. Mohammed, N. Tomic, S. Aldelaijan, F. De Blois, J. Seuntjens, S. 
Lehnert, S. Faria, "FDG-PET-based differential uptake volume histograms: a possible 
approach towards definition of biological target volumes," The British journal of 2085 
radiology 89, 20150388 (2016). 
82
 B. Berthon, C. Marshall, M. Evans, E. Spezi, "ATLAAS: an automatic decision tree-
based learning algorithm for advanced image segmentation in positron emission 
tomography," Phys Med Biol 61, 4855-4869 (2016). 
83
 A. Schaefer, M. Vermandel, C. Baillet, A.S. Dewalle-Vignion, R. Modzelewski, P. 2090 
Vera, L. Massoptier, C. Parcq, D. Gibon, T. Fechter, U. Nemer, I. Gardin, U. Nestle, 
"Impact of consensus contours from multiple PET segmentation methods on the 
accuracy of functional volume delineation," Eur J Nucl Med Mol Imaging 43, 911-924 
(2016). 
84
 W. Pieczynski, "Modèles de Markov en traitement d'images," Traitement du Signal 2095 
20, 255-278 (2003). 
85
 Y. Delignon, A. Marzouki, W. Pieczynski, "Estimation of generalized mixtures and its 
application in image segmentation," IEEE Trans Image Process 6, 1364-1375 (1997). 
86
 "NEMA NU 2-2001, Performance Measurements of Positron Emission Tomographs,"  
(National Electrical Manufacturers Association, Rosslyn, VA, 2001). 2100 
87
 H. Caillol, W. Pieczynski, A. Hillion, "Estimation of fuzzy Gaussian mixture and 
unsupervised statistical image segmentation," IEEE Trans Image Process 6, 425-440 
(1997). 
 64 
 
88
 F. Salzenstein, C. Collet, S. Lecam, M. Hatt, "Non-stationary fuzzy Markov chain," 
Pattern Recognition Letters 28, 2201-2008 (2007). 2105 
89
 R.O. Duda, P.E. Hart, D.G. Stork, Pattern classification, 2nd ed. (Wiley, New York, 
2001). 
90
 A.K. Jain, M.N. Murty, P.J. Flynn, "Data clustering: a review," ACM Comput. Surv. 31, 
264-323 (1999). 
91
 Y. LeCun, Y. Bengio, G. Hinton, "Deep learning," Nature 521, 436-444 (2015). 2110 
92
 M.R. Avendi, A. Kheradvar, H. Jafarkhani, "A combined deep-learning and 
deformable-model approach to fully automatic segmentation of the left ventricle in 
cardiac MRI," Medical image analysis 30, 108-119 (2016). 
93
 K.H. Cha, L. Hadjiiski, R.K. Samala, H.P. Chan, E.M. Caoili, R.H. Cohan, "Urinary 
bladder segmentation in CT urography using deep-learning convolutional neural 2115 
network and level sets," Med Phys 43, 1882 (2016). 
94
 A. Kerhet, C. Small, H. Quon, T. Riauka, L. Schrader, R. Greiner, D. Yee, A. McEwan, 
W. Roa, "Application of machine learning methodology for PET-based definition of 
lung cancer," Current oncology 17, 41-47 (2010). 
95
 C. Lian, S. Ruan, T. Denoeux, F. Jardin, P. Vera, "Selecting radiomic features from 2120 
FDG-PET images for cancer treatment outcome prediction," Medical image analysis 
32, 257-268 (2016). 
96
 M. Hatt, F. Tixier, L. Pierce, P.E. Kinahan, C.C. Le Rest, D. Visvikis, "Characterization 
of PET/CT images using texture analysis: the past, the present... any future?," Eur J 
Nucl Med Mol Imaging 44, 151-165 (2017). 2125 
97
 A. Materka, M. Strzelecki, "Texture Analysis Methods – A Review," in COST B11 
(Technical University of Lodz, Institute of Electronics, Brussels, 1988). 
98
 A.K. Jain, F. Farrokhnia, "Unsupervised Texture Segmentation Using Gabor Filters," 
Pattern Recogn 24, 1167-1186 (1991). 
99
 S. Arivazhagan, L. Ganesan, "Texture classification using wavelet transform," Pattern 2130 
Recognition Letters 24, 1513-1521 (2003). 
100
 G.P. Stachowiak, P. Podsiadlo, G.W. Stachowiak, "A comparison of texture feature 
extraction methods for machine condition monitoring and failure analysis," Tribol Lett 
20, 133-147 (2005). 
101
 R.M. Haralick, Shanmuga.K, I. Dinstein, "Textural Features for Image Classification," 2135 
Ieee T Syst Man Cyb Smc3, 610-621 (1973). 
102
 M. Amadasun, R. King, "Textural features corresponding to textural properties," 
Systems, Man and Cybernetics, IEEE Transactions on 19, 1264-1274 (1989). 
103
 M. Galloway, "Texture analysis using grey level run lengths," Computer Graphics and 
Image Processing 4, 172-179 (1975). 2140 
104
 S.S. Mohamed, A.M. Youssed, E.F.E. Saadany, M.M.A. Salama, "Artificial life feature 
selection techniques for prostate cancer diagnosis using TRUS images," Lecture 
Notes in Computer Science 3656, 903-913 (2005). 
105
 B.J. Woods, B.D. Clymer, T. Kurc, J.T. Heverhagen, R. Stevens, A. Orsdemir, O. 
Bulan, M.V. Knopp, "Malignant-lesion segmentation using 4D co-occurrence texture 2145 
analysis applied to dynamic contrast-enhanced magnetic resonance breast image 
data," J Magn Reson Imaging 25, 495-501 (2007). 
106
 M.F. McNitt-Gray, E.M. Har, N. Wyckoff, J.W. Sayre, J.G. Goldin, D.R. Aberle, "A 
pattern classification approach to characterizing solitary pulmonary nodules imaged 
on high resolution CT: Preliminary results," Medical Physics 26, 880-888 (1999). 2150 
107
 A.C. Silva, A.C. Paiva, P.C.P. Carvalho, M. Gattass, "Semivariogram and SGLDM 
methods comparison for the diagnosis of solitary lung nodule," Pattern Recognition 
and Image Analysis, Pt 2, Proceedings 3523, 479-486 (2005). 
108
 R. Uppaluri, E.A. Hoffman, M. Sonka, P.G. Hartley, G.W. Hunninghake, G. 
McLennan, "Computer recognition of regional lung disease patterns," Am J Resp Crit 2155 
Care 160, 648-654 (1999). 
109
 H.U. Kauczor, K. Heitmann, C.P. Heussel, D. Marwede, T. Uthmann, M. Thelen, 
"Automatic detection and quantification of ground-glass opacities on high-resolution 
 65 
 
CT using multiple neural networks: Comparison with a density mask," Am J 
Roentgenol 175, 1329-1334 (2000). 2160 
110
 F. Chabat, G.Z. Yang, D.M. Hansell, "Obstructive lung diseases: Texture 
classification for differentiation at CT," Radiology 228, 871-877 (2003). 
111
 B. Ganeshan, S. Abaleke, R.C.D. Young, C.R. Chatwin, K.A. Miles, "Texture analysis 
of non-small cell lung cancer on unenhanced computed tomography: initial evidence 
for a relationship with tumour glucose metabolism and stage," Cancer Imaging 10, 2165 
137-143 (2010). 
112
 B.J. Pichler, A. Kolb, T. Nagele, H.P. Schlemmer, "PET/MRI: paving the way for the 
next generation of clinical multimodality imaging applications," J Nucl Med 51, 333-
336 (2010). 
113
 H. Zaidi, A. Del Guerra, "An outlook on future design of hybrid PET/MRI systems," 2170 
Med Phys 38, 5667-5689 (2011). 
114
 H. Yu, C. Caldwell, K. Mah, I. Poon, J. Balogh, R. MacKenzie, N. Khaouam, R. 
Tirona, "Automated Radiation Targeting in Head-and-Neck Cancer Using Region-
Based Texture Analysis of PET and CT Images," Int J Radiat Oncol Biol Phys 75, 
618-625 (2009). 2175 
115
 T. Shepherd, M. Teras, R.R. Beichel, R. Boellaard, M. Bruynooghe, V. Dicken, M.J. 
Gooding, P.J. Julyan, J.A. Lee, S. Lefevre, "Comparative study with new accuracy 
metrics for target volume contouring in PET image guided radiation therapy," IEEE 
Trans Med Imaging 31, 2006-2024 (2012). 
116
 S.K. Warfield, K.H. Zou, W.M. Wells, "Simultaneous truth and performance level 2180 
estimation (STAPLE): an algorithm for the validation of image segmentation," IEEE 
Trans Med Imaging 23, 903-921 (2004). 
117
 R.J. McGurk, J. Bowsher, J.A. Lee, S.K. Das, "Combining multiple FDG-PET 
radiotherapy target segmentation methods to reduce the effect of variable 
performance of individual segmentation methods," Med Phys 40, 042501 (2013). 2185 
118
 D.L. Pham, C. Xu, J.L. Prince, "Current methods in medical image segmentation," 
Annual review of biomedical engineering 2, 315-337 (2000). 
119
 V. Bettinardi, I. Castiglioni, E. De Bernardi, M.C. Gilardi, "PET quantification: 
strategies for partial volume correction," Clinical and Translational Imaging, 2 199-218 
(2014). 2190 
120
 L.B. Lucy, "An iterative technique for the rectification of observed distributions," 
Astronomical Journal, Vol. 79, 745 (1974). 
121
 W.H. Richardson, "Bayesian-Based Iterative Method of Image Restoration," Journal 
of the Optical Society of America, vol. 62, issue 1, 55 (1972). 
122
 A.S. Kirov, J.Z. Piao, C.R. Schmidtlein, "Partial volume effect correction in PET using 2195 
regularized iterative deconvolution with variance control based on local topology," 
Phys Med Biol 53, 2577-2591 (2008). 
123
 N. Boussion, C. Cheze Le Rest, M. Hatt, D. Visvikis, "Incorporation of wavelet-based 
denoising in iterative deconvolution for partial volume correction in whole-body PET 
imaging," Eur J Nucl Med Mol Imaging 36, 1064-1075 (2009). 2200 
124
 D.L. Barbee, R.T. Flynn, J.E. Holden, R.J. Nickles, R. Jeraj, "A method for partial 
volume correction of PET-imaged tumor heterogeneity using expectation 
maximization with a spatially varying point spread function," Phys Med Biol 55, 221-
236 (2010). 
125
 A.M. Alessio, C.W. Stearns, S. Tong, S.G. Ross, S. Kohlmyer, A. Ganin, P.E. 2205 
Kinahan, "Application and evaluation of a measured spatially variant system model for 
PET image reconstruction," IEEE Trans Med Imaging 29, 938-949 (2010). 
126
 B.W. Jakoby, Y. Bercier, C.C. Watson, B. Bendriem, D.W. Townsend, "Performance 
Characteristics of a New LSO PET/CT Scanner With Extended Axial Field-of-View 
and PSF Reconstruction," IEEE Transactions on Nuclear Science 56, 633-639 2210 
(2009). 
127
 E. De Bernardi, M. Mazzoli, F. Zito, G. Baselli, "Resolution recovery in PET during 
AWOSEM reconstruction: a performance evaluation study," IEEE Trans Nucl Sci 54, 
1626-1638 (2007). 
 66 
 
128
 J.W. Chung, H.C. Kim, Y.H. Choi, S.J. Kim, W. Lee, J.H. Park, "Patterns of aortic 2215 
involvement in Takayasu arteritis and its clinical implications: evaluation with spiral 
computed tomography angiography," Journal of vascular surgery : official publication, 
the Society for Vascular Surgery [and] International Society for Cardiovascular 
Surgery, North American Chapter 45, 906-914 (2007). 
129
 N. Boussion, M. Hatt, D. Visvikis, "Partial volume correction in PET based on 2220 
functional volumes," Journal of Nuclear Medicine 49, 388P (2008). 
130
 C.H. Chen, R.F. Muzic, Jr., A.D. Nelson, L.P. Adler, "Simultaneous recovery of size 
and radioactivity concentration of small spheroids with PET data," J Nucl Med 40, 
118-130 (1999). 
131
 E. De Bernardi, C. Soffientini, F. Zito, G. Baselli, presented at the IEEE NSS MIC 2225 
2012, October 29 - November 3, 2012, Anaheim, California, pp. 3306-3310,  2012 
(unpublished). 
132
 A.D. King, "Multimodality imaging of head and neck cancer," Cancer Imaging 7 Spec 
No A, S37-46 (2007). 
133
 M.T. Munley, L.B. Marks, C. Scarfone, G.S. Sibley, E.F. Patz Jr, T.G. Turkington, R.J. 2230 
Jaszczak, D.R. Gilland, M.S. Anscher, R.E. Coleman, "Multimodality nuclear medicine 
imaging in three-dimensional radiation treatment planning for lung cancer: challenges 
and prospects," Lung Cancer 23, 105-114 (1999). 
134
 R. Chen, J.J. Parry, W.J. Akers, M.Y. Berezin, I.M. El Naqa, S. Achilefu, W.B. 
Edwards, B.E. Rogers, "Multimodality imaging of gene transfer with a receptor-based 2235 
reporter gene," J Nucl Med 51, 1456-1463 (2010). 
135
 E.M. DeFeo, C.-L. Wu, W.S. McDougal, L.L. Cheng, "A decade in prostate cancer: 
from NMR to metabolomics," Nat Rev Urol 8, 301-311 (2011). 
136
 A.R. Hsu, W. Cai, A. Veeravagu, K.A. Mohamedali, K. Chen, S. Kim, H. Vogel, L.C. 
Hou, V. Tse, M.G. Rosenblum, X. Chen, "Multimodality molecular imaging of 2240 
glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel," 
J Nucl Med 48, 445-454 (2007). 
137
 W.L. Smith, C. Lewis, G. Bauman, G. Rodrigues, D. D'Souza, R. Ash, D. Ho, V. 
Venkatesan, D. Downey, A. Fenster, "Prostate volume contouring: a 3D analysis of 
segmentation using 3DTRUS, CT, and MR," Int J Radiat Oncol Biol Phys 67, 1238-2245 
1247 (2007). 
138
 J. Buijsen, J. van den Bogaard, H. van der Weide, S. Engelsman, R. van Stiphout, M. 
Janssen, G. Beets, R. Beets-Tan, P. Lambin, G. Lammering, "FDG-PET-CT reduces 
the interobserver variability in rectal tumor delineation," Radiother Oncol 102, 371-376 
(2012). 2250 
139
 A. van Baardwijk, G. Bosmans, L. Boersma, J. Buijsen, S. Wanders, M. Hochstenbag, 
R.J. van Suylen, A. Dekker, C. Dehing-Oberije, R. Houben, S.M. Bentzen, M. van 
Kroonenburgh, P. Lambin, D. De Ruysscher, "PET-CT-based auto-contouring in non-
small-cell lung cancer correlates with pathology and reduces interobserver variability 
in the delineation of the primary tumor and involved nodal volumes," Int J Radiat 2255 
Oncol Biol Phys 68, 771-778 (2007). 
140
 H. Metwally, F. Courbon, I. David, T. Filleron, A. Blouet, M. Rives, F. Izar, S. Zerdoud, 
G. Plat, J. Vial, A. Robert, A. Laprie, "Coregistration of prechemotherapy PET-CT for 
planning pediatric Hodgkin's disease radiotherapy significantly diminishes 
interobserver variability of clinical target volume definition," Int J Radiat Oncol Biol 2260 
Phys 80, 793-799 (2011). 
141
 C.M. Anderson, W. Sun, J.M. Buatti, J.E. Maley, B. Policeni, S.L. Mott, J.E. Bayouth, 
"Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-
PET, and MR Images of Head and Neck Cancer," Jacobs journal of radiation 
oncology 1, 006 (2014). 2265 
142
 Y. Zheng, X. Sun, J. Wang, L. Zhang, X. Di, Y. Xu, "FDG-PET/CT imaging for tumor 
staging and definition of tumor volumes in radiation treatment planning in non-small 
cell lung cancer," Oncology letters 7, 1015-1020 (2014). 
 67 
 
143
 A. Sebbahi, A. Herment, A. de Cesare, E. Mousseaux, "Multimodality cardiovascular 
image segmentation using a deformable contour model," Computerized Medical 2270 
Imaging and Graphics 21, 79-89 (1997). 
144
 J. Zheng, I. El Naqa, F.E. Rowold, T.K. Pilgram, P.K. Woodard, J.E. Saffitz, D. Tang, 
"Quantitative assessment of coronary artery plaque vulnerability by high-resolution 
magnetic resonance imaging and computational biomechanics: a pilot study ex vivo," 
Magn Reson Med 54, 1360-1368 (2005). 2275 
145
 D. Yang, J. Zheng, A. Nofal , Y. Wu, J. Deasy, I. El Naqa, "Techniques and software 
tool for 3D multimodality medical image segmentation," Journal of radiation oncology 
informatics 1, 1-21 (2009). 
146
 T.F. Chan, B.Y. Sandberg, L.A. Vese, "Active Contours without Edges for Vector-
Valued Images," Journal of Visual Communication and Image Representation 11, 2280 
130-141 (2000). 
147
 J. Shah, "Curve evolution and segmentation functionals: application to color images," 
in International Conference on Image Processing Proceedings, Vol. 1 (1996), pp. 
461-464. 
148
 S.E. Fogh, A. Farach, C. Intenzo, R. Axelrod, P. McCue, A. Harper, A. Nelson, M. 2285 
Werner-Wasik, "Pathologic Correlation of PET-CT Based Auto Contouring for 
Radiation Planning in Lung Cancer," Int J Radiat Oncol Biol Phys 78, S202-S203 
(2010). 
149
 J.F. Daisne, M. Sibomana, A. Bol, T. Doumont, M. Lonneux, V. Gregoire, "Tri-
dimensional automatic segmentation of PET volumes based on measured source-to-2290 
background ratios: influence of reconstruction algorithms," Radiother Oncol 69, 247-
250 (2003). 
150
 H. Zaidi, M. Abdoli, C.L. Fuentes, I.M. El Naqa, "Comparative methods for PET image 
segmentation in pharyngolaryngeal squamous cell carcinoma," Eur J Nucl Med Mol 
Imaging (2012). 2295 
151
 J.F. Daisne, T. Duprez, B. Weynand, M. Lonneux, M. Hamoir, H. Reychler, V. 
Gregoire, "Tumor volume in pharyngolaryngeal squamous cell carcinoma: 
comparison at CT, MR imaging, and FDG PET and validation with surgical 
specimen," Radiology 233, 93-100 (2004). 
152
 M. Hatt, C. Cheze-le Rest, A. van Baardwijk, P. Lambin, O. Pradier, D. Visvikis, 2300 
"Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-
small cell lung cancer tumor delineation," J Nucl Med 52, 1690-1697 (2011). 
153
 M. Hatt, A.L. Maitre, D. Wallach, H. Fayad, D. Visvikis, "Comparison of different 
methods of incorporating respiratory motion for lung cancer tumor volume delineation 
on PET images: a simulation study," Phys Med Biol 57, 7409-7430 (2012). 2305 
154
 B. Berthon, C. Marshall, M. Evans, E. Spezi, "Implementation and optimization of 
automatic 18F-FDG PET segmentation methods," Eur J Nucl Med Mol Imaging 
39(Suppl 2), S385 (2013). 
155
 M. Ollers, G. Bosmans, A. van Baardwijk, A. Dekker, P. Lambin, J. Teule, W. 
Thimister, A. Rhamy, D. De Ruysscher, "The integration of PET-CT scans from 2310 
different hospitals into radiotherapy treatment planning," Radiotherapy and Oncology 
87, 142-146 (2008). 
156
 B. Knausl, A. Hirtl, G. Dobrozemsky, H. Bergmann, K. Kletter, R. Dudczak, D. Georg, 
"PET based volume segmentation with emphasis on the iterative TrueX algorithm," 
Zeitschrift fur medizinische Physik 22, 29-39 (2012). 2315 
157
 A. Schaefer, U. Nestle, S. Kremp, D. Hellwig, A. Grgic, H.G. Buchholz, W. Mischke, 
C. Gromoll, P. Dennert, M. Plotkin, S. Senftleben, D. Thorwarth, M. Tosch, A. Wahl, 
H. Wengenmair, C. Rube, C.M. Kirsch, "Multi-centre calibration of an adaptive 
thresholding method for PET-based delineation of tumour volumes in radiotherapy 
planning of lung cancer," Nuklearmed-Nucl Med 51, 101-110 (2012). 2320 
158
 D.A. Schinagl, W.V. Vogel, A.L. Hoffmann, J.A. van Dalen, W.J. Oyen, J.H. Kaanders, 
"Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron 
emission tomography-based target volume definition in head and neck cancer," Int J 
Radiat Oncol Biol Phys 69, 1282-1289 (2007). 
 68 
 
159
 C. Greco, S.A. Nehmeh, H. Schoder, M. Gonen, B. Raphael, H.E. Stambuk, J.L. 2325 
Humm, S.M. Larson, N.Y. Lee, "Evaluation of different methods of 18F-FDG-PET 
target volume delineation in the radiotherapy of head and neck cancer," Am J Clin 
Oncol 31, 439-445 (2008). 
160
 H. Vees, S. Senthamizhchelvan, R. Miralbell, D.C. Weber, O. Ratib, H. Zaidi, 
"Assessment of various strategies for 18F-FET PET-guided delineation of target 2330 
volumes in high-grade glioma patients," Eur J Nucl Med Mol Imaging 36, 182-193 
(2009). 
161
 S. Belhassen, et al, "Comparative methods for 18F-FDG PET-based delineation of 
target volumes in non-small-cell lung cancer," J Nucl Med, 50, 27P (2009). 
162
 A.S. Dewalle-Vignion, N. Yeni, G. Petyt, L. Verscheure, D. Huglo, A. Beron, S. Adib, 2335 
G. Lion, M. Vermandel, "Evaluation of PET volume segmentation methods: 
comparisons with expert manual delineations," Nuclear Medicine Communications 33, 
34-42 (2012). 
163
 A. Lacout, P.Y. Marcy, J. Giron, J. Thariat, "Gradient-PET based delineation may be 
improved with combined post contrast high resolution CT scan: in regard to Werner-2340 
Wasik M et al. (Int J Radiat Oncol Biol Phys 2011 Apr 28)," Int J Radiat Oncol Biol 
Phys 82, 496; author reply 496-497 (2012). 
164
 D.A. Schinagl, P.N. Span, F.J. van den Hoogen, M.A. Merkx, P.J. Slootweg, W.J. 
Oyen, J.H. Kaanders, "Pathology-based validation of FDG PET segmentation tools 
for volume assessment of lymph node metastases from head and neck cancer," Eur J 2345 
Nucl Med Mol Imaging 40, 1828-1835 (2013). 
165
 A.S. Kirov, L. Fanchon, "Pathology-validated PET image data sets and their role for 
PET segmentation," Clinical and Translational Imaging 2, 253-267 (2014). 
166
 T.R. Mackie, V. Gregoire, "International Commission on Radiation Units and 
Measurements (ICRU) Report 83. Prescribing, Recording, and Reporting Photon-2350 
Beam Intensity-Modulated Radiation Therapy (IMRT),"  Vol. 10(1) (2010). 
167
 B.M. Fischer, M.W.B. Olsen, C.D. Ley, T.L. Klausen, J. Mortensen, L. Hojgaard, 
P.E.G. Kristjansen, "How few cancer cells can be detected by positron emission 
tomography? A frequent question addressed by an in vitro study," Eur J Nucl Med Mol 
I 33, 697-702 (2006). 2355 
168
 B. Berthon, E. Spezi, P. Galavis, A.T. Shepherd, A. Apte, M. Hatt, H. Fayad, E. De 
Bernardi, C. Soffientini, C. R. Schmidtlein, I. El Naqa, R. Jeraj, W. Lu, S. Das, H. 
Zaidi, O. Mawlawi, D. Visvikis, J. A. Lee, A.S. Kirov, "Towards a standard for the 
evaluation of PET Auto-Segmentation methods: requirements and implementation," 
submitted to Med. Phys. J (2016). 2360 
169
 T. Shepherd, R. Owenius, "Gaussian Process Models of Dynamic PET for Functional 
Volume Definition in Radiation Oncology," IEEE Trans Med Imaging 31, 1542-1556 
(2012). 
170
 B. Lelandais, S. Ruan, T. Denoeux, P. Vera, I. Gardin, "Fusion of multi-tracer PET 
images for dose painting," Medical image analysis 18, 1247-1259 (2014). 2365 
171
 A. Hunt, P. Schonknecht, M. Henze, U. Seidl, U. Haberkorn, J. Schroder, "Reduced 
cerebral glucose metabolism in patients at risk for Alzheimer's disease," Psychiatry 
Res 155, 147-154 (2007). 
172
 F.P. DiFilippo, J.P. Price, D.N. Kelsch, R.F. Muzic, Jr., "Porous phantoms for PET 
and SPECT performance evaluation and quality assurance," Med Phys 31, 1183-2370 
1194 (2004). 
173
 D.C. Hunt, H. Easton, C.B. Caldwell, "Design and construction of a quality control 
phantom for SPECT and PET imaging," Med Phys 36, 5404-5411 (2009). 
174
 F. Zito, E. De Bernardi, C. Soffientini, C. Canzi, R. Casati, P. Gerundini, G. Baselli, 
"The use of zeolites to generate PET phantoms for the validation of quantification 2375 
strategies in oncology," Med Phys, 39, 5353-5361 (2012). 
175
 S.A. Larsson, C. Jonsson, M. Pagani, L. Johansson, H. Jacobsson, "A novel phantom 
design for emission tomography enabling scatter- and attenuation-"free" single-
photon emission tomography imaging," European journal of nuclear medicine 27, 
131-139 (2000). 2380 
 69 
 
176
 H. El-Ali, M. Ljungberg, S.E. Strand, J. Palmer, L. Malmgren, J. Nilsson, "Calibration 
of a radioactive ink-based stack phantom and its applications in nuclear medicine," 
Cancer Biother Radiopharm 18, 201-207 (2003). 
177
 M. Miller, G. Hutchins, "3D Anatomically accurate phantoms for PET and SPECT 
imaging," J. Nucl. Med. 49, 65P (2008). 2385 
178
 A.S. Kirov, E. Sculley, C.R. Schmidtlein, W. Siman, B. Kandel, R. Zdenek, R. Schwar, 
G. Ayzenberg, E. Yorke, H. Schöder, J.L. Humm, H. Amols, "A New Phantom 
Allowing Realistic Non-Uniform Activity Distributions for PET Quantification, Abstract 
presented at the 2011 Joint AAPM/COMP meeting," Med. Phys. 38, 3387 (2011 ). 
179
 H. Zaidi, X.G. Xu, "Computational anthropomorphic models of the human anatomy: 2390 
The path to realistic Monte Carlo modeling in medical imaging," Annual review of 
biomedical engineering 9, 471-500 (2007). 
180
 W. Wang, J.C. Georgi, S.A. Nehmeh, M. Narayanan, T. Paulus, M. Bal, J. 
O'Donoghue, P.B. Zanzonico, C.R. Schmidtlein, N.Y. Lee, J.L. Humm, "Evaluation of 
a compartmental model for estimating tumor hypoxia via FMISO dynamic PET 2395 
imaging," Phys Med Biol 54, 3083-3099 (2009). 
181
 B. Berthon, I. Häggström, A. Apte, B.J. Beattie, A.S. Kirov, J. Humm, C. Marshall, E. 
Spezi, A. Larsson, C.R. Schmidtlein, "PETSTEP: Generation of Synthetic PET 
Lesions for Fast Evaluation of Segmentation Methods," Physica Medica doi: 
10.1016/j.ejmp.2015.07.139. (2015). 2400 
182
 L.A. Shepp, Y. Vardi, "Maximum likelihood reconstruction for emission tomography," 
IEEE Trans Med Imaging 1, 113-122 (1982). 
183
 E. Asma, A. Sangtae, S.G. Ross, A. Chen, R.M. Manjeshwar, "Accurate and 
Consistent Lesion Quantitation with Clinically Acceptable Penalized Likelihood 
Images," 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference 2405 
Record (NSS/MIC) M23-7, (  (2012). 
184
 W.P. Segars, G. Sturgeon, S. Mendonca, J. Grimes, B.M. Tsui, "4D XCAT phantom 
for multimodality imaging research," Med Phys 37, 4902-4915 (2010). 
185
 I.G. Zubal, C.R. Harrell, E.O. Smith, Z. Rattner, G. Gindi, P.B. Hoffer, "Computerized 
three-dimensional segmented human anatomy," Med Phys 21, 299-302 (1994). 2410 
186
 A. McLennan, A. Reilhac, M. Brady, "SORTEO: Monte Carlo-based simulator with list-
mode capabilities," Conf Proc IEEE Eng Med Biol Soc 2009, 3751-3754 (2009). 
187
 S. Jan, D. Benoit, E. Becheva, T. Carlier, F. Cassol, P. Descourt, T. Frisson, L. 
Grevillot, L. Guigues, L. Maigne, C. Morel, Y. Perrot, N. Rehfeld, D. Sarrut, D.R. 
Schaart, S. Stute, U. Pietrzyk, D. Visvikis, N. Zahra, I. Buvat, "GATE V6: a major 2415 
enhancement of the GATE simulation platform enabling modelling of CT and 
radiotherapy," Phys Med Biol 56, 881-901 (2011). 
188
 S. Jan, G. Santin, D. Strul, S. Staelens, K. Assie, D. Autret, S. Avner, R. Barbier, M. 
Bardies, P.M. Bloomfield, D. Brasse, V. Breton, P. Bruyndonckx, I. Buvat, A.F. 
Chatziioannou, Y. Choi, Y.H. Chung, C. Comtat, D. Donnarieix, L. Ferrer, S.J. Glick, 2420 
C.J. Groiselle, D. Guez, P.F. Honore, S. Kerhoas-Cavata, A.S. Kirov, V. Kohli, M. 
Koole, M. Krieguer, D.J. van der Laan, F. Lamare, G. Largeron, C. Lartizien, D. 
Lazaro, M.C. Maas, L. Maigne, F. Mayet, F. Melot, C. Merheb, E. Pennacchio, J. 
Perez, U. Pietrzyk, F.R. Rannou, M. Rey, D.R. Schaart, C.R. Schmidtlein, L. Simon, 
T.Y. Song, J.M. Vieira, D. Visvikis, R. Van de Walle, E. Wieers, C. Morel, "GATE: a 2425 
simulation toolkit for PET and SPECT," Phys Med Biol 49, 4543-4561 (2004). 
189
 R. Harrison, S. Gillispie, R. Schmitz, T. Lewellen, "Modeling block detectors in 
SimSET," J Nucl Med 49 Suppl 1, 410P (2008). 
190
 F. Lamare, A. Turzo, Y. Bizais, C.C. Le Rest, D. Visvikis, "Validation of a Monte Carlo 
simulation of the Philips Allegro/GEMINI PET systems using GATE," Phys Med Biol 2430 
51, 943-962 (2006). 
191
 M. Bayne, R.J. Hicks, S. Everitt, N. Fimmell, D. Ball, J. Reynolds, E. Lau, A. Pitman, 
R. Ware, M. MacManus, "Reproducibility of "intelligent" contouring of gross tumor 
volume in non-small-cell lung cancer on PET/CT images using a standardized visual 
method," Int J Radiat Oncol Biol Phys 77, 1151-1157 (2010). 2435 
 70 
 
192
 S.E. Fogh, J. Kannarkatt, A. Farach, P. McCue, R. Axelrod, A. Nelson, M. Werner-
Wasik, "Pathologic correlation of PET-CT based auto contouring for radiation 
treatment planning in lung cancer," J Thorac Oncol 4, S528-S529 (2009). 
193
 J. van Loon, C. Siedschlag, J. Stroom, H. Blauwgeers, R.J. van Suylen, J. Knegjens, 
M. Rossi, A. van Baardwijk, L. Boersma, H. Klomp, W. Vogel, S. Burgers, K. Gilhuijs, 2440 
"Microscopic Disease Extension in Three Dimensions for Non-Small-Cell Lung 
Cancer: Development of a Prediction Model Using Pathology-Validated Positron 
Emission Tomography and Computed Tomography Features," Int J Radiat Oncol Biol 
Phys 82, 448-456 (2012). 
194
 M. Axente, J. He, C.P. Bass, G. Sundaresan, J. Zweit, J.F. Williamson, A. Pugachev, 2445 
"An alternative approach to histopathological validation of PET imaging for radiation 
therapy image-guidance: a proof of concept," Radiother Oncol 110, 309-316 (2014). 
195
 L.M. Fanchon, S. Dogan, A.L. Moreira, S.A. Carlin, C.R. Schmidtlein, E. Yorke, A.P. 
Apte, I.A. Burger, J.C. Durack, J.P. Erinjeri, M. Maybody, H. Schoder, R.H. 
Siegelbaum, C.T. Sofocleous, J.O. Deasy, S.B. Solomon, J.L. Humm, A.S. Kirov, 2450 
"Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology 
by quantitative autoradiography of biopsy specimens obtained under 18F-FDG 
PET/CT guidance," J Nucl Med 56, 538-544 (2015). 
196
 M.-P. Dubuisson, A.K. Jain, "“A Modified Hausdorff Distance for Object Matching,” " 
Pattern Recognition, 1994. Vol. 1 - Conference A: Computer Vision &amp; Image 2455 
Processing., Proceedings of the 12th IAPR International Conference on pp. 566-568, 
(1994). 
197
 Kim H, J.I. Monroe, S. Lo, M. Yao, P.M. Harari, M. Machtay, J.W. Sohn, "Quantitative 
evaluation of image segmentation incorporating medical consideration functions," 
Medical Physics 42, 3013 (2015); doi: 10.1118/1.49210. 2460 
198
 V. Gregoire, R. Jeraj, J.A. Lee, B. O'Sullivan, "Radiotherapy for head and neck 
tumours in 2012 and beyond: conformal, tailored, and adaptive?," The lancet 
oncology 13, e292-300 (2012). 
199
 A. Skretting, J.F. Evensen, A.M. Londalen, T.V. Bogsrud, O.K. Glomset, K. Eilertsen, 
"A gel tumour phantom for assessment of the accuracy of manual and automatic 2465 
delineation of gross tumour volume from FDG-PET/CT," Acta Oncol 52, 636-644 
(2013). 
200
 S. David, D. Visvikis, C. Roux, M. Hatt, "Multi-observation PET image analysis for 
patient follow-up quantitation and therapy assessment," Phys Med Biol 56, 5771-5788 
(2011). 2470 
201
 S. David, D. Visvikis, G. Quellec, C.C. Le Rest, P. Fernandez, M. Allard, C. Roux, M. 
Hatt, "Image Change Detection Using Paradoxical Theory for Patient Follow-Up 
Quantitation and Therapy Assessment," Ieee Transactions on Medical Imaging 31, 
1743-1753 (2012). 
202
 B. Lelandais, I. Gardin, L. Mouchard, P. Vera, S. Ruan, "Segmentation of biological 2475 
target volumes on multi-tracer PET images based on information fusion for achieving 
dose painting in radiotherapy," Medical image computing and computer-assisted 
intervention : MICCAI ... International Conference on Medical Image Computing and 
Computer-Assisted Intervention 15, 545-552 (2012). 
203
 V. Frings, A.J. de Langen, E.F. Smit, F.H. van Velden, O.S. Hoekstra, H. van 2480 
Tinteren, R. Boellaard, "Repeatability of metabolically active volume measurements 
with 18F-FDG and 18F-FLT PET in non-small cell lung cancer," J Nucl Med 51, 1870-
1877 (2010). 
204
 M. Hatt, C. Cheze-Le Rest, E.O. Aboagye, L.M. Kenny, L. Rosso, F.E. Turkheimer, 
N.M. Albarghach, J.P. Metges, O. Pradier, D. Visvikis, "Reproducibility of 18F-FDG 2485 
and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements," J Nucl Med 
51, 1368-1376 (2010). 
205
 A.J. Buckler, R. Boellaard, "Standardization of Quantitative Imaging: The Time Is 
Right, and F-18-FDG PET/CT Is a Good Place to Start," Journal of Nuclear Medicine 
52, 171-172 (2011). 2490 
 71 
 
206
 R.L. Wahl, H. Jacene, Y. Kasamon, M.A. Lodge, "From RECIST to PERCIST: 
Evolving Considerations for PET Response Criteria in Solid Tumors," Journal of 
Nuclear Medicine 50, 122s-150s (2009). 
207
 C.R. MacFarlane, R. American College of, "ACR accreditation of nuclear medicine 
and PET imaging departments," Journal of nuclear medicine technology 34, 18-24 2495 
(2006). 
208
 H.H. Barrett, "Objective assessment of image quality: effects of quantum noise and 
object variability," Journal of the Optical Society of America. A, Optics and image 
science 7, 1266-1278 (1990). 
209
 H.H. Barrett, C.K. Abbey, E. Clarkson, "Objective assessment of image quality. III. 2500 
ROC metrics, ideal observers, and likelihood-generating functions," Journal of the 
Optical Society of America. A, Optics, image science, and vision 15, 1520-1535 
(1998). 
210
 H.H. Barrett, J.L. Denny, R.F. Wagner, K.J. Myers, "Objective assessment of image 
quality. II. Fisher information, Fourier crosstalk, and figures of merit for task 2505 
performance," Journal of the Optical Society of America. A, Optics, image science, 
and vision 12, 834-852 (1995). 
211
 H.H. Barrett, M.A. Kupinski, S. Mueller, H.J. Halpern, J.C. Morris, R. Dwyer, 
"Objective assessment of image quality VI: imaging in radiation therapy," Phys Med 
Biol 58, 8197-8213 (2013). 2510 
212
 J.A. Fessler, W.L. Rogers, "Spatial resolution properties of penalized-likelihood image 
reconstruction: Space-invariant tomographs," Ieee T Image Process 5, 1346-1358 
(1996). 
213
 H.H. Barrett, D.W. Wilson, B.M.W. Tsui, "Noise Properties of the Em Algorithm .1. 
Theory," Phys Med Biol 39, 833-846 (1994). 2515 
214
 D.F. Yu, J.A. Fessler, "Edge-preserving tomographic reconstruction with nonlocal 
regularization," IEEE Trans Med Imaging 21, 159-173 (2002). 
215
 J.A. Fessler, E.P. Ficaro, N.H. Clinthorne, K. Lange, "Grouped-coordinate ascent 
algorithms for penalized-likelihood transmission image reconstruction," IEEE Trans 
Med Imaging 16, 166-175 (1997). 2520 
216
 A. Krol, S. Li, L. Shen, Y. Xu, "Preconditioned Alternating Projection Algorithms for 
Maximum a Posteriori ECT Reconstruction," Inverse problems 28, 115005 (2012). 
217
 E. Rapisarda, L. Presotto, E. De Bernardi, M.C. Gilardi, V. Bettinardi, "Optimized 
Bayes variational regularization prior for 3D PET images," Computerized Medical 
Imaging and Graphics 38, 445-457 (2014). 2525 
218
 S. Ahn, S.G. Ross, E. Asma, J. Miao, X. Jin, L.S. Cheng, S.D. Wollenweber, R.M. 
Manjeshwar, "Quantitative comparison of OSEM and penalized likelihood image 
reconstruction using relative difference penalties for clinical PET," Phys Med Biol 60, 
5733-5751 (2015). 
219
 A.I. Arens, E.G. Troost, B.A. Hoeben, W. Grootjans, J.A. Lee, V. Gregoire, M. Hatt, D. 2530 
Visvikis, J. Bussink, W.J. Oyen, J.H. Kaanders, E.P. Visser, "Semiautomatic methods 
for segmentation of the proliferative tumour volume on sequential FLT PET/CT 
images in head and neck carcinomas and their relation to clinical outcome," Eur J 
Nucl Med Mol Imaging 41, 915-924 (2014). 
220
 B. Henriques de Figueiredo, C. Zacharatou, S. Galland-Girodet, J. Benech, H. De 2535 
Clermont-Gallerande, F. Lamare, M. Hatt, L. Digue, E. De Mones del Pujol, P. 
Fernandez, "Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with 
intensity-modulated radiotherapy in head-and-neck cancers," Strahlentherapie und 
Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 191, 217-224 (2015). 
221
 D.A. Low, M. Nystrom, E. Kalinin, P. Parikh, J.F. Dempsey, J.D. Bradley, S. Mutic, 2540 
S.H. Wahab, T. Islam, G. Christensen, D.G. Politte, B.R. Whiting, "A method for the 
reconstruction of four-dimensional synchronized CT scans acquired during free 
breathing," Medical physics 30, 1254-1263 (2003). 
222
 N. Wink, C. Panknin, T.D. Solberg, "Phase versus amplitude sorting of 4D-CT data," 
Journal of applied clinical medical physics / American College of Medical Physics 7, 2545 
77-85 (2006). 
 72 
 
223
 J.R. Olsen, W. Lu, J.P. Hubenschmidt, M.M. Nystrom, P. Klahr, J.D. Bradley, D.A. 
Low, P.J. Parikh, "Effect of novel amplitude/phase binning algorithm on commercial 
four-dimensional computed tomography quality," International journal of radiation 
oncology, biology, physics 70, 243-252 (2008). 2550 
224
 S.A. Nehmeh, Y.E. Erdi, K.E. Rosenzweig, H. Schoder, S.M. Larson, O.D. Squire, 
J.L. Humm, "Reduction of respiratory motion artifacts in PET imaging of lung cancer 
by respiratory correlated dynamic PET: Methodology and comparison with respiratory 
gated PET," Journal of Nuclear Medicine 44, 1644-1648 (2003). 
225
 F. Qiao, T. Pan, J.W. Clark Jr., O.R. Mawlawi, "A motion-incorporated reconstruction 2555 
method for gated PET studies," Physics in medicine and biology, 3769 (2006). 
226
 C. Pai-Chun Melinda, M. Osama, A.N. Sadek, E.E. Yusuf, A.B. Peter, L. Dershan, M. 
Radhe, P. Tinsu, "Design of respiration averaged CT for attenuation correction of the 
PET data from PET/CT," Med Phys 34, 2039-2047 (2007). 
227
 K. Berlinger, O. Sauer, L. Vences, M. Roth, "A simple method for labeling CT images 2560 
with respiratory states," Med Phys 33, 3144-3148 (2006). 
228
 F. Qiao, T. Pan, J.J.W. Clark, O. Mawlawi, "Joint model of motion and anatomy for 
PET image reconstruction," Med Phys 34, 4626-4639 (2007). 
229
 M. Dawood, F. Buther, N. Lang, O. Schober, K.P. Schafers, "Respiratory gating in 
positron emission tomography: A quantitative comparison of different gating 2565 
schemes," Med Phys 34, 3067-3076 (2007). 
230
 P.P. Bruyant, C.C.L. Rest, A. Turzo, P. Jarritt, K. Carson, D. Visvikis, "A method for 
synchronizing an external respiratory signal with a list-mode PET acquisition," Med 
Phys 34, 4472-4475 (2007). 
231
 S.A. Nehmeh, Y.E. Erdi, G.S. Meirelles, O. Squire, S.M. Larson, J.L. Humm, H. 2570 
Schoder, "Deep-inspiration breath-hold PET/CT of the thorax," J Nucl Med 48, 22-26 
(2007). 
232
 W. Sureshbabu, O. Mawlawi, "PET/CT imaging artifacts," J Nucl Med Technol 33, 
156-161; quiz 163-154 (2005). 
233
 G. Chang, T. Chang, T. Pan, J.W. Clark, Jr., O.R. Mawlawi, "Implementation of an 2575 
automated respiratory amplitude gating technique for PET/CT: clinical evaluation," 
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 51, 16-
24 (2010). 
234
 F. Buther, I. Ernst, M. Dawood, P. Kraxner, M. Schafers, O. Schober, K.P. Schafers, 
"Detection of respiratory tumour motion using intrinsic list mode-driven gating in 2580 
positron emission tomography," Eur J Nucl Med Mol I 37, 2315-2327 (2010). 
235
 P.J. Schleyer, M.J. O'Doherty, S.F. Barrington, P.K. Marsden, "Retrospective data-
driven respiratory gating for PET/CT," Physics in medicine and biology 54, 1935-1950 
(2009). 
236
 A.L. Kesner, C. Kuntner, "A new fast and fully automated software based algorithm 2585 
for extracting respiratory signal from raw PET data and its comparison to other 
methods," Med Phys 37, 5550-5559 (2010). 
237
 I. El Naqa, D.A. Low, J.D. Bradley, M. Vicic, J.O. Deasy, "Deblurring of breathing 
motion artifacts in thoracic PET images by deconvolution methods," Medical Physics 
33, 3587-3600 (2006). 2590 
238
 P.K. Yalavarthy, D. Low, C. Noel, W. Zhouping, Y. Deshan, A. Apte, J. Bradley, J. 
Deasy, I. El Naqa, "Current role of PET in oncology: Potentials and challenges in the 
management of non-small cell lung cancer," 2008 42nd Asilomar Conference on 
Signals, Systems and Computers, 1067-1071 (2008). 
239
 F. Buther, T. Vehren, K.P. Schafers, M. Schafers, "Impact of Data-driven Respiratory 2595 
Gating in Clinical PET," Radiology, 152067 (2016). 
240
 A.L. Kesner, J.H. Chung, K.E. Lind, J.J. Kwak, D. Lynch, D. Burckhardt, P.J. Koo, 
"Validation of Software Gating: A Practical Technology for Respiratory Motion 
Correction in PET," Radiology, 152105 (2016). 
241
 A.L. Kesner, P.J. Schleyer, F. Buther, M.A. Walter, K.P. Schafers, P.J. Koo, "On 2600 
transcending the impasse of respiratory motion correction applications in routine 
 73 
 
clinical imaging - a consideration of a fully automated data driven motion control 
framework," EJNMMI physics 1, 8 (2014). 
242
 M. Aristophanous, J.T. Yap, J.H. Killoran, A.B. Chen, R.I. Berbeco, "Four-dimensional 
positron emission tomography: implications for dose painting of high-uptake regions," 2605 
Int J Radiat Oncol Biol Phys 80, 900-908 (2011). 
243
 M. Aristophanous, R.I. Berbeco, J.H. Killoran, J.T. Yap, D.J. Sher, A.M. Allen, E. 
Larson, A.B. Chen, "Clinical utility of 4D FDG-PET/CT scans in radiation treatment 
planning," Int J Radiat Oncol Biol Phys 82, e99-105 (2012). 
244
 J.M. Lamb, C. Robinson, J. Bradley, R. Laforest, F. Dehdashti, B.M. White, S. 2610 
Wuenschel, D.A. Low, "Generating lung tumor internal target volumes from 4D-PET 
maximum intensity projections," Med Phys 38, 5732-5737 (2011). 
245
 L. Guerra, S. Meregalli, A. Zorz, R. Niespolo, E. De Ponti, F. Elisei, S. Morzenti, S. 
Brenna, A. Crespi, G. Gardani, C. Messa, "Comparative evaluation of CT-based and 
respiratory-gated PET/CT-based planning target volume (PTV) in the definition of 2615 
radiation treatment planning in lung cancer: preliminary results," Eur J Nucl Med Mol 
Imaging 41, 702-710 (2014). 
246
 A. Chirindel, S. Adebahr, D. Schuster, T. Schimek-Jasch, D.H. Schanne, U. Nemer, 
M. Mix, P. Meyer, A.L. Grosu, T. Brunner, U. Nestle, "Impact of 4D-(18)FDG-PET/CT 
imaging on target volume delineation in SBRT patients with central versus peripheral 2620 
lung tumors. Multi-reader comparative study," Radiother Oncol 115, 335-341 (2015). 
247
 L.A. Pierce, 2nd, B.F. Elston, D.A. Clunie, D. Nelson, P.E. Kinahan, "A Digital 
Reference Object to Analyze Calculation Accuracy of PET Standardized Uptake 
Value," Radiology, 141262 (2015). 
248
 N. Withofs, C. Bernard, C. Van der Rest, P. Martinive, M. Hatt, S. Jodogne, D. 2625 
Visvikis, J.A. Lee, P.A. Coucke, R. Hustinx, "FDG PET/CT for rectal carcinoma 
radiotherapy treatment planning: comparison of functional volume delineation 
algorithms and clinical challenges," Journal of applied clinical medical physics / 
American College of Medical Physics 15, 4696 (2014). 
249
 T. Shepherd, B. Berthon, P. Galavis, E. Spezi, A. Apte, J. Lee, D. Visvikis, M. Hatt, E. 2630 
de Bernardi, S. Das, I. El Naqa, U. Nestle, C.R. Schmidtlein, H. Zaidi, A. Kirov, 
"Design of a Benchmark Platform for Evaluating PET-based Contouring Accuracy in 
Oncology Applications, presented at the European  Association for Nuclear Medicine 
Annual Congress, 27-31 Oct.,  Milan, Italy," Eur. J. Nucl Med Mol Imaging, 39, S264 
(2012). 2635 
250
 B. Berthon, E. Spezi, C.R. Schmidtlein, A. Apte, P. Galavis, H. Zaidi, E. De Bernardi, 
J.A. Lee, A. Kirov, "Development of a software platform for evaluating automatic PET 
segmentation methods," European Society for Radiotherapy and Oncology Meeting 
2013, Radiotherapy and Oncology 111, S166 (2013). 
251
 M. Mamede, E.L.P. Abreu, M.R. Oliva, V. Nose, H. Mamon, V.H. Gerbaudo, "FDG-2640 
PET/CT tumor segmentation-derived indices of metabolic activity to assess response 
to neoadjuvant therapy and progression-free survival in esophageal cancer: 
correlation with histopathology results," Am J Clin Oncol 30, 377-388 (2007). 
252
 H. Necib, C. Garcia, A. Wagner, B. Vanderlinden, P. Emonts, A. Hendlisz, P. Flamen, 
I. Buvat, "Detection and characterization of tumor changes in 18F-FDG PET patient 2645 
monitoring using parametric imaging," J Nucl Med 52, 354-361 (2011). 
253
 H.M. Mi, C. Petitjean, P. Vera, S. Ruan, "Joint tumor growth prediction and tumor 
segmentation on therapeutic follow-up PET images," Medical image analysis 23, 84-
91 (2015). 
254
 H.M. Mi, C. Petitjean, B. Dubray, P. Vera, S. Ruan, "Prediction of Lung Tumor 2650 
Evolution During Radiotherapy in Individual Patients With PET," Ieee Transactions on 
Medical Imaging 33, 995-1003 (2014). 
255
 F. Sampedro, S. Escalera, A. Domenech, I. Carrio, "A computational framework for 
cancer response assessment based on oncological PET-CT scans," Comput Biol 
Med 55, 92-99 (2014). 2655 
256
 P. Obara, H. Liu, K. Wroblewski, C.P. Zhang, P. Hou, Y. Jiang, P. Chen, Y. Pu, 
"Quantification of metabolic tumor activity and burden in patients with non-small-cell 
 74 
 
lung cancer: Is manual adjustment of semiautomatic gradient-based measurements 
necessary?," Nucl Med Commun 36, 782-789 (2015). 
257
 R.R. Beichel, M. Van Tol, E.J. Ulrich, C. Bauer, T. Chang, K.A. Plichta, B.J. Smith, 2660 
J.J. Sunderland, M.M. Graham, M. Sonka, J.M. Buatti, "Semiautomated segmentation 
of head and neck cancers in 18F-FDG PET scans: A just-enough-interaction 
approach," Med Phys 43, 2948 (2016). 
258
 A.I.J. Arens, E.G.C. Troost, B.A.W. Hoeben, W. Grootjans, J.A. Lee, V. Gregoire, M. 
Hatt, D. Visvikis, J. Bussink, W.J.G. Oyen, J.H.A.M. Kaanders, E.P. Visser, 2665 
"Semiautomatic methods for segmentation of the proliferative tumour volume on 
sequential FLT PET/CT images in head and neck carcinomas and their relation to 
clinical outcome," Eur J Nucl Med Mol I 41, 915-924 (2014). 
259
 L. Drever, D.M. Robinson, A. McEwan, W. Roa, "A local contrast based approach to 
threshold segmentation for PET target volume delineation," Med Phys 33, 1583-1594 2670 
(2006). 
260
 S. Vauclin, K. Doyeux, S. Hapdey, A. Edet-Sanson, P. Vera, I. Gardin, "Development 
of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: 
application to the comparison of three thresholding models," Phys Med Biol 54, 6901-
6916 (2009). 2675 
261
 I.A. Burger, H.A. Vargas, A. Apte, B.J. Beattie, J.L. Humm, M. Gonen, S.M. Larson, 
C. Ross Schmidtlein, "PET quantification with a histogram derived total activity metric: 
superior quantitative consistency compared to total lesion glycolysis with absolute or 
relative SUV thresholds in phantoms and lung cancer patients," Nuclear medicine and 
biology 41, 410-418 (2014). 2680 
262
 G. Li, C.R. Schmidtlein, I.A. Burger, C.A. Ridge, S.B. Solomon, J.L. Humm, 
"Assessing and accounting for the impact of respiratory motion on FDG uptake and 
viable volume for liver lesions in free-breathing PET using respiration-suspended PET 
images as reference," Medical Physics 41 (2014). 
263
 L. Drever, W. Roa, A. McEwan, D. Robinson, "Iterative threshold segmentation for 2685 
PET target volume delineation," Med Phys 34, 1253-1265 (2007). 
264
 N.C. Krak, R. Boellaard, O.S. Hoekstra, J.W. Twisk, C.J. Hoekstra, A.A. 
Lammertsma, "Effects of ROI definition and reconstruction method on quantitative 
outcome and applicability in a response monitoring trial," Eur J Nucl Med Mol Imaging 
32, 294-301 (2005). 2690 
265
 I.A. Burger, H.A. Vargas, B.J. Beattie, D.A. Goldman, J. Zheng, S.M. Larson, J.L. 
Humm, C.R. Schmidtlein, "How to assess background activity: introducing a 
histogram-based analysis as a first step for accurate one-step PET quantification," 
Nucl Med Commun 35, 316-324 (2013). 
266
 M. Vanderhoek, S.B. Perlman, R. Jeraj, "Impact of the definition of peak standardized 2695 
uptake value on quantification of treatment response," J Nucl Med 53, 4-11 (2012). 
267
 J. Seuntjens, H. Mohammed, S. Devic, N. Tomic, S. Aldelaijan, F. Deblois, J. 
Seuntjens, S. Lehnert, S. Faria, "Uptake Volume Histograms: A Novel Avenue 
Towards Delineation of Biological Target Volumes (BTV) in Radiotherapy," Med. 
Phys. 38, 3786 (2011). 2700 
268
 M. Miller, G. Hutchins, "3D Anatomically accurate phantoms for PET and SPECT 
imaging," IEEE Nuclear Science Symposium and Medical Imaging Conference 
Record, Proceedings paper, M26-8, p. 4252-4256, 49 ( (2007). 
269
 A. Le Maitre, W.P. Segars, S. Marache, A. Reilhac, J.M. Hatt, S. Tomei, C. Lartizien, 
D. Visvikis, "Incorporating Patient-Specific Variability in the Simulation of 2705 
RealisticWhole-Body 18F-FDG Distributions for Oncology Applications," Proceedings 
of the IEEE 97, 2026-2038 (2009). 
270
 P. Papadimitroulas, G. Loudos, A. Le Maitre, M. Hatt, F. Tixier, N. Efthimiou, G.C. 
Nikiforidis, D. Visvikis, G.C. Kagadis, "Investigation of realistic PET simulations 
incorporating tumor patient's specificity using anthropomorphic models: Creation of an 2710 
oncology database," Medical Physics 40 (2013). 
271
 J.R. Munkres, Topology (2nd ed.). (Prentice Hall, 1999). 
 75 
 
272
 N. Aspert, D. Santa-Cruz, T. Ebrahimi, "Mesh: Measuring errors between surfaces 
using the Hausdorff distance," Ieee International Conference on Multimedia and 
Expo, Vol I and Ii, Proceedings, 705-708 (2002). 2715 
 
